SK4032001A3 - Novel substituted indolinones with an inhibitory effect on various kinases and cyclin/cdk complexes - Google Patents
Novel substituted indolinones with an inhibitory effect on various kinases and cyclin/cdk complexes Download PDFInfo
- Publication number
- SK4032001A3 SK4032001A3 SK403-2001A SK4032001A SK4032001A3 SK 4032001 A3 SK4032001 A3 SK 4032001A3 SK 4032001 A SK4032001 A SK 4032001A SK 4032001 A3 SK4032001 A3 SK 4032001A3
- Authority
- SK
- Slovakia
- Prior art keywords
- alkyl
- substituted
- amino
- group
- alkylamino
- Prior art date
Links
- JYGFTBXVXVMTGB-UHFFFAOYSA-N indolin-2-one Chemical class C1=CC=C2NC(=O)CC2=C1 JYGFTBXVXVMTGB-UHFFFAOYSA-N 0.000 title claims abstract description 26
- 102000016736 Cyclin Human genes 0.000 title abstract description 9
- 108050006400 Cyclin Proteins 0.000 title abstract description 9
- 230000002401 inhibitory effect Effects 0.000 title abstract description 4
- 108091000080 Phosphotransferase Proteins 0.000 title description 4
- 102000020233 phosphotransferase Human genes 0.000 title description 4
- 150000001875 compounds Chemical class 0.000 claims abstract description 342
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 claims abstract description 254
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims abstract description 45
- 150000003839 salts Chemical class 0.000 claims abstract description 30
- 229940002612 prodrug Drugs 0.000 claims abstract description 4
- 239000000651 prodrug Substances 0.000 claims abstract description 4
- -1 carboxy- Chemical class 0.000 claims description 757
- 229910052757 nitrogen Inorganic materials 0.000 claims description 297
- 229910052739 hydrogen Inorganic materials 0.000 claims description 263
- 125000000217 alkyl group Chemical group 0.000 claims description 91
- 239000000460 chlorine Substances 0.000 claims description 60
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 45
- 125000006274 (C1-C3)alkoxy group Chemical group 0.000 claims description 42
- 125000006559 (C1-C3) alkylamino group Chemical group 0.000 claims description 39
- 229910052801 chlorine Inorganic materials 0.000 claims description 39
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 37
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 34
- 229910052794 bromium Inorganic materials 0.000 claims description 29
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 27
- 229910052731 fluorine Inorganic materials 0.000 claims description 27
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 26
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 19
- 239000011737 fluorine Substances 0.000 claims description 19
- 238000006243 chemical reaction Methods 0.000 claims description 18
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims description 17
- 239000001257 hydrogen Substances 0.000 claims description 17
- 229910052740 iodine Inorganic materials 0.000 claims description 17
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 17
- 125000003277 amino group Chemical group 0.000 claims description 16
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 16
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 16
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 claims description 15
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 15
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims description 14
- 125000001624 naphthyl group Chemical group 0.000 claims description 14
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 13
- 125000003282 alkyl amino group Chemical group 0.000 claims description 13
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims description 13
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 claims description 13
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 13
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 13
- 125000001424 substituent group Chemical group 0.000 claims description 12
- 238000006467 substitution reaction Methods 0.000 claims description 12
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 11
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims description 11
- 238000000034 method Methods 0.000 claims description 11
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 11
- 150000001412 amines Chemical class 0.000 claims description 10
- 125000005122 aminoalkylamino group Chemical group 0.000 claims description 10
- 125000004430 oxygen atom Chemical group O* 0.000 claims description 10
- 125000003118 aryl group Chemical group 0.000 claims description 8
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 8
- 125000001153 fluoro group Chemical group F* 0.000 claims description 8
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 8
- 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 claims description 7
- 150000002148 esters Chemical class 0.000 claims description 7
- 125000006239 protecting group Chemical group 0.000 claims description 7
- 125000006526 (C1-C2) alkyl group Chemical group 0.000 claims description 6
- 125000006842 cycloalkyleneimino group Chemical group 0.000 claims description 6
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 claims description 6
- 125000005544 phthalimido group Chemical group 0.000 claims description 6
- 125000000587 piperidin-1-yl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 6
- 125000004769 (C1-C4) alkylsulfonyl group Chemical group 0.000 claims description 5
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims description 5
- 230000010933 acylation Effects 0.000 claims description 5
- 238000005917 acylation reaction Methods 0.000 claims description 5
- 125000003545 alkoxy group Chemical group 0.000 claims description 5
- 125000001841 imino group Chemical group [H]N=* 0.000 claims description 5
- 150000003951 lactams Chemical group 0.000 claims description 5
- 125000006518 morpholino carbonyl group Chemical group [H]C1([H])OC([H])([H])C([H])([H])N(C(*)=O)C1([H])[H] 0.000 claims description 5
- 239000008194 pharmaceutical composition Substances 0.000 claims description 5
- 125000003170 phenylsulfonyl group Chemical group C1(=CC=CC=C1)S(=O)(=O)* 0.000 claims description 5
- 239000002243 precursor Chemical group 0.000 claims description 5
- 239000007790 solid phase Chemical group 0.000 claims description 5
- 229910052717 sulfur Inorganic materials 0.000 claims description 5
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical compound [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 claims description 4
- 125000004457 alkyl amino carbonyl group Chemical group 0.000 claims description 4
- 230000029936 alkylation Effects 0.000 claims description 4
- 238000005804 alkylation reaction Methods 0.000 claims description 4
- 239000000969 carrier Substances 0.000 claims description 4
- 239000003085 diluting agent Substances 0.000 claims description 4
- 230000032050 esterification Effects 0.000 claims description 4
- 238000005886 esterification reaction Methods 0.000 claims description 4
- 125000005241 heteroarylamino group Chemical group 0.000 claims description 4
- 239000000126 substance Substances 0.000 claims description 4
- 125000004434 sulfur atom Chemical group 0.000 claims description 4
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 claims description 4
- YZQYLXVWTQKHNY-QPLCGJKRSA-N (3z)-3-[[4-(2-morpholin-4-ylethyl)anilino]-phenylmethylidene]-5-nitro-1h-indol-2-one Chemical compound C12=CC([N+](=O)[O-])=CC=C2NC(=O)\C1=C(C=1C=CC=CC=1)/NC(C=C1)=CC=C1CCN1CCOCC1 YZQYLXVWTQKHNY-QPLCGJKRSA-N 0.000 claims description 3
- HNCRQCVXZXSJRP-FCQUAONHSA-N (3z)-3-[[4-[(dimethylamino)methyl]anilino]-phenylmethylidene]-5-nitro-1h-indol-2-one Chemical compound C1=CC(CN(C)C)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC([N+]([O-])=O)=CC=C2NC\1=O HNCRQCVXZXSJRP-FCQUAONHSA-N 0.000 claims description 3
- JUXFRGURUWQIRC-VHXPQNKSSA-N (3z)-3-[[4-[2-(dimethylamino)ethyl]anilino]-phenylmethylidene]-5-nitro-1h-indol-2-one Chemical compound C1=CC(CCN(C)C)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC([N+]([O-])=O)=CC=C2NC\1=O JUXFRGURUWQIRC-VHXPQNKSSA-N 0.000 claims description 3
- 125000006602 (C1-C3) alkylsulfonylamino group Chemical group 0.000 claims description 3
- 125000006272 (C3-C7) cycloalkyl group Chemical group 0.000 claims description 3
- 230000009435 amidation Effects 0.000 claims description 3
- 238000007112 amidation reaction Methods 0.000 claims description 3
- 230000004663 cell proliferation Effects 0.000 claims description 3
- 125000005843 halogen group Chemical group 0.000 claims description 3
- 230000007062 hydrolysis Effects 0.000 claims description 3
- 238000006460 hydrolysis reaction Methods 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 125000006525 methoxy ethyl amino group Chemical group [H]N(*)C([H])([H])C([H])([H])OC([H])([H])[H] 0.000 claims description 3
- SGVAUCIEUYKEQF-IZHYLOQSSA-N n-[2-(dimethylamino)ethyl]-n-[4-[[(z)-(2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]phenyl]methanesulfonamide Chemical compound C1=CC(N(CCN(C)C)S(C)(=O)=O)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC=CC=C2NC\1=O SGVAUCIEUYKEQF-IZHYLOQSSA-N 0.000 claims description 3
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims description 3
- 229910052760 oxygen Inorganic materials 0.000 claims description 3
- 125000006603 (C1-C3) alkylaminosulfonyl group Chemical group 0.000 claims description 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims description 2
- 125000004209 (C1-C8) alkyl group Chemical group 0.000 claims description 2
- 125000006592 (C2-C3) alkenyl group Chemical group 0.000 claims description 2
- 125000003006 2-dimethylaminoethyl group Chemical group [H]C([H])([H])N(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 claims description 2
- QOXOZONBQWIKDA-UHFFFAOYSA-N 3-hydroxypropyl Chemical group [CH2]CCO QOXOZONBQWIKDA-UHFFFAOYSA-N 0.000 claims description 2
- 230000002159 abnormal effect Effects 0.000 claims description 2
- 150000003855 acyl compounds Chemical class 0.000 claims description 2
- 125000002947 alkylene group Chemical group 0.000 claims description 2
- 125000004202 aminomethyl group Chemical group [H]N([H])C([H])([H])* 0.000 claims description 2
- 125000004429 atom Chemical group 0.000 claims description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 2
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 2
- 125000006310 cycloalkyl amino group Chemical group 0.000 claims description 2
- 125000001072 heteroaryl group Chemical group 0.000 claims description 2
- 125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 claims description 2
- 150000007522 mineralic acids Chemical class 0.000 claims description 2
- 150000007524 organic acids Chemical class 0.000 claims description 2
- 239000001301 oxygen Substances 0.000 claims description 2
- 125000004076 pyridyl group Chemical group 0.000 claims description 2
- 125000000714 pyrimidinyl group Chemical group 0.000 claims description 2
- 238000005932 reductive alkylation reaction Methods 0.000 claims description 2
- 230000002829 reductive effect Effects 0.000 claims description 2
- 125000005147 toluenesulfonyl group Chemical group C=1(C(=CC=CC1)S(=O)(=O)*)C 0.000 claims description 2
- 125000001589 carboacyl group Chemical group 0.000 claims 3
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 claims 2
- 125000004454 (C1-C6) alkoxycarbonyl group Chemical group 0.000 claims 1
- 125000004466 alkoxycarbonylamino group Chemical group 0.000 claims 1
- 125000004390 alkyl sulfonyl group Chemical group 0.000 claims 1
- 125000000440 benzylamino group Chemical group [H]N(*)C([H])([H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 claims 1
- 125000001721 carboxyacetyl group Chemical group 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 125000006260 ethylaminocarbonyl group Chemical group [H]N(C(*)=O)C([H])([H])C([H])([H])[H] 0.000 claims 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 claims 1
- 230000000144 pharmacologic effect Effects 0.000 abstract description 6
- 102000001253 Protein Kinase Human genes 0.000 abstract description 3
- 108060006633 protein kinase Proteins 0.000 abstract description 3
- 102000027426 receptor tyrosine kinases Human genes 0.000 abstract description 3
- 108091008598 receptor tyrosine kinases Proteins 0.000 abstract description 3
- 230000003612 virological effect Effects 0.000 abstract description 3
- 239000013067 intermediate product Substances 0.000 abstract 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 681
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 378
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 319
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 318
- 238000001819 mass spectrum Methods 0.000 description 293
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 171
- 229910052799 carbon Inorganic materials 0.000 description 161
- 239000000047 product Substances 0.000 description 153
- 238000002844 melting Methods 0.000 description 139
- 230000008018 melting Effects 0.000 description 139
- 239000000243 solution Substances 0.000 description 126
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 108
- 239000000741 silica gel Substances 0.000 description 107
- 229910002027 silica gel Inorganic materials 0.000 description 107
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 93
- 238000011282 treatment Methods 0.000 description 90
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 86
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 71
- 238000004458 analytical method Methods 0.000 description 66
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 57
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 48
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 47
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 45
- 239000002904 solvent Substances 0.000 description 45
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 42
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 42
- 239000011541 reaction mixture Substances 0.000 description 40
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 38
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 38
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 38
- RQFHATRKMMVQPC-UHFFFAOYSA-N 1-acetyl-3-[ethoxy(phenyl)methylidene]-5-nitroindol-2-one Chemical compound O=C1N(C(C)=O)C2=CC=C([N+]([O-])=O)C=C2C1=C(OCC)C1=CC=CC=C1 RQFHATRKMMVQPC-UHFFFAOYSA-N 0.000 description 33
- 235000011114 ammonium hydroxide Nutrition 0.000 description 33
- 239000000203 mixture Substances 0.000 description 33
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 30
- QNWGMJXVSLRFMR-UHFFFAOYSA-N 1-acetyl-3-[ethoxy(phenyl)methylidene]indol-2-one Chemical compound O=C1N(C(C)=O)C2=CC=CC=C2C1=C(OCC)C1=CC=CC=C1 QNWGMJXVSLRFMR-UHFFFAOYSA-N 0.000 description 27
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 27
- CQMHZLKNXHIIOT-UHFFFAOYSA-N 3-[ethoxy(phenyl)methylidene]-5-nitro-1h-indol-2-one Chemical compound O=C1NC2=CC=C([N+]([O-])=O)C=C2C1=C(OCC)C1=CC=CC=C1 CQMHZLKNXHIIOT-UHFFFAOYSA-N 0.000 description 25
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 25
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 24
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 22
- 229960000583 acetic acid Drugs 0.000 description 21
- 238000000354 decomposition reaction Methods 0.000 description 20
- 238000000967 suction filtration Methods 0.000 description 20
- 239000012317 TBTU Substances 0.000 description 19
- CLZISMQKJZCZDN-UHFFFAOYSA-N [benzotriazol-1-yloxy(dimethylamino)methylidene]-dimethylazanium Chemical compound C1=CC=C2N(OC(N(C)C)=[N+](C)C)N=NC2=C1 CLZISMQKJZCZDN-UHFFFAOYSA-N 0.000 description 19
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 18
- NPZTUJOABDZTLV-UHFFFAOYSA-N hydroxybenzotriazole Substances O=C1C=CC=C2NNN=C12 NPZTUJOABDZTLV-UHFFFAOYSA-N 0.000 description 18
- 239000012362 glacial acetic acid Substances 0.000 description 16
- NNCCQALFJIMRKB-UHFFFAOYSA-N 4-[(dimethylamino)methyl]aniline Chemical compound CN(C)CC1=CC=C(N)C=C1 NNCCQALFJIMRKB-UHFFFAOYSA-N 0.000 description 14
- 239000003054 catalyst Substances 0.000 description 14
- 238000001816 cooling Methods 0.000 description 14
- 239000002244 precipitate Substances 0.000 description 14
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 12
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 12
- 239000002253 acid Substances 0.000 description 12
- 125000002490 anilino group Chemical group [H]N(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 12
- 239000002585 base Substances 0.000 description 12
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 11
- 210000004027 cell Anatomy 0.000 description 11
- OANCBHUMQGJXQG-UHFFFAOYSA-N 1-acetyl-3-[methoxy(phenyl)methylidene]-5-nitroindol-2-one Chemical compound O=C1N(C(C)=O)C2=CC=C([N+]([O-])=O)C=C2C1=C(OC)C1=CC=CC=C1 OANCBHUMQGJXQG-UHFFFAOYSA-N 0.000 description 10
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 10
- UAOMVDZJSHZZME-UHFFFAOYSA-N diisopropylamine Substances CC(C)NC(C)C UAOMVDZJSHZZME-UHFFFAOYSA-N 0.000 description 10
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 9
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 9
- SJRJJKPEHAURKC-UHFFFAOYSA-N N-Methylmorpholine Chemical compound CN1CCOCC1 SJRJJKPEHAURKC-UHFFFAOYSA-N 0.000 description 9
- 238000003776 cleavage reaction Methods 0.000 description 9
- 239000012074 organic phase Substances 0.000 description 9
- 239000003208 petroleum Substances 0.000 description 9
- 230000007017 scission Effects 0.000 description 9
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 8
- 125000002252 acyl group Chemical group 0.000 description 8
- CBHOOMGKXCMKIR-UHFFFAOYSA-N azane;methanol Chemical compound N.OC CBHOOMGKXCMKIR-UHFFFAOYSA-N 0.000 description 8
- WBJINCZRORDGAQ-UHFFFAOYSA-N formic acid ethyl ester Natural products CCOC=O WBJINCZRORDGAQ-UHFFFAOYSA-N 0.000 description 8
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 8
- 238000010992 reflux Methods 0.000 description 8
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 8
- JWNSTRPJMURHFG-VXPUYCOJSA-N (3z)-3-[(4-aminoanilino)-phenylmethylidene]-1h-indol-2-one Chemical compound C1=CC(N)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC=CC=C2NC\1=O JWNSTRPJMURHFG-VXPUYCOJSA-N 0.000 description 7
- OEUVIWACIDHWEK-UHFFFAOYSA-N 1-acetyl-3-[chloro(phenyl)methylidene]indol-2-one Chemical compound C12=CC=CC=C2N(C(=O)C)C(=O)C1=C(Cl)C1=CC=CC=C1 OEUVIWACIDHWEK-UHFFFAOYSA-N 0.000 description 7
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 7
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 7
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 7
- 238000009903 catalytic hydrogenation reaction Methods 0.000 description 7
- 150000002168 ethanoic acid esters Chemical class 0.000 description 7
- 239000012071 phase Substances 0.000 description 7
- 239000012312 sodium hydride Substances 0.000 description 7
- 229910000104 sodium hydride Inorganic materials 0.000 description 7
- WIOYKFWBEJIPSC-UHFFFAOYSA-N 1-benzoyl-3-[chloro(phenyl)methylidene]indol-2-one Chemical compound C=1C=CC=CC=1C(Cl)=C(C1=CC=CC=C11)C(=O)N1C(=O)C1=CC=CC=C1 WIOYKFWBEJIPSC-UHFFFAOYSA-N 0.000 description 6
- GGWSFLUBMUADJZ-VXPUYCOJSA-N 3-[[(z)-(2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]benzoic acid Chemical compound OC(=O)C1=CC=CC(N\C(=C/2C3=CC=CC=C3NC\2=O)C=2C=CC=CC=2)=C1 GGWSFLUBMUADJZ-VXPUYCOJSA-N 0.000 description 6
- LKCAYVNUYKFCHK-UHFFFAOYSA-N 3-[ethoxy(phenyl)methylidene]-1h-indol-2-one Chemical compound O=C1NC2=CC=CC=C2C1=C(OCC)C1=CC=CC=C1 LKCAYVNUYKFCHK-UHFFFAOYSA-N 0.000 description 6
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 6
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 6
- AHGINQNOTUEATM-MRCUWXFGSA-N C1=CC(CN)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC([N+]([O-])=O)=CC=C2NC\1=O Chemical compound C1=CC(CN)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC([N+]([O-])=O)=CC=C2NC\1=O AHGINQNOTUEATM-MRCUWXFGSA-N 0.000 description 6
- 108010025468 Cyclin-Dependent Kinase 6 Proteins 0.000 description 6
- 102100026804 Cyclin-dependent kinase 6 Human genes 0.000 description 6
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 6
- ZTQSAGDEMFDKMZ-UHFFFAOYSA-N butyric aldehyde Natural products CCCC=O ZTQSAGDEMFDKMZ-UHFFFAOYSA-N 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- QKIUAMUSENSFQQ-UHFFFAOYSA-N dimethylazanide Chemical compound C[N-]C QKIUAMUSENSFQQ-UHFFFAOYSA-N 0.000 description 6
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 6
- 230000005764 inhibitory process Effects 0.000 description 6
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 6
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- 125000004044 trifluoroacetyl group Chemical group FC(C(=O)*)(F)F 0.000 description 6
- DISPNGORCUKYCX-VXPUYCOJSA-N (3z)-3-[(3-aminoanilino)-phenylmethylidene]-1h-indol-2-one Chemical compound NC1=CC=CC(N\C(=C/2C3=CC=CC=C3NC\2=O)C=2C=CC=CC=2)=C1 DISPNGORCUKYCX-VXPUYCOJSA-N 0.000 description 5
- FHMSKLNTXOVLBZ-FCQUAONHSA-N 2-[n-methylsulfonyl-4-[[(z)-(2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]anilino]acetic acid Chemical compound C1=CC(N(CC(O)=O)S(=O)(=O)C)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC=CC=C2NC\1=O FHMSKLNTXOVLBZ-FCQUAONHSA-N 0.000 description 5
- 108010025464 Cyclin-Dependent Kinase 4 Proteins 0.000 description 5
- 102100036252 Cyclin-dependent kinase 4 Human genes 0.000 description 5
- 239000007868 Raney catalyst Substances 0.000 description 5
- 229910000564 Raney nickel Inorganic materials 0.000 description 5
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 5
- 229940043279 diisopropylamine Drugs 0.000 description 5
- 238000006722 reduction reaction Methods 0.000 description 5
- 238000007127 saponification reaction Methods 0.000 description 5
- 239000011734 sodium Substances 0.000 description 5
- BEOOHQFXGBMRKU-UHFFFAOYSA-N sodium cyanoborohydride Chemical compound [Na+].[B-]C#N BEOOHQFXGBMRKU-UHFFFAOYSA-N 0.000 description 5
- 239000000758 substrate Substances 0.000 description 5
- 210000004881 tumor cell Anatomy 0.000 description 5
- NWZSZGALRFJKBT-KNIFDHDWSA-N (2s)-2,6-diaminohexanoic acid;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.NCCCC[C@H](N)C(O)=O NWZSZGALRFJKBT-KNIFDHDWSA-N 0.000 description 4
- DCTJTQZOTXKFGZ-MRCUWXFGSA-N (3z)-3-[[4-(aminomethyl)anilino]-phenylmethylidene]-1h-indol-2-one Chemical compound C1=CC(CN)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC=CC=C2NC\1=O DCTJTQZOTXKFGZ-MRCUWXFGSA-N 0.000 description 4
- NRWLXCRLJQEJHE-UHFFFAOYSA-N 1-acetyl-3h-indol-2-one Chemical compound C1=CC=C2N(C(=O)C)C(=O)CC2=C1 NRWLXCRLJQEJHE-UHFFFAOYSA-N 0.000 description 4
- CQESFAASTCHWKL-MRCUWXFGSA-N 3-[[(z)-(2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]benzonitrile Chemical compound O=C1NC2=CC=CC=C2\C1=C(C=1C=CC=CC=1)\NC1=CC=CC(C#N)=C1 CQESFAASTCHWKL-MRCUWXFGSA-N 0.000 description 4
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 4
- QYOIHOJGUJDOPM-VXPUYCOJSA-N 4-[[(z)-(2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC=CC=C2NC\1=O QYOIHOJGUJDOPM-VXPUYCOJSA-N 0.000 description 4
- 108010024986 Cyclin-Dependent Kinase 2 Proteins 0.000 description 4
- 102100036239 Cyclin-dependent kinase 2 Human genes 0.000 description 4
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 4
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical group NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 4
- AMIMRNSIRUDHCM-UHFFFAOYSA-N Isopropylaldehyde Chemical compound CC(C)C=O AMIMRNSIRUDHCM-UHFFFAOYSA-N 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- NBBJYMSMWIIQGU-UHFFFAOYSA-N Propionic aldehyde Chemical compound CCC=O NBBJYMSMWIIQGU-UHFFFAOYSA-N 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- BLFLLBZGZJTVJG-UHFFFAOYSA-N benzocaine Chemical compound CCOC(=O)C1=CC=C(N)C=C1 BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 description 4
- PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 4
- IQDGSYLLQPDQDV-UHFFFAOYSA-N dimethylazanium;chloride Chemical compound Cl.CNC IQDGSYLLQPDQDV-UHFFFAOYSA-N 0.000 description 4
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 4
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine monohydrate Substances O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 description 4
- NQMRYBIKMRVZLB-UHFFFAOYSA-N methylamine hydrochloride Chemical compound [Cl-].[NH3+]C NQMRYBIKMRVZLB-UHFFFAOYSA-N 0.000 description 4
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 4
- 229910052763 palladium Inorganic materials 0.000 description 4
- 229910052700 potassium Inorganic materials 0.000 description 4
- 229910000027 potassium carbonate Inorganic materials 0.000 description 4
- 230000035755 proliferation Effects 0.000 description 4
- 238000010898 silica gel chromatography Methods 0.000 description 4
- FWPIDFUJEMBDLS-UHFFFAOYSA-L tin(II) chloride dihydrate Chemical compound O.O.Cl[Sn]Cl FWPIDFUJEMBDLS-UHFFFAOYSA-L 0.000 description 4
- JVKQPQCTRCTUMD-VXPUYCOJSA-N (3z)-3-[(4-aminoanilino)-phenylmethylidene]-5-nitro-1h-indol-2-one Chemical compound C1=CC(N)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC([N+]([O-])=O)=CC=C2NC\1=O JVKQPQCTRCTUMD-VXPUYCOJSA-N 0.000 description 3
- ASOKPJOREAFHNY-UHFFFAOYSA-N 1-Hydroxybenzotriazole Chemical compound C1=CC=C2N(O)N=NC2=C1 ASOKPJOREAFHNY-UHFFFAOYSA-N 0.000 description 3
- IQFYYKKMVGJFEH-OYDXRQHMSA-N 1-[(2r,4s,5s)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H]([14CH2]O)[C@@H](O)C1 IQFYYKKMVGJFEH-OYDXRQHMSA-N 0.000 description 3
- NBFVFIMXPGSTOC-UHFFFAOYSA-N 1-acetyl-5-nitro-3h-indol-2-one Chemical compound [O-][N+](=O)C1=CC=C2N(C(=O)C)C(=O)CC2=C1 NBFVFIMXPGSTOC-UHFFFAOYSA-N 0.000 description 3
- AMYQISBOZHIMDW-UHFFFAOYSA-N 2-[[4-[(1-acetyl-5-nitro-2-oxoindol-3-ylidene)-chloromethyl]phenyl]methyl]isoindole-1,3-dione Chemical compound C12=CC([N+]([O-])=O)=CC=C2N(C(=O)C)C(=O)C1=C(Cl)C(C=C1)=CC=C1CN1C(=O)C2=CC=CC=C2C1=O AMYQISBOZHIMDW-UHFFFAOYSA-N 0.000 description 3
- YRTORNKKGFKARW-FCQUAONHSA-N 2-[n-methylsulfonyl-4-[[(z)-(5-nitro-2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]anilino]acetic acid Chemical compound C1=CC(N(CC(O)=O)S(=O)(=O)C)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC([N+]([O-])=O)=CC=C2NC\1=O YRTORNKKGFKARW-FCQUAONHSA-N 0.000 description 3
- BYHQTRFJOGIQAO-GOSISDBHSA-N 3-(4-bromophenyl)-8-[(2R)-2-hydroxypropyl]-1-[(3-methoxyphenyl)methyl]-1,3,8-triazaspiro[4.5]decan-2-one Chemical compound C[C@H](CN1CCC2(CC1)CN(C(=O)N2CC3=CC(=CC=C3)OC)C4=CC=C(C=C4)Br)O BYHQTRFJOGIQAO-GOSISDBHSA-N 0.000 description 3
- WOYHSQKKHZAMOR-UHFFFAOYSA-N 4-[3-(dimethylamino)prop-1-ynyl]aniline Chemical compound CN(C)CC#CC1=CC=C(N)C=C1 WOYHSQKKHZAMOR-UHFFFAOYSA-N 0.000 description 3
- YBAZINRZQSAIAY-UHFFFAOYSA-N 4-aminobenzonitrile Chemical compound NC1=CC=C(C#N)C=C1 YBAZINRZQSAIAY-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 108091007914 CDKs Proteins 0.000 description 3
- 108010058546 Cyclin D1 Proteins 0.000 description 3
- 108010058545 Cyclin D3 Proteins 0.000 description 3
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 3
- QMMFVYPAHWMCMS-UHFFFAOYSA-N Dimethyl sulfide Chemical compound CSC QMMFVYPAHWMCMS-UHFFFAOYSA-N 0.000 description 3
- 102100024165 G1/S-specific cyclin-D1 Human genes 0.000 description 3
- 102100037859 G1/S-specific cyclin-D3 Human genes 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 3
- 229910021529 ammonia Inorganic materials 0.000 description 3
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 3
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 3
- 238000009835 boiling Methods 0.000 description 3
- HQABUPZFAYXKJW-UHFFFAOYSA-N butan-1-amine Chemical compound CCCCN HQABUPZFAYXKJW-UHFFFAOYSA-N 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- VNCJFMWKJVHAFO-VHXPQNKSSA-N ethyl 2-[3-[[(z)-(2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]phenyl]acetate Chemical compound CCOC(=O)CC1=CC=CC(N\C(=C/2C3=CC=CC=C3NC\2=O)C=2C=CC=CC=2)=C1 VNCJFMWKJVHAFO-VHXPQNKSSA-N 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- STBXWCPKHDZQSX-UHFFFAOYSA-N n-(4-aminophenyl)-2-morpholin-4-ylacetamide Chemical compound C1=CC(N)=CC=C1NC(=O)CN1CCOCC1 STBXWCPKHDZQSX-UHFFFAOYSA-N 0.000 description 3
- UHZYTMXLRWXGPK-UHFFFAOYSA-N phosphorus pentachloride Chemical compound ClP(Cl)(Cl)(Cl)Cl UHZYTMXLRWXGPK-UHFFFAOYSA-N 0.000 description 3
- 229910052697 platinum Inorganic materials 0.000 description 3
- 229920005990 polystyrene resin Polymers 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 3
- 239000011975 tartaric acid Substances 0.000 description 3
- 235000002906 tartaric acid Nutrition 0.000 description 3
- WIVYTYZCVWHWSH-UHFFFAOYSA-N tert-butyl n-(4-aminophenyl)carbamate Chemical compound CC(C)(C)OC(=O)NC1=CC=C(N)C=C1 WIVYTYZCVWHWSH-UHFFFAOYSA-N 0.000 description 3
- WPEGHQMOTZMIDX-IZHYLOQSSA-N tert-butyl n-[[4-[[(z)-[4-(aminomethyl)phenyl]-(5-nitro-2-oxo-1h-indol-3-ylidene)methyl]amino]phenyl]methyl]carbamate Chemical compound C1=CC(CNC(=O)OC(C)(C)C)=CC=C1N\C(C=1C=CC(CN)=CC=1)=C/1C2=CC([N+]([O-])=O)=CC=C2NC\1=O WPEGHQMOTZMIDX-IZHYLOQSSA-N 0.000 description 3
- ZMCBYSBVJIMENC-UHFFFAOYSA-N tricaine Chemical compound CCOC(=O)C1=CC=CC(N)=C1 ZMCBYSBVJIMENC-UHFFFAOYSA-N 0.000 description 3
- 241000701447 unidentified baculovirus Species 0.000 description 3
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 2
- HZYYGWRRTPETCK-VXPUYCOJSA-N (3z)-3-[(4-chloroanilino)-phenylmethylidene]-5-nitro-1h-indol-2-one Chemical compound C12=CC([N+](=O)[O-])=CC=C2NC(=O)\C1=C(C=1C=CC=CC=1)/NC1=CC=C(Cl)C=C1 HZYYGWRRTPETCK-VXPUYCOJSA-N 0.000 description 2
- CVCFEUIATAMBTM-MRCUWXFGSA-N (3z)-3-[(4-methoxyanilino)-phenylmethylidene]-1h-indol-2-one Chemical compound C1=CC(OC)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC=CC=C2NC\1=O CVCFEUIATAMBTM-MRCUWXFGSA-N 0.000 description 2
- FPDNXGSNEKKVOW-MRCUWXFGSA-N (3z)-3-[[3-(methylamino)anilino]-phenylmethylidene]-1h-indol-2-one Chemical compound CNC1=CC=CC(N\C(=C/2C3=CC=CC=C3NC\2=O)C=2C=CC=CC=2)=C1 FPDNXGSNEKKVOW-MRCUWXFGSA-N 0.000 description 2
- UWUHCQWBMCWQIO-CFRCJOIHSA-N (3z)-3-[[4-(aminomethyl)anilino]-phenylmethylidene]-5-nitro-1h-indol-2-one;hydrochloride Chemical compound Cl.C1=CC(CN)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC([N+]([O-])=O)=CC=C2NC\1=O UWUHCQWBMCWQIO-CFRCJOIHSA-N 0.000 description 2
- BSTIBGTZWMWAAY-IZHYLOQSSA-N (3z)-3-[[4-[(1,1-dioxo-1,4-thiazinan-4-yl)methyl]anilino]-phenylmethylidene]-5-nitro-1h-indol-2-one Chemical compound C12=CC([N+](=O)[O-])=CC=C2NC(=O)\C1=C(C=1C=CC=CC=1)/NC(C=C1)=CC=C1CN1CCS(=O)(=O)CC1 BSTIBGTZWMWAAY-IZHYLOQSSA-N 0.000 description 2
- WPOQFKYZFKHODE-FCQUAONHSA-N (3z)-3-[[4-[2-(methylamino)ethyl]anilino]-phenylmethylidene]-5-nitro-1h-indol-2-one Chemical compound C1=CC(CCNC)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC([N+]([O-])=O)=CC=C2NC\1=O WPOQFKYZFKHODE-FCQUAONHSA-N 0.000 description 2
- OSRGDDJLFPMCNJ-IZHYLOQSSA-N (3z)-3-[[4-[3-(dimethylamino)prop-1-ynyl]anilino]-phenylmethylidene]-5-nitro-1h-indol-2-one Chemical compound C1=CC(C#CCN(C)C)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC([N+]([O-])=O)=CC=C2NC\1=O OSRGDDJLFPMCNJ-IZHYLOQSSA-N 0.000 description 2
- CTLDUSIJSKDCSU-VXPUYCOJSA-N (3z)-3-[anilino(phenyl)methylidene]-1h-indol-2-one Chemical compound O=C1NC2=CC=CC=C2\C1=C(C=1C=CC=CC=1)\NC1=CC=CC=C1 CTLDUSIJSKDCSU-VXPUYCOJSA-N 0.000 description 2
- WITCLTDVNJCOIB-IZHYLOQSSA-N (3z)-5-nitro-3-[[4-[(1-oxo-1,4-thiazinan-4-yl)methyl]anilino]-phenylmethylidene]-1h-indol-2-one Chemical compound C12=CC([N+](=O)[O-])=CC=C2NC(=O)\C1=C(C=1C=CC=CC=1)/NC(C=C1)=CC=C1CN1CCS(=O)CC1 WITCLTDVNJCOIB-IZHYLOQSSA-N 0.000 description 2
- MOFRHNRHVBXTJD-VHXPQNKSSA-N (3z)-5-nitro-3-[phenyl-[4-[(pyrimidin-2-ylamino)methyl]anilino]methylidene]-1h-indol-2-one Chemical compound C12=CC([N+](=O)[O-])=CC=C2NC(=O)\C1=C(C=1C=CC=CC=1)/NC(C=C1)=CC=C1CNC1=NC=CC=N1 MOFRHNRHVBXTJD-VHXPQNKSSA-N 0.000 description 2
- ZGYIXVSQHOKQRZ-COIATFDQSA-N (e)-n-[4-[3-chloro-4-(pyridin-2-ylmethoxy)anilino]-3-cyano-7-[(3s)-oxolan-3-yl]oxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide Chemical compound N#CC1=CN=C2C=C(O[C@@H]3COCC3)C(NC(=O)/C=C/CN(C)C)=CC2=C1NC(C=C1Cl)=CC=C1OCC1=CC=CC=N1 ZGYIXVSQHOKQRZ-COIATFDQSA-N 0.000 description 2
- LNPHQJHJCPPYNQ-UHFFFAOYSA-N 1-[(4-nitrophenyl)methyl]azetidine Chemical compound C1=CC([N+](=O)[O-])=CC=C1CN1CCC1 LNPHQJHJCPPYNQ-UHFFFAOYSA-N 0.000 description 2
- PPCAIWGFEPHQSD-UHFFFAOYSA-N 1-acetyl-3-[hydroxy(phenyl)methylidene]indol-2-one Chemical compound C12=CC=CC=C2N(C(=O)C)C(=O)C1=C(O)C1=CC=CC=C1 PPCAIWGFEPHQSD-UHFFFAOYSA-N 0.000 description 2
- LLAPDLPYIYKTGQ-UHFFFAOYSA-N 1-aminoethyl Chemical group C[CH]N LLAPDLPYIYKTGQ-UHFFFAOYSA-N 0.000 description 2
- PZAJDPNKJFPWPH-UHFFFAOYSA-N 1-benzoyl-3-[hydroxy(phenyl)methylidene]indol-2-one Chemical compound C=1C=CC=CC=1C(O)=C(C1=CC=CC=C11)C(=O)N1C(=O)C1=CC=CC=C1 PZAJDPNKJFPWPH-UHFFFAOYSA-N 0.000 description 2
- CPBCUGSVXVUEAG-VXPUYCOJSA-N 2,2,2-trifluoro-n-[3-[[(z)-(2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]phenyl]acetamide Chemical compound FC(F)(F)C(=O)NC1=CC=CC(N\C(=C/2C3=CC=CC=C3NC\2=O)C=2C=CC=CC=2)=C1 CPBCUGSVXVUEAG-VXPUYCOJSA-N 0.000 description 2
- LJVKXLINXJXDMA-MRCUWXFGSA-N 2,2,2-trifluoro-n-methyl-n-[3-[[(z)-(2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]phenyl]acetamide Chemical compound FC(F)(F)C(=O)N(C)C1=CC=CC(N\C(=C/2C3=CC=CC=C3NC\2=O)C=2C=CC=CC=2)=C1 LJVKXLINXJXDMA-MRCUWXFGSA-N 0.000 description 2
- HIXDQWDOVZUNNA-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-hydroxy-7-methoxychromen-4-one Chemical compound C=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(OC)C(OC)=C1 HIXDQWDOVZUNNA-UHFFFAOYSA-N 0.000 description 2
- UMGGQKZTMCJREZ-YHZPTAEISA-N 2-(4-benzylpiperazin-1-yl)-n-methyl-n-[4-[[(z)-(5-nitro-2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]phenyl]acetamide Chemical compound C=1C=C(N\C(=C/2C3=CC(=CC=C3NC\2=O)[N+]([O-])=O)C=2C=CC=CC=2)C=CC=1N(C)C(=O)CN(CC1)CCN1CC1=CC=CC=C1 UMGGQKZTMCJREZ-YHZPTAEISA-N 0.000 description 2
- BCIANEXIQTWQLJ-IZHYLOQSSA-N 2-(dimethylamino)-n-[[4-[[(z)-(5-nitro-2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]phenyl]methyl]acetamide Chemical compound C1=CC(CNC(=O)CN(C)C)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC([N+]([O-])=O)=CC=C2NC\1=O BCIANEXIQTWQLJ-IZHYLOQSSA-N 0.000 description 2
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
- VRPJIFMKZZEXLR-UHFFFAOYSA-N 2-[(2-methylpropan-2-yl)oxycarbonylamino]acetic acid Chemical compound CC(C)(C)OC(=O)NCC(O)=O VRPJIFMKZZEXLR-UHFFFAOYSA-N 0.000 description 2
- QOLIDEWZENKAII-UHFFFAOYSA-N 2-[[4-[(1-acetyl-5-nitro-2-oxoindol-3-ylidene)-hydroxymethyl]phenyl]methyl]isoindole-1,3-dione Chemical compound C12=CC([N+]([O-])=O)=CC=C2N(C(=O)C)C(=O)C1=C(O)C(C=C1)=CC=C1CN1C(=O)C2=CC=CC=C2C1=O QOLIDEWZENKAII-UHFFFAOYSA-N 0.000 description 2
- WMYPIMUNISOZME-RQZHXJHFSA-N 2-[[4-[(z)-anilino-(5-nitro-2-oxo-1h-indol-3-ylidene)methyl]phenyl]methyl]isoindole-1,3-dione Chemical compound C12=CC([N+](=O)[O-])=CC=C2NC(=O)\C1=C(C=1C=CC(CN2C(C3=CC=CC=C3C2=O)=O)=CC=1)/NC1=CC=CC=C1 WMYPIMUNISOZME-RQZHXJHFSA-N 0.000 description 2
- LHPDTIKGSKIAOU-FCQUAONHSA-N 2-amino-n-methyl-n-[4-[[(z)-(5-nitro-2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]phenyl]acetamide Chemical compound C1=CC(N(C(=O)CN)C)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC([N+]([O-])=O)=CC=C2NC\1=O LHPDTIKGSKIAOU-FCQUAONHSA-N 0.000 description 2
- 125000000022 2-aminoethyl group Chemical group [H]C([*])([H])C([H])([H])N([H])[H] 0.000 description 2
- OAALILYXVYVIOP-UHFFFAOYSA-N 2-morpholin-4-yl-n-(4-nitrophenyl)acetamide Chemical compound C1=CC([N+](=O)[O-])=CC=C1NC(=O)CN1CCOCC1 OAALILYXVYVIOP-UHFFFAOYSA-N 0.000 description 2
- JTZWBARQMHFPBI-QPLCGJKRSA-N 2-morpholin-4-yl-n-[4-[[(z)-(2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]phenyl]acetamide Chemical compound C=1C=C(N\C(=C/2C3=CC=CC=C3NC\2=O)C=2C=CC=CC=2)C=CC=1NC(=O)CN1CCOCC1 JTZWBARQMHFPBI-QPLCGJKRSA-N 0.000 description 2
- IVTAMNNBGCKOBI-UHFFFAOYSA-N 3-(4-nitrophenyl)prop-2-yn-1-ol Chemical compound OCC#CC1=CC=C([N+]([O-])=O)C=C1 IVTAMNNBGCKOBI-UHFFFAOYSA-N 0.000 description 2
- KLKPXPUSBCYLLB-UHFFFAOYSA-N 3-(4-nitrophenyl)prop-2-ynyl 4-methylbenzenesulfonate Chemical compound C1=CC(C)=CC=C1S(=O)(=O)OCC#CC1=CC=C([N+]([O-])=O)C=C1 KLKPXPUSBCYLLB-UHFFFAOYSA-N 0.000 description 2
- WWWFHMFBQVJSBI-DQRAZIAOSA-N 3-[[(z)-(1-methyl-2-oxoindol-3-ylidene)-phenylmethyl]amino]benzonitrile Chemical compound C12=CC=CC=C2N(C)C(=O)\C1=C(C=1C=CC=CC=1)/NC1=CC=CC(C#N)=C1 WWWFHMFBQVJSBI-DQRAZIAOSA-N 0.000 description 2
- FOPASVGIZAQTIU-UHFFFAOYSA-N 3-[hydroxy(phenyl)methylidene]-1-methylindol-2-one Chemical compound C12=CC=CC=C2N(C)C(=O)C1=C(O)C1=CC=CC=C1 FOPASVGIZAQTIU-UHFFFAOYSA-N 0.000 description 2
- NJXPYZHXZZCTNI-UHFFFAOYSA-N 3-aminobenzonitrile Chemical compound NC1=CC=CC(C#N)=C1 NJXPYZHXZZCTNI-UHFFFAOYSA-N 0.000 description 2
- JJYPMNFTHPTTDI-UHFFFAOYSA-N 3-methylaniline Chemical compound CC1=CC=CC(N)=C1 JJYPMNFTHPTTDI-UHFFFAOYSA-N 0.000 description 2
- MQWIENFKSMUTOO-UHFFFAOYSA-N 4-(azetidin-1-ylmethyl)aniline Chemical compound C1=CC(N)=CC=C1CN1CCC1 MQWIENFKSMUTOO-UHFFFAOYSA-N 0.000 description 2
- WNYFVEFUHMDIRQ-UHFFFAOYSA-N 4-(morpholin-4-ylmethyl)aniline Chemical compound C1=CC(N)=CC=C1CN1CCOCC1 WNYFVEFUHMDIRQ-UHFFFAOYSA-N 0.000 description 2
- NIHMCLGGARGAHJ-UHFFFAOYSA-N 4-[(1,3-dioxoisoindol-2-yl)methyl]benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1CN1C(=O)C2=CC=CC=C2C1=O NIHMCLGGARGAHJ-UHFFFAOYSA-N 0.000 description 2
- DXCVNMRMPORTSF-UHFFFAOYSA-N 4-[(4-nitrophenyl)methyl]-1,4-thiazinane 1-oxide Chemical compound C1=CC([N+](=O)[O-])=CC=C1CN1CCS(=O)CC1 DXCVNMRMPORTSF-UHFFFAOYSA-N 0.000 description 2
- LUUYXRHNNSDDNY-UHFFFAOYSA-N 4-[2-(3,6-dihydro-2h-pyridin-1-yl)ethyl]aniline Chemical compound C1=CC(N)=CC=C1CCN1CC=CCC1 LUUYXRHNNSDDNY-UHFFFAOYSA-N 0.000 description 2
- NNIPOYNUFNLQMO-UHFFFAOYSA-N 4-[2-(methylamino)ethyl]aniline Chemical compound CNCCC1=CC=C(N)C=C1 NNIPOYNUFNLQMO-UHFFFAOYSA-N 0.000 description 2
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 2
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 2
- 239000005695 Ammonium acetate Substances 0.000 description 2
- BMTAFVWTTFSTOG-UHFFFAOYSA-N Butylate Chemical compound CCSC(=O)N(CC(C)C)CC(C)C BMTAFVWTTFSTOG-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 229910021595 Copper(I) iodide Inorganic materials 0.000 description 2
- XZMCDFZZKTWFGF-UHFFFAOYSA-N Cyanamide Chemical compound NC#N XZMCDFZZKTWFGF-UHFFFAOYSA-N 0.000 description 2
- 102100032857 Cyclin-dependent kinase 1 Human genes 0.000 description 2
- 101710106279 Cyclin-dependent kinase 1 Proteins 0.000 description 2
- 102100036329 Cyclin-dependent kinase 3 Human genes 0.000 description 2
- 102100026810 Cyclin-dependent kinase 7 Human genes 0.000 description 2
- 102100024456 Cyclin-dependent kinase 8 Human genes 0.000 description 2
- 102100024457 Cyclin-dependent kinase 9 Human genes 0.000 description 2
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- 108010024636 Glutathione Proteins 0.000 description 2
- 241000238631 Hexapoda Species 0.000 description 2
- 108010025076 Holoenzymes Proteins 0.000 description 2
- 101000715946 Homo sapiens Cyclin-dependent kinase 3 Proteins 0.000 description 2
- 101000911952 Homo sapiens Cyclin-dependent kinase 7 Proteins 0.000 description 2
- 101000980937 Homo sapiens Cyclin-dependent kinase 8 Proteins 0.000 description 2
- 101000980930 Homo sapiens Cyclin-dependent kinase 9 Proteins 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 2
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 2
- 229920002684 Sepharose Polymers 0.000 description 2
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 238000001042 affinity chromatography Methods 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- 235000019257 ammonium acetate Nutrition 0.000 description 2
- 229940043376 ammonium acetate Drugs 0.000 description 2
- 150000008064 anhydrides Chemical class 0.000 description 2
- RDOXTESZEPMUJZ-UHFFFAOYSA-N anisole Chemical compound COC1=CC=CC=C1 RDOXTESZEPMUJZ-UHFFFAOYSA-N 0.000 description 2
- 239000003125 aqueous solvent Substances 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- PASDCCFISLVPSO-UHFFFAOYSA-N benzoyl chloride Chemical compound ClC(=O)C1=CC=CC=C1 PASDCCFISLVPSO-UHFFFAOYSA-N 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- QOPVNWQGBQYBBP-UHFFFAOYSA-N chloroethyl chloroformate Chemical compound CC(Cl)OC(Cl)=O QOPVNWQGBQYBBP-UHFFFAOYSA-N 0.000 description 2
- IJOOHPMOJXWVHK-UHFFFAOYSA-N chlorotrimethylsilane Chemical compound C[Si](C)(C)Cl IJOOHPMOJXWVHK-UHFFFAOYSA-N 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 235000015165 citric acid Nutrition 0.000 description 2
- LSXDOTMGLUJQCM-UHFFFAOYSA-M copper(i) iodide Chemical compound I[Cu] LSXDOTMGLUJQCM-UHFFFAOYSA-M 0.000 description 2
- PAFZNILMFXTMIY-UHFFFAOYSA-N cyclohexylamine Chemical compound NC1CCCCC1 PAFZNILMFXTMIY-UHFFFAOYSA-N 0.000 description 2
- 239000000824 cytostatic agent Substances 0.000 description 2
- 230000001085 cytostatic effect Effects 0.000 description 2
- YNHIGQDRGKUECZ-UHFFFAOYSA-N dichloropalladium;triphenylphosphanium Chemical compound Cl[Pd]Cl.C1=CC=CC=C1[PH+](C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1[PH+](C=1C=CC=CC=1)C1=CC=CC=C1 YNHIGQDRGKUECZ-UHFFFAOYSA-N 0.000 description 2
- XHFGWHUWQXTGAT-UHFFFAOYSA-N dimethylamine hydrochloride Natural products CNC(C)C XHFGWHUWQXTGAT-UHFFFAOYSA-N 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 239000003623 enhancer Substances 0.000 description 2
- 102000052116 epidermal growth factor receptor activity proteins Human genes 0.000 description 2
- 108700015053 epidermal growth factor receptor activity proteins Proteins 0.000 description 2
- PLVJDNXPHLSRAE-DQSJHHFOSA-N ethyl 1-[[4-[[(z)-(5-nitro-2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]phenyl]methyl]piperidine-4-carboxylate Chemical compound C1CC(C(=O)OCC)CCN1CC(C=C1)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC([N+]([O-])=O)=CC=C2NC\1=O PLVJDNXPHLSRAE-DQSJHHFOSA-N 0.000 description 2
- KMNUHQRTQANIKU-UHFFFAOYSA-N ethyl 2-(4-amino-n-methylsulfonylanilino)acetate Chemical compound CCOC(=O)CN(S(C)(=O)=O)C1=CC=C(N)C=C1 KMNUHQRTQANIKU-UHFFFAOYSA-N 0.000 description 2
- SYYPWIAFXOUTCH-VHXPQNKSSA-N ethyl 2-[4-[[(z)-(2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]phenyl]acetate Chemical compound C1=CC(CC(=O)OCC)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC=CC=C2NC\1=O SYYPWIAFXOUTCH-VHXPQNKSSA-N 0.000 description 2
- KOKNIUZCPLRENT-VHXPQNKSSA-N ethyl 2-[[3-[[(z)-(2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]benzoyl]amino]acetate Chemical compound CCOC(=O)CNC(=O)C1=CC=CC(N\C(=C/2C3=CC=CC=C3NC\2=O)C=2C=CC=CC=2)=C1 KOKNIUZCPLRENT-VHXPQNKSSA-N 0.000 description 2
- BRPQQAMQPVUSSG-IZHYLOQSSA-N ethyl 2-[methyl-[3-[[(z)-(2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]benzoyl]amino]acetate Chemical compound CCOC(=O)CN(C)C(=O)C1=CC=CC(N\C(=C/2C3=CC=CC=C3NC\2=O)C=2C=CC=CC=2)=C1 BRPQQAMQPVUSSG-IZHYLOQSSA-N 0.000 description 2
- UFMBQAUGDBDDSL-DQRAZIAOSA-N ethyl 4-[[(z)-(2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]benzoate Chemical compound C1=CC(C(=O)OCC)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC=CC=C2NC\1=O UFMBQAUGDBDDSL-DQRAZIAOSA-N 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 229960003180 glutathione Drugs 0.000 description 2
- 150000004820 halides Chemical class 0.000 description 2
- 150000002431 hydrogen Chemical class 0.000 description 2
- 238000005984 hydrogenation reaction Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 2
- 239000005457 ice water Substances 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 239000000543 intermediate Substances 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000006166 lysate Substances 0.000 description 2
- NCBZRJODKRCREW-UHFFFAOYSA-N m-anisidine Chemical compound COC1=CC=CC(N)=C1 NCBZRJODKRCREW-UHFFFAOYSA-N 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- XPWJKKYUVHQGNP-MRCUWXFGSA-N methyl 2-[[(z)-(2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]benzoate Chemical compound COC(=O)C1=CC=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC=CC=C2NC\1=O XPWJKKYUVHQGNP-MRCUWXFGSA-N 0.000 description 2
- RTAZPLWDCXSOOF-MRCUWXFGSA-N methyl 4-[[(z)-(5-nitro-2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC([N+]([O-])=O)=CC=C2NC\1=O RTAZPLWDCXSOOF-MRCUWXFGSA-N 0.000 description 2
- VAMXMNNIEUEQDV-UHFFFAOYSA-N methyl anthranilate Chemical compound COC(=O)C1=CC=CC=C1N VAMXMNNIEUEQDV-UHFFFAOYSA-N 0.000 description 2
- RLERYLSFSGSSTR-UHFFFAOYSA-N n,n-dimethyl-3-(4-nitrophenyl)prop-2-yn-1-amine Chemical compound CN(C)CC#CC1=CC=C([N+]([O-])=O)C=C1 RLERYLSFSGSSTR-UHFFFAOYSA-N 0.000 description 2
- ZVBILJXZKYASHH-UHFFFAOYSA-N n-(4-aminophenyl)-2-(4-benzylpiperazin-1-yl)-n-methylacetamide Chemical compound C=1C=C(N)C=CC=1N(C)C(=O)CN(CC1)CCN1CC1=CC=CC=C1 ZVBILJXZKYASHH-UHFFFAOYSA-N 0.000 description 2
- IRXSLDSGVBCBSS-UHFFFAOYSA-N n-(4-aminophenyl)-2-(diethylamino)-n-methylacetamide Chemical compound CCN(CC)CC(=O)N(C)C1=CC=C(N)C=C1 IRXSLDSGVBCBSS-UHFFFAOYSA-N 0.000 description 2
- GVHLGRUOHQCCLA-UHFFFAOYSA-N n-(4-aminophenyl)-2-(diethylamino)acetamide Chemical compound CCN(CC)CC(=O)NC1=CC=C(N)C=C1 GVHLGRUOHQCCLA-UHFFFAOYSA-N 0.000 description 2
- FXTJCYDXMWCGAE-UHFFFAOYSA-N n-(4-aminophenyl)-2-(dimethylamino)-n-methylacetamide Chemical compound CN(C)CC(=O)N(C)C1=CC=C(N)C=C1 FXTJCYDXMWCGAE-UHFFFAOYSA-N 0.000 description 2
- QACLSTIJJPYRJI-UHFFFAOYSA-N n-(4-aminophenyl)-2-(dimethylamino)acetamide Chemical compound CN(C)CC(=O)NC1=CC=C(N)C=C1 QACLSTIJJPYRJI-UHFFFAOYSA-N 0.000 description 2
- HNMJLMSVPJYVFA-UHFFFAOYSA-N n-(4-aminophenyl)-n-(cyanomethyl)methanesulfonamide Chemical compound N#CCN(S(=O)(=O)C)C1=CC=C(N)C=C1 HNMJLMSVPJYVFA-UHFFFAOYSA-N 0.000 description 2
- TXCOFUNEYLUKHR-UHFFFAOYSA-N n-(4-aminophenyl)-n-[2-(dimethylamino)ethyl]methanesulfonamide Chemical compound CN(C)CCN(S(C)(=O)=O)C1=CC=C(N)C=C1 TXCOFUNEYLUKHR-UHFFFAOYSA-N 0.000 description 2
- LBWNQLVDYPNHAV-UHFFFAOYSA-N n-(4-aminophenyl)-n-methyl-2-(4-methylpiperazin-1-yl)acetamide Chemical compound C=1C=C(N)C=CC=1N(C)C(=O)CN1CCN(C)CC1 LBWNQLVDYPNHAV-UHFFFAOYSA-N 0.000 description 2
- GCQFMJFKLZDMRV-UHFFFAOYSA-N n-(4-aminophenyl)-n-methyl-2-morpholin-4-ylacetamide Chemical compound C=1C=C(N)C=CC=1N(C)C(=O)CN1CCOCC1 GCQFMJFKLZDMRV-UHFFFAOYSA-N 0.000 description 2
- BTHUVPGZNFZKAQ-UHFFFAOYSA-N n-(4-aminophenyl)-n-methyl-2-piperidin-1-ylacetamide Chemical compound C=1C=C(N)C=CC=1N(C)C(=O)CN1CCCCC1 BTHUVPGZNFZKAQ-UHFFFAOYSA-N 0.000 description 2
- ZGZFEDUYJFEJAW-UHFFFAOYSA-N n-(4-aminophenyl)methanesulfonamide Chemical compound CS(=O)(=O)NC1=CC=C(N)C=C1 ZGZFEDUYJFEJAW-UHFFFAOYSA-N 0.000 description 2
- MOUFEEIQCXUUMY-UHFFFAOYSA-N n-(4-aminophenyl)propanamide Chemical compound CCC(=O)NC1=CC=C(N)C=C1 MOUFEEIQCXUUMY-UHFFFAOYSA-N 0.000 description 2
- XHHRFANWCYGWQW-UHFFFAOYSA-N n-(4-nitrophenyl)propanamide Chemical compound CCC(=O)NC1=CC=C([N+]([O-])=O)C=C1 XHHRFANWCYGWQW-UHFFFAOYSA-N 0.000 description 2
- URPUDZICZVQSBW-UHFFFAOYSA-N n-(cyanomethyl)-n-(4-nitrophenyl)methanesulfonamide Chemical compound N#CCN(S(=O)(=O)C)C1=CC=C([N+]([O-])=O)C=C1 URPUDZICZVQSBW-UHFFFAOYSA-N 0.000 description 2
- HAKWORPZMFBEHA-FCQUAONHSA-N n-(cyanomethyl)-n-[4-[[(z)-(2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]phenyl]methanesulfonamide Chemical compound C1=CC(N(CC#N)S(=O)(=O)C)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC=CC=C2NC\1=O HAKWORPZMFBEHA-FCQUAONHSA-N 0.000 description 2
- MMIIBRRCVZEKFI-UHFFFAOYSA-N n-[(4-aminophenyl)methyl]pyrimidin-2-amine Chemical compound C1=CC(N)=CC=C1CNC1=NC=CC=N1 MMIIBRRCVZEKFI-UHFFFAOYSA-N 0.000 description 2
- ZUYLAIBQWHNNGZ-UHFFFAOYSA-N n-[(4-nitrophenyl)methyl]pyrimidin-2-amine Chemical compound C1=CC([N+](=O)[O-])=CC=C1CNC1=NC=CC=N1 ZUYLAIBQWHNNGZ-UHFFFAOYSA-N 0.000 description 2
- RJWZKQUBIMCOON-DQRAZIAOSA-N n-[3-[[(z)-(5-nitro-2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]phenyl]acetamide Chemical compound CC(=O)NC1=CC=CC(N\C(=C/2C3=CC(=CC=C3NC\2=O)[N+]([O-])=O)C=2C=CC=CC=2)=C1 RJWZKQUBIMCOON-DQRAZIAOSA-N 0.000 description 2
- YOHYSYJDKVYCJI-UHFFFAOYSA-N n-[3-[[6-[3-(trifluoromethyl)anilino]pyrimidin-4-yl]amino]phenyl]cyclopropanecarboxamide Chemical compound FC(F)(F)C1=CC=CC(NC=2N=CN=C(NC=3C=C(NC(=O)C4CC4)C=CC=3)C=2)=C1 YOHYSYJDKVYCJI-UHFFFAOYSA-N 0.000 description 2
- AZROSFPDEUPLHW-MRCUWXFGSA-N n-[4-[[(z)-(2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]phenyl]formamide Chemical compound C1=CC(NC=O)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC=CC=C2NC\1=O AZROSFPDEUPLHW-MRCUWXFGSA-N 0.000 description 2
- ZJFXNWSCKSSOCL-FCQUAONHSA-N n-[4-[[(z)-(2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]phenyl]propanamide Chemical compound C1=CC(NC(=O)CC)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC=CC=C2NC\1=O ZJFXNWSCKSSOCL-FCQUAONHSA-N 0.000 description 2
- OSXCBKPPWSNHQG-VHXPQNKSSA-N n-[[4-[(z)-[4-(aminomethyl)anilino]-(5-nitro-2-oxo-1h-indol-3-ylidene)methyl]phenyl]methyl]acetamide Chemical compound C1=CC(CNC(=O)C)=CC=C1C(\NC=1C=CC(CN)=CC=1)=C\1C2=CC([N+]([O-])=O)=CC=C2NC/1=O OSXCBKPPWSNHQG-VHXPQNKSSA-N 0.000 description 2
- PTPPVTUXJDJAGY-UHFFFAOYSA-N n-methyl-2-(4-nitrophenyl)ethanamine Chemical compound CNCCC1=CC=C([N+]([O-])=O)C=C1 PTPPVTUXJDJAGY-UHFFFAOYSA-N 0.000 description 2
- 150000007530 organic bases Chemical group 0.000 description 2
- BHAAPTBBJKJZER-UHFFFAOYSA-N p-anisidine Chemical compound COC1=CC=C(N)C=C1 BHAAPTBBJKJZER-UHFFFAOYSA-N 0.000 description 2
- FAIAAWCVCHQXDN-UHFFFAOYSA-N phosphorus trichloride Chemical compound ClP(Cl)Cl FAIAAWCVCHQXDN-UHFFFAOYSA-N 0.000 description 2
- 125000001557 phthalyl group Chemical group C(=O)(O)C1=C(C(=O)*)C=CC=C1 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 239000001632 sodium acetate Substances 0.000 description 2
- 235000017281 sodium acetate Nutrition 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- DAEPDZWVDSPTHF-UHFFFAOYSA-M sodium pyruvate Chemical compound [Na+].CC(=O)C([O-])=O DAEPDZWVDSPTHF-UHFFFAOYSA-M 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- FGXNWBQQFYASNX-UHFFFAOYSA-N tert-butyl 4-[(1,3-dioxoisoindol-2-yl)methyl]benzoate Chemical compound C1=CC(C(=O)OC(C)(C)C)=CC=C1CN1C(=O)C2=CC=CC=C2C1=O FGXNWBQQFYASNX-UHFFFAOYSA-N 0.000 description 2
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- YHYHFEIWDXKDLH-DQSJHHFOSA-N tert-butyl n-[2-[4-[[(z)-[4-(acetamidomethyl)phenyl]-(5-nitro-2-oxo-1h-indol-3-ylidene)methyl]amino]phenyl]ethyl]carbamate Chemical compound C1=CC(CNC(=O)C)=CC=C1C(\NC=1C=CC(CCNC(=O)OC(C)(C)C)=CC=1)=C\1C2=CC([N+]([O-])=O)=CC=C2NC/1=O YHYHFEIWDXKDLH-DQSJHHFOSA-N 0.000 description 2
- SUZDGHMOOQUVTI-QPLCGJKRSA-N tert-butyl n-[2-[[4-[[(z)-(5-nitro-2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]phenyl]methylamino]-2-oxoethyl]carbamate Chemical compound C1=CC(CNC(=O)CNC(=O)OC(C)(C)C)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC([N+]([O-])=O)=CC=C2NC\1=O SUZDGHMOOQUVTI-QPLCGJKRSA-N 0.000 description 2
- ANWKSMCOWOZHDM-QPLCGJKRSA-N tert-butyl n-[2-oxo-2-[[4-[[(z)-(2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]phenyl]methylamino]ethyl]carbamate Chemical compound C1=CC(CNC(=O)CNC(=O)OC(C)(C)C)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC=CC=C2NC\1=O ANWKSMCOWOZHDM-QPLCGJKRSA-N 0.000 description 2
- IRYKZPYNYRQHFX-FCQUAONHSA-N tert-butyl n-[4-[[(z)-(2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]phenyl]carbamate Chemical compound C1=CC(NC(=O)OC(C)(C)C)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC=CC=C2NC\1=O IRYKZPYNYRQHFX-FCQUAONHSA-N 0.000 description 2
- KCCTXVUEVVFORV-FCQUAONHSA-N tert-butyl n-[4-[[(z)-(5-nitro-2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]phenyl]carbamate Chemical compound C1=CC(NC(=O)OC(C)(C)C)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC([N+]([O-])=O)=CC=C2NC\1=O KCCTXVUEVVFORV-FCQUAONHSA-N 0.000 description 2
- LCMFRTYCPVYGPB-VHXPQNKSSA-N tert-butyl n-[[3-[[(z)-(2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]phenyl]methyl]carbamate Chemical compound CC(C)(C)OC(=O)NCC1=CC=CC(N\C(=C/2C3=CC=CC=C3NC\2=O)C=2C=CC=CC=2)=C1 LCMFRTYCPVYGPB-VHXPQNKSSA-N 0.000 description 2
- SEQFKABCLHFBCZ-VHXPQNKSSA-N tert-butyl n-[[4-[[(z)-(5-nitro-2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]phenyl]methyl]carbamate Chemical compound C1=CC(CNC(=O)OC(C)(C)C)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC([N+]([O-])=O)=CC=C2NC\1=O SEQFKABCLHFBCZ-VHXPQNKSSA-N 0.000 description 2
- QGFVMFKYKGCKRV-RQZHXJHFSA-N tert-butyl n-[[4-[[(z)-[4-(acetamidomethyl)phenyl]-(5-nitro-2-oxo-1h-indol-3-ylidene)methyl]amino]phenyl]methyl]carbamate Chemical compound C1=CC(CNC(=O)C)=CC=C1C(\NC=1C=CC(CNC(=O)OC(C)(C)C)=CC=1)=C\1C2=CC([N+]([O-])=O)=CC=C2NC/1=O QGFVMFKYKGCKRV-RQZHXJHFSA-N 0.000 description 2
- 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- IMFACGCPASFAPR-UHFFFAOYSA-N tributylamine Chemical compound CCCCN(CCCC)CCCC IMFACGCPASFAPR-UHFFFAOYSA-N 0.000 description 2
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 2
- QAEDZJGFFMLHHQ-UHFFFAOYSA-N trifluoroacetic anhydride Chemical compound FC(F)(F)C(=O)OC(=O)C(F)(F)F QAEDZJGFFMLHHQ-UHFFFAOYSA-N 0.000 description 2
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 2
- 230000004614 tumor growth Effects 0.000 description 2
- HGBOYTHUEUWSSQ-UHFFFAOYSA-N valeric aldehyde Natural products CCCCC=O HGBOYTHUEUWSSQ-UHFFFAOYSA-N 0.000 description 2
- 238000010626 work up procedure Methods 0.000 description 2
- 229940075966 (+)- menthol Drugs 0.000 description 1
- NOOLISFMXDJSKH-AEJSXWLSSA-N (+)-menthol Chemical compound CC(C)[C@H]1CC[C@H](C)C[C@@H]1O NOOLISFMXDJSKH-AEJSXWLSSA-N 0.000 description 1
- VCGRFBXVSFAGGA-UHFFFAOYSA-N (1,1-dioxo-1,4-thiazinan-4-yl)-[6-[[3-(4-fluorophenyl)-5-methyl-1,2-oxazol-4-yl]methoxy]pyridin-3-yl]methanone Chemical compound CC=1ON=C(C=2C=CC(F)=CC=2)C=1COC(N=C1)=CC=C1C(=O)N1CCS(=O)(=O)CC1 VCGRFBXVSFAGGA-UHFFFAOYSA-N 0.000 description 1
- TXUICONDJPYNPY-UHFFFAOYSA-N (1,10,13-trimethyl-3-oxo-4,5,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl) heptanoate Chemical compound C1CC2CC(=O)C=C(C)C2(C)C2C1C1CCC(OC(=O)CCCCCC)C1(C)CC2 TXUICONDJPYNPY-UHFFFAOYSA-N 0.000 description 1
- QBYIENPQHBMVBV-HFEGYEGKSA-N (2R)-2-hydroxy-2-phenylacetic acid Chemical compound O[C@@H](C(O)=O)c1ccccc1.O[C@@H](C(O)=O)c1ccccc1 QBYIENPQHBMVBV-HFEGYEGKSA-N 0.000 description 1
- DOMQFIFVDIAOOT-ROUUACIJSA-N (2S,3R)-N-[4-(2,6-dimethoxyphenyl)-5-(5-methylpyridin-3-yl)-1,2,4-triazol-3-yl]-3-(5-methylpyrimidin-2-yl)butane-2-sulfonamide Chemical compound COC1=C(C(=CC=C1)OC)N1C(=NN=C1C=1C=NC=C(C=1)C)NS(=O)(=O)[C@@H](C)[C@H](C)C1=NC=C(C=N1)C DOMQFIFVDIAOOT-ROUUACIJSA-N 0.000 description 1
- AAWZDTNXLSGCEK-LNVDRNJUSA-N (3r,5r)-1,3,4,5-tetrahydroxycyclohexane-1-carboxylic acid Chemical compound O[C@@H]1CC(O)(C(O)=O)C[C@@H](O)C1O AAWZDTNXLSGCEK-LNVDRNJUSA-N 0.000 description 1
- MAYZWDRUFKUGGP-VIFPVBQESA-N (3s)-1-[5-tert-butyl-3-[(1-methyltetrazol-5-yl)methyl]triazolo[4,5-d]pyrimidin-7-yl]pyrrolidin-3-ol Chemical compound CN1N=NN=C1CN1C2=NC(C(C)(C)C)=NC(N3C[C@@H](O)CC3)=C2N=N1 MAYZWDRUFKUGGP-VIFPVBQESA-N 0.000 description 1
- RDKRMHQNJJTUOX-MRCUWXFGSA-N (3z)-3-[(2-methoxyanilino)-phenylmethylidene]-1h-indol-2-one Chemical compound COC1=CC=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC=CC=C2NC\1=O RDKRMHQNJJTUOX-MRCUWXFGSA-N 0.000 description 1
- UATLSGKWRYMRIU-FCQUAONHSA-N (3z)-3-[(3-chlorophenyl)-[4-[(dimethylamino)methyl]anilino]methylidene]-1h-indol-2-one Chemical compound C1=CC(CN(C)C)=CC=C1N\C(C=1C=C(Cl)C=CC=1)=C/1C2=CC=CC=C2NC\1=O UATLSGKWRYMRIU-FCQUAONHSA-N 0.000 description 1
- AUAQOFDWDDKXNL-FCQUAONHSA-N (3z)-3-[(3-chlorophenyl)-[4-[(dimethylamino)methyl]anilino]methylidene]-5-nitro-1h-indol-2-one Chemical compound C1=CC(CN(C)C)=CC=C1N\C(C=1C=C(Cl)C=CC=1)=C/1C2=CC([N+]([O-])=O)=CC=C2NC\1=O AUAQOFDWDDKXNL-FCQUAONHSA-N 0.000 description 1
- MSNQCQANLWLYLE-MRCUWXFGSA-N (3z)-3-[(3-methoxyanilino)-phenylmethylidene]-1h-indol-2-one Chemical compound COC1=CC=CC(N\C(=C/2C3=CC=CC=C3NC\2=O)C=2C=CC=CC=2)=C1 MSNQCQANLWLYLE-MRCUWXFGSA-N 0.000 description 1
- MRFAKPBKMYVGDN-MRCUWXFGSA-N (3z)-3-[(3-methylanilino)-phenylmethylidene]-1h-indol-2-one Chemical compound CC1=CC=CC(N\C(=C/2C3=CC=CC=C3NC\2=O)C=2C=CC=CC=2)=C1 MRFAKPBKMYVGDN-MRCUWXFGSA-N 0.000 description 1
- XWBXYJXTGUDLIO-VXPUYCOJSA-N (3z)-3-[(3-nitroanilino)-phenylmethylidene]-1h-indol-2-one Chemical compound [O-][N+](=O)C1=CC=CC(N\C(=C/2C3=CC=CC=C3NC\2=O)C=2C=CC=CC=2)=C1 XWBXYJXTGUDLIO-VXPUYCOJSA-N 0.000 description 1
- AMJTWJCMKICSBL-DQRAZIAOSA-N (3z)-3-[(4-acetylanilino)-phenylmethylidene]-1h-indol-2-one Chemical compound C1=CC(C(=O)C)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC=CC=C2NC\1=O AMJTWJCMKICSBL-DQRAZIAOSA-N 0.000 description 1
- SODXHBKTCHCTEX-VXPUYCOJSA-N (3z)-3-[(4-bromoanilino)-phenylmethylidene]-5-nitro-1h-indol-2-one Chemical compound C12=CC([N+](=O)[O-])=CC=C2NC(=O)\C1=C(C=1C=CC=CC=1)/NC1=CC=C(Br)C=C1 SODXHBKTCHCTEX-VXPUYCOJSA-N 0.000 description 1
- AEJNJFCNIVPNMQ-FCQUAONHSA-N (3z)-3-[(4-chlorophenyl)-[4-[(dimethylamino)methyl]anilino]methylidene]-1h-indol-2-one Chemical compound C1=CC(CN(C)C)=CC=C1N\C(C=1C=CC(Cl)=CC=1)=C/1C2=CC=CC=C2NC\1=O AEJNJFCNIVPNMQ-FCQUAONHSA-N 0.000 description 1
- ZECMFSOGDLUBIH-FCQUAONHSA-N (3z)-3-[(4-chlorophenyl)-[4-[(dimethylamino)methyl]anilino]methylidene]-5-nitro-1h-indol-2-one Chemical compound C1=CC(CN(C)C)=CC=C1N\C(C=1C=CC(Cl)=CC=1)=C/1C2=CC([N+]([O-])=O)=CC=C2NC\1=O ZECMFSOGDLUBIH-FCQUAONHSA-N 0.000 description 1
- FMCYTHNTBXQNQI-MRCUWXFGSA-N (3z)-3-[(4-methoxyanilino)-phenylmethylidene]-5-nitro-1h-indol-2-one Chemical compound C1=CC(OC)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC([N+]([O-])=O)=CC=C2NC\1=O FMCYTHNTBXQNQI-MRCUWXFGSA-N 0.000 description 1
- WTRUKJXQATXWSQ-VHXPQNKSSA-N (3z)-3-[(4-morpholin-4-ylanilino)-phenylmethylidene]-5-nitro-1h-indol-2-one Chemical compound C12=CC([N+](=O)[O-])=CC=C2NC(=O)\C1=C(C=1C=CC=CC=1)/NC(C=C1)=CC=C1N1CCOCC1 WTRUKJXQATXWSQ-VHXPQNKSSA-N 0.000 description 1
- ABRRGORRKDZVKD-VXPUYCOJSA-N (3z)-3-[(4-nitroanilino)-phenylmethylidene]-1h-indol-2-one Chemical compound C1=CC([N+](=O)[O-])=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC=CC=C2NC\1=O ABRRGORRKDZVKD-VXPUYCOJSA-N 0.000 description 1
- AVDIMKBDPKWNSS-MRCUWXFGSA-N (3z)-3-[[3-(aminomethyl)anilino]-phenylmethylidene]-1h-indol-2-one Chemical compound NCC1=CC=CC(N\C(=C/2C3=CC=CC=C3NC\2=O)C=2C=CC=CC=2)=C1 AVDIMKBDPKWNSS-MRCUWXFGSA-N 0.000 description 1
- MJHHGGOANMDING-DQRAZIAOSA-N (3z)-3-[[3-(methoxymethyl)anilino]-phenylmethylidene]-1h-indol-2-one Chemical compound COCC1=CC=CC(N\C(=C/2C3=CC=CC=C3NC\2=O)C=2C=CC=CC=2)=C1 MJHHGGOANMDING-DQRAZIAOSA-N 0.000 description 1
- VTGUYGMIIVVDFP-IZHYLOQSSA-N (3z)-3-[[3-(morpholin-4-ylmethyl)anilino]-phenylmethylidene]-5-nitro-1h-indol-2-one Chemical compound C12=CC([N+](=O)[O-])=CC=C2NC(=O)\C1=C(C=1C=CC=CC=1)/NC(C=1)=CC=CC=1CN1CCOCC1 VTGUYGMIIVVDFP-IZHYLOQSSA-N 0.000 description 1
- CIPDBOGJSDCWHQ-QPLCGJKRSA-N (3z)-3-[[3-[(4-methylpiperazin-1-yl)methyl]anilino]-phenylmethylidene]-5-nitro-1h-indol-2-one Chemical compound C1CN(C)CCN1CC1=CC=CC(N\C(=C/2C3=CC(=CC=C3NC\2=O)[N+]([O-])=O)C=2C=CC=CC=2)=C1 CIPDBOGJSDCWHQ-QPLCGJKRSA-N 0.000 description 1
- RYQIMUPDGYSWCF-FCQUAONHSA-N (3z)-3-[[3-[(dimethylamino)methyl]anilino]-phenylmethylidene]-5-nitro-1h-indol-2-one Chemical compound CN(C)CC1=CC=CC(N\C(=C/2C3=CC(=CC=C3NC\2=O)[N+]([O-])=O)C=2C=CC=CC=2)=C1 RYQIMUPDGYSWCF-FCQUAONHSA-N 0.000 description 1
- DVBKSFJAKPARLE-DQRAZIAOSA-N (3z)-3-[[4-(2-aminoethyl)anilino]-phenylmethylidene]-5-nitro-1h-indol-2-one Chemical compound C1=CC(CCN)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC([N+]([O-])=O)=CC=C2NC\1=O DVBKSFJAKPARLE-DQRAZIAOSA-N 0.000 description 1
- ZLRAXEARPVKVBN-MRCUWXFGSA-N (3z)-3-[[4-(aminomethyl)phenyl]-anilinomethylidene]-5-nitro-1h-indol-2-one Chemical compound C1=CC(CN)=CC=C1C(\NC=1C=CC=CC=1)=C\1C2=CC([N+]([O-])=O)=CC=C2NC/1=O ZLRAXEARPVKVBN-MRCUWXFGSA-N 0.000 description 1
- WSOKIAHKPDOKMK-RQZHXJHFSA-N (3z)-3-[[4-(anilinomethyl)anilino]-phenylmethylidene]-5-nitro-1h-indol-2-one Chemical compound C12=CC([N+](=O)[O-])=CC=C2NC(=O)\C1=C(C=1C=CC=CC=1)/NC(C=C1)=CC=C1CNC1=CC=CC=C1 WSOKIAHKPDOKMK-RQZHXJHFSA-N 0.000 description 1
- MYWFHOGHDWEWKK-RQZHXJHFSA-N (3z)-3-[[4-(azepan-1-ylmethyl)anilino]-phenylmethylidene]-5-nitro-1h-indol-2-one Chemical compound C12=CC([N+](=O)[O-])=CC=C2NC(=O)\C1=C(C=1C=CC=CC=1)/NC(C=C1)=CC=C1CN1CCCCCC1 MYWFHOGHDWEWKK-RQZHXJHFSA-N 0.000 description 1
- NRTKSWQJVDILJS-VHXPQNKSSA-N (3z)-3-[[4-(azetidin-1-ylmethyl)anilino]-phenylmethylidene]-5-nitro-1h-indol-2-one Chemical compound C12=CC([N+](=O)[O-])=CC=C2NC(=O)\C1=C(C=1C=CC=CC=1)/NC(C=C1)=CC=C1CN1CCC1 NRTKSWQJVDILJS-VHXPQNKSSA-N 0.000 description 1
- HEOSDETWUNCHCA-IZHYLOQSSA-N (3z)-3-[[4-(butylaminomethyl)anilino]-phenylmethylidene]-5-nitro-1h-indol-2-one Chemical compound C1=CC(CNCCCC)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC([N+]([O-])=O)=CC=C2NC\1=O HEOSDETWUNCHCA-IZHYLOQSSA-N 0.000 description 1
- IEVJKOIOFYGCLD-IZHYLOQSSA-N (3z)-3-[[4-(diethylaminomethyl)anilino]-phenylmethylidene]-5-nitro-1h-indol-2-one Chemical compound C1=CC(CN(CC)CC)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC([N+]([O-])=O)=CC=C2NC\1=O IEVJKOIOFYGCLD-IZHYLOQSSA-N 0.000 description 1
- ZGPKVPAGCLHCQD-DQRAZIAOSA-N (3z)-3-[[4-(methylaminomethyl)anilino]-phenylmethylidene]-5-nitro-1h-indol-2-one Chemical compound C1=CC(CNC)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC([N+]([O-])=O)=CC=C2NC\1=O ZGPKVPAGCLHCQD-DQRAZIAOSA-N 0.000 description 1
- RGRSQNSFQCQBHB-IZHYLOQSSA-N (3z)-3-[[4-(morpholin-4-ylmethyl)anilino]-phenylmethylidene]-1h-indol-2-one Chemical compound O=C1NC2=CC=CC=C2\C1=C(C=1C=CC=CC=1)\NC(C=C1)=CC=C1CN1CCOCC1 RGRSQNSFQCQBHB-IZHYLOQSSA-N 0.000 description 1
- LHCDORZBZWYWEZ-IZHYLOQSSA-N (3z)-3-[[4-(morpholin-4-ylmethyl)anilino]-phenylmethylidene]-5-nitro-1h-indol-2-one Chemical compound C12=CC([N+](=O)[O-])=CC=C2NC(=O)\C1=C(C=1C=CC=CC=1)/NC(C=C1)=CC=C1CN1CCOCC1 LHCDORZBZWYWEZ-IZHYLOQSSA-N 0.000 description 1
- YIYILNTVGDOISI-FCQUAONHSA-N (3z)-3-[[4-[(2-hydroxyethylamino)methyl]anilino]-phenylmethylidene]-5-nitro-1h-indol-2-one Chemical compound C1=CC(CNCCO)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC([N+]([O-])=O)=CC=C2NC\1=O YIYILNTVGDOISI-FCQUAONHSA-N 0.000 description 1
- AOCBINXLFBMEHU-VHXPQNKSSA-N (3z)-3-[[4-[(2-methoxyethylamino)methyl]anilino]-phenylmethylidene]-5-nitro-1h-indol-2-one Chemical compound C1=CC(CNCCOC)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC([N+]([O-])=O)=CC=C2NC\1=O AOCBINXLFBMEHU-VHXPQNKSSA-N 0.000 description 1
- ZLGOZHORWUERKD-IZHYLOQSSA-N (3z)-3-[[4-[(2-methylpropylamino)methyl]anilino]-phenylmethylidene]-5-nitro-1h-indol-2-one Chemical compound C1=CC(CNCC(C)C)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC([N+]([O-])=O)=CC=C2NC\1=O ZLGOZHORWUERKD-IZHYLOQSSA-N 0.000 description 1
- QCKPOIOQGIKLLK-RQZHXJHFSA-N (3z)-3-[[4-[(4-acetylpiperazin-1-yl)methyl]anilino]-phenylmethylidene]-5-nitro-1h-indol-2-one Chemical compound C1CN(C(=O)C)CCN1CC(C=C1)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC([N+]([O-])=O)=CC=C2NC\1=O QCKPOIOQGIKLLK-RQZHXJHFSA-N 0.000 description 1
- MXOKMKCJIILOEZ-KARKAFJISA-N (3z)-3-[[4-[(4-benzylpiperidin-1-yl)methyl]anilino]-phenylmethylidene]-5-nitro-1h-indol-2-one Chemical compound C12=CC([N+](=O)[O-])=CC=C2NC(=O)\C1=C(C=1C=CC=CC=1)/NC(C=C1)=CC=C1CN(CC1)CCC1CC1=CC=CC=C1 MXOKMKCJIILOEZ-KARKAFJISA-N 0.000 description 1
- HENCJKZKUPGFKN-DQSJHHFOSA-N (3z)-3-[[4-[(4-ethylpiperidin-1-yl)methyl]anilino]-phenylmethylidene]-5-nitro-1h-indol-2-one Chemical compound C1CC(CC)CCN1CC(C=C1)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC([N+]([O-])=O)=CC=C2NC\1=O HENCJKZKUPGFKN-DQSJHHFOSA-N 0.000 description 1
- CFPRGDKUKGTMDY-QPLCGJKRSA-N (3z)-3-[[4-[(4-hydroxy-4-methylpiperidin-1-yl)methyl]anilino]-phenylmethylidene]-5-nitro-1h-indol-2-one Chemical compound C1CC(C)(O)CCN1CC(C=C1)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC([N+]([O-])=O)=CC=C2NC\1=O CFPRGDKUKGTMDY-QPLCGJKRSA-N 0.000 description 1
- WXZNYPRTKYPOJY-QPLCGJKRSA-N (3z)-3-[[4-[(4-hydroxypiperidin-1-yl)methyl]anilino]-phenylmethylidene]-5-nitro-1h-indol-2-one Chemical compound C1CC(O)CCN1CC(C=C1)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC([N+]([O-])=O)=CC=C2NC\1=O WXZNYPRTKYPOJY-QPLCGJKRSA-N 0.000 description 1
- LQLDPVBRNRPHMC-RQZHXJHFSA-N (3z)-3-[[4-[(4-methoxypiperidin-1-yl)methyl]anilino]-phenylmethylidene]-5-nitro-1h-indol-2-one Chemical compound C1CC(OC)CCN1CC(C=C1)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC([N+]([O-])=O)=CC=C2NC\1=O LQLDPVBRNRPHMC-RQZHXJHFSA-N 0.000 description 1
- OHUQVHALEVBFCI-RQZHXJHFSA-N (3z)-3-[[4-[(4-methylpiperidin-1-yl)methyl]anilino]-phenylmethylidene]-5-nitro-1h-indol-2-one Chemical compound C1CC(C)CCN1CC(C=C1)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC([N+]([O-])=O)=CC=C2NC\1=O OHUQVHALEVBFCI-RQZHXJHFSA-N 0.000 description 1
- SPGRVIMEKHIJQM-LXCLTORNSA-N (3z)-3-[[4-[(benzylamino)methyl]anilino]-phenylmethylidene]-5-nitro-1h-indol-2-one;hydrochloride Chemical compound Cl.C12=CC([N+](=O)[O-])=CC=C2NC(=O)\C1=C(C=1C=CC=CC=1)/NC(C=C1)=CC=C1CNCC1=CC=CC=C1 SPGRVIMEKHIJQM-LXCLTORNSA-N 0.000 description 1
- WJJUEWGTBXFLDC-RQZHXJHFSA-N (3z)-3-[[4-[(cyclohexylamino)methyl]anilino]-phenylmethylidene]-5-nitro-1h-indol-2-one Chemical compound C12=CC([N+](=O)[O-])=CC=C2NC(=O)\C1=C(C=1C=CC=CC=1)/NC(C=C1)=CC=C1CNC1CCCCC1 WJJUEWGTBXFLDC-RQZHXJHFSA-N 0.000 description 1
- DGCMYFHLHBXRPE-QPLCGJKRSA-N (3z)-3-[[4-[(cyclopentylamino)methyl]anilino]-phenylmethylidene]-5-nitro-1h-indol-2-one Chemical compound C12=CC([N+](=O)[O-])=CC=C2NC(=O)\C1=C(C=1C=CC=CC=1)/NC(C=C1)=CC=C1CNC1CCCC1 DGCMYFHLHBXRPE-QPLCGJKRSA-N 0.000 description 1
- CCDRTJXXXHIRSR-VHXPQNKSSA-N (3z)-3-[[4-[(cyclopropylamino)methyl]anilino]-phenylmethylidene]-5-nitro-1h-indol-2-one Chemical compound C12=CC([N+](=O)[O-])=CC=C2NC(=O)\C1=C(C=1C=CC=CC=1)/NC(C=C1)=CC=C1CNC1CC1 CCDRTJXXXHIRSR-VHXPQNKSSA-N 0.000 description 1
- SHKFQWMODCTALJ-ZIADKAODSA-N (3z)-3-[[4-[(dibutylamino)methyl]anilino]-phenylmethylidene]-5-nitro-1h-indol-2-one Chemical compound C1=CC(CN(CCCC)CCCC)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC([N+]([O-])=O)=CC=C2NC\1=O SHKFQWMODCTALJ-ZIADKAODSA-N 0.000 description 1
- WFCJOROZONWIIH-VHXPQNKSSA-N (3z)-3-[[4-[(dimethylamino)methyl]anilino]-(3-methoxyphenyl)methylidene]-1h-indol-2-one Chemical compound COC1=CC=CC(C(\NC=2C=CC(CN(C)C)=CC=2)=C\2C3=CC=CC=C3NC/2=O)=C1 WFCJOROZONWIIH-VHXPQNKSSA-N 0.000 description 1
- LKDUVTQCOOJZNP-VHXPQNKSSA-N (3z)-3-[[4-[(dimethylamino)methyl]anilino]-(3-methoxyphenyl)methylidene]-5-nitro-1h-indol-2-one Chemical compound COC1=CC=CC(C(\NC=2C=CC(CN(C)C)=CC=2)=C\2C3=CC(=CC=C3NC/2=O)[N+]([O-])=O)=C1 LKDUVTQCOOJZNP-VHXPQNKSSA-N 0.000 description 1
- ADVPPIOWSHFWRR-VHXPQNKSSA-N (3z)-3-[[4-[(dimethylamino)methyl]anilino]-(3-methylphenyl)methylidene]-1h-indol-2-one Chemical compound C1=CC(CN(C)C)=CC=C1N\C(C=1C=C(C)C=CC=1)=C/1C2=CC=CC=C2NC\1=O ADVPPIOWSHFWRR-VHXPQNKSSA-N 0.000 description 1
- FNRMRRLBTWJGSX-VHXPQNKSSA-N (3z)-3-[[4-[(dimethylamino)methyl]anilino]-(3-methylphenyl)methylidene]-5-nitro-1h-indol-2-one Chemical compound C1=CC(CN(C)C)=CC=C1N\C(C=1C=C(C)C=CC=1)=C/1C2=CC([N+]([O-])=O)=CC=C2NC\1=O FNRMRRLBTWJGSX-VHXPQNKSSA-N 0.000 description 1
- LJLREOYRDPFFGA-VHXPQNKSSA-N (3z)-3-[[4-[(dimethylamino)methyl]anilino]-(4-methoxyphenyl)methylidene]-1h-indol-2-one Chemical compound C1=CC(OC)=CC=C1C(\NC=1C=CC(CN(C)C)=CC=1)=C\1C2=CC=CC=C2NC/1=O LJLREOYRDPFFGA-VHXPQNKSSA-N 0.000 description 1
- NQBJBYLXYMXOHO-VHXPQNKSSA-N (3z)-3-[[4-[(dimethylamino)methyl]anilino]-(4-methoxyphenyl)methylidene]-5-nitro-1h-indol-2-one Chemical compound C1=CC(OC)=CC=C1C(\NC=1C=CC(CN(C)C)=CC=1)=C\1C2=CC([N+]([O-])=O)=CC=C2NC/1=O NQBJBYLXYMXOHO-VHXPQNKSSA-N 0.000 description 1
- JSFREYCPIWDFPB-VHXPQNKSSA-N (3z)-3-[[4-[(dimethylamino)methyl]anilino]-(4-methylphenyl)methylidene]-1h-indol-2-one Chemical compound C1=CC(CN(C)C)=CC=C1N\C(C=1C=CC(C)=CC=1)=C/1C2=CC=CC=C2NC\1=O JSFREYCPIWDFPB-VHXPQNKSSA-N 0.000 description 1
- KWRKFLMBNYQVGL-VHXPQNKSSA-N (3z)-3-[[4-[(dimethylamino)methyl]anilino]-(4-methylphenyl)methylidene]-5-nitro-1h-indol-2-one Chemical compound C1=CC(CN(C)C)=CC=C1N\C(C=1C=CC(C)=CC=1)=C/1C2=CC([N+]([O-])=O)=CC=C2NC\1=O KWRKFLMBNYQVGL-VHXPQNKSSA-N 0.000 description 1
- ISDRCDYJTLSZFM-FCQUAONHSA-N (3z)-3-[[4-[(dimethylamino)methyl]anilino]-(4-nitrophenyl)methylidene]-1h-indol-2-one Chemical compound C1=CC(CN(C)C)=CC=C1N\C(C=1C=CC(=CC=1)[N+]([O-])=O)=C/1C2=CC=CC=C2NC\1=O ISDRCDYJTLSZFM-FCQUAONHSA-N 0.000 description 1
- VEWFFLAXQXNGBU-FCQUAONHSA-N (3z)-3-[[4-[(dimethylamino)methyl]anilino]-(4-nitrophenyl)methylidene]-5-nitro-1h-indol-2-one Chemical compound C1=CC(CN(C)C)=CC=C1N\C(C=1C=CC(=CC=1)[N+]([O-])=O)=C/1C2=CC([N+]([O-])=O)=CC=C2NC\1=O VEWFFLAXQXNGBU-FCQUAONHSA-N 0.000 description 1
- GAESRXUHYVDBGC-FCQUAONHSA-N (3z)-3-[[4-[(dimethylamino)methyl]anilino]-phenylmethylidene]-1h-indol-2-one Chemical compound C1=CC(CN(C)C)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC=CC=C2NC\1=O GAESRXUHYVDBGC-FCQUAONHSA-N 0.000 description 1
- NYTDXBVHDZDDFL-RQZHXJHFSA-N (3z)-3-[[4-[(dipropylamino)methyl]anilino]-phenylmethylidene]-5-nitro-1h-indol-2-one Chemical compound C1=CC(CN(CCC)CCC)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC([N+]([O-])=O)=CC=C2NC\1=O NYTDXBVHDZDDFL-RQZHXJHFSA-N 0.000 description 1
- CCDNNMRSCMQPRW-DQSJHHFOSA-N (3z)-3-[[4-[(n-methylanilino)methyl]anilino]-phenylmethylidene]-5-nitro-1h-indol-2-one Chemical compound C=1C=CC=CC=1N(C)CC(C=C1)=CC=C1N\C(=C/1C2=CC(=CC=C2NC\1=O)[N+]([O-])=O)C1=CC=CC=C1 CCDNNMRSCMQPRW-DQSJHHFOSA-N 0.000 description 1
- XHXVSVBZUNQJNF-VHXPQNKSSA-N (3z)-3-[[4-[2-(2-hydroxyethylamino)ethyl]anilino]-phenylmethylidene]-5-nitro-1h-indol-2-one Chemical compound C1=CC(CCNCCO)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC([N+]([O-])=O)=CC=C2NC\1=O XHXVSVBZUNQJNF-VHXPQNKSSA-N 0.000 description 1
- VDQICWZCNJLTHO-BJFQDICYSA-N (3z)-3-[[4-[2-(2-methoxyethylamino)ethyl]anilino]-phenylmethylidene]-5-nitro-1h-indol-2-one;hydrobromide Chemical compound Br.C1=CC(CCNCCOC)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC([N+]([O-])=O)=CC=C2NC\1=O VDQICWZCNJLTHO-BJFQDICYSA-N 0.000 description 1
- RFDCHWPBNLQVRS-RQZHXJHFSA-N (3z)-3-[[4-[2-(3,6-dihydro-2h-pyridin-1-yl)ethyl]anilino]-phenylmethylidene]-5-nitro-1h-indol-2-one Chemical compound C12=CC([N+](=O)[O-])=CC=C2NC(=O)\C1=C(C=1C=CC=CC=1)/NC(C=C1)=CC=C1CCN1CCC=CC1 RFDCHWPBNLQVRS-RQZHXJHFSA-N 0.000 description 1
- QOJCHHSEDDASMI-RQZHXJHFSA-N (3z)-3-[[4-[2-(4-hydroxypiperidin-1-yl)ethyl]anilino]-phenylmethylidene]-5-nitro-1h-indol-2-one Chemical compound C1CC(O)CCN1CCC(C=C1)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC([N+]([O-])=O)=CC=C2NC\1=O QOJCHHSEDDASMI-RQZHXJHFSA-N 0.000 description 1
- NUQUPXGMMMXQIL-DQSJHHFOSA-N (3z)-3-[[4-[2-(4-methoxypiperidin-1-yl)ethyl]anilino]-phenylmethylidene]-5-nitro-1h-indol-2-one Chemical compound C1CC(OC)CCN1CCC(C=C1)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC([N+]([O-])=O)=CC=C2NC\1=O NUQUPXGMMMXQIL-DQSJHHFOSA-N 0.000 description 1
- QICHKIUSSNJJGW-RQZHXJHFSA-N (3z)-3-[[4-[2-(4-methylpiperazin-1-yl)ethyl]anilino]-phenylmethylidene]-5-nitro-1h-indol-2-one Chemical compound C1CN(C)CCN1CCC(C=C1)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC([N+]([O-])=O)=CC=C2NC\1=O QICHKIUSSNJJGW-RQZHXJHFSA-N 0.000 description 1
- YLXSJMLFQOVGBB-DQSJHHFOSA-N (3z)-3-[[4-[2-(4-methylpiperidin-1-yl)ethyl]anilino]-phenylmethylidene]-5-nitro-1h-indol-2-one Chemical compound C1CC(C)CCN1CCC(C=C1)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC([N+]([O-])=O)=CC=C2NC\1=O YLXSJMLFQOVGBB-DQSJHHFOSA-N 0.000 description 1
- HNYLECNDMZJUOQ-DQSJHHFOSA-N (3z)-3-[[4-[2-(azepan-1-yl)ethyl]anilino]-phenylmethylidene]-5-nitro-1h-indol-2-one Chemical compound C12=CC([N+](=O)[O-])=CC=C2NC(=O)\C1=C(C=1C=CC=CC=1)/NC(C=C1)=CC=C1CCN1CCCCCC1 HNYLECNDMZJUOQ-DQSJHHFOSA-N 0.000 description 1
- UXMIAFRULUESBA-VHXPQNKSSA-N (3z)-3-[[4-[2-(dimethylamino)ethyl]anilino]-phenylmethylidene]-1h-indol-2-one Chemical compound C1=CC(CCN(C)C)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC=CC=C2NC\1=O UXMIAFRULUESBA-VHXPQNKSSA-N 0.000 description 1
- CTJCDXRACXIQMO-VHXPQNKSSA-N (3z)-3-[[4-[2-(ethylamino)ethyl]anilino]-phenylmethylidene]-5-nitro-1h-indol-2-one Chemical compound C1=CC(CCNCC)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC([N+]([O-])=O)=CC=C2NC\1=O CTJCDXRACXIQMO-VHXPQNKSSA-N 0.000 description 1
- ZDWPWCLPLJVOLM-QPLCGJKRSA-N (3z)-3-[[4-[2-[ethyl(2-hydroxyethyl)amino]ethyl]anilino]-phenylmethylidene]-5-nitro-1h-indol-2-one Chemical compound C1=CC(CCN(CCO)CC)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC([N+]([O-])=O)=CC=C2NC\1=O ZDWPWCLPLJVOLM-QPLCGJKRSA-N 0.000 description 1
- VVKHXXIQOSGNGV-RQZHXJHFSA-N (3z)-3-[[4-[[4-(hydroxymethyl)piperidin-1-yl]methyl]anilino]-phenylmethylidene]-5-nitro-1h-indol-2-one Chemical compound C1CC(CO)CCN1CC(C=C1)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC([N+]([O-])=O)=CC=C2NC\1=O VVKHXXIQOSGNGV-RQZHXJHFSA-N 0.000 description 1
- GDNZCPVVOQNGJL-ZIADKAODSA-N (3z)-3-[[4-[[benzyl(methyl)amino]methyl]anilino]-phenylmethylidene]-5-nitro-1h-indol-2-one Chemical compound C=1C=C(N\C(=C/2C3=CC(=CC=C3NC\2=O)[N+]([O-])=O)C=2C=CC=CC=2)C=CC=1CN(C)CC1=CC=CC=C1 GDNZCPVVOQNGJL-ZIADKAODSA-N 0.000 description 1
- SJSPVQMORSWGNM-ZIADKAODSA-N (3z)-3-[[4-[[bis(2-methylpropyl)amino]methyl]anilino]-phenylmethylidene]-5-nitro-1h-indol-2-one Chemical compound C1=CC(CN(CC(C)C)CC(C)C)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC([N+]([O-])=O)=CC=C2NC\1=O SJSPVQMORSWGNM-ZIADKAODSA-N 0.000 description 1
- UGNLIPQNGPMHRB-RQZHXJHFSA-N (3z)-3-[[4-[[cyclopentyl(methyl)amino]methyl]anilino]-phenylmethylidene]-5-nitro-1h-indol-2-one Chemical compound C1CCCC1N(C)CC(C=C1)=CC=C1N\C(=C/1C2=CC(=CC=C2NC\1=O)[N+]([O-])=O)C1=CC=CC=C1 UGNLIPQNGPMHRB-RQZHXJHFSA-N 0.000 description 1
- IVYHRWWWVUQNDV-IZHYLOQSSA-N (3z)-3-[[4-[[cyclopropyl(methyl)amino]methyl]anilino]-phenylmethylidene]-5-nitro-1h-indol-2-one Chemical compound C1CC1N(C)CC(C=C1)=CC=C1N\C(=C/1C2=CC(=CC=C2NC\1=O)[N+]([O-])=O)C1=CC=CC=C1 IVYHRWWWVUQNDV-IZHYLOQSSA-N 0.000 description 1
- VDHYOYBNTYVPOF-RQZHXJHFSA-N (3z)-3-[[4-[[methyl(pyridin-2-yl)amino]methyl]anilino]-phenylmethylidene]-5-nitro-1h-indol-2-one Chemical compound C=1C=CC=NC=1N(C)CC(C=C1)=CC=C1N\C(=C/1C2=CC(=CC=C2NC\1=O)[N+]([O-])=O)C1=CC=CC=C1 VDHYOYBNTYVPOF-RQZHXJHFSA-N 0.000 description 1
- HWKFHOOPBVMQAF-IZHYLOQSSA-N (3z)-3-[[4-[[methyl(pyrimidin-2-yl)amino]methyl]anilino]-phenylmethylidene]-5-nitro-1h-indol-2-one Chemical compound N=1C=CC=NC=1N(C)CC(C=C1)=CC=C1N\C(=C/1C2=CC(=CC=C2NC\1=O)[N+]([O-])=O)C1=CC=CC=C1 HWKFHOOPBVMQAF-IZHYLOQSSA-N 0.000 description 1
- VBVJQGOFYMMHKC-QPLCGJKRSA-N (3z)-3-[phenyl-[4-(piperidin-1-ylmethyl)anilino]methylidene]-1h-indol-2-one Chemical compound O=C1NC2=CC=CC=C2\C1=C(C=1C=CC=CC=1)\NC(C=C1)=CC=C1CN1CCCCC1 VBVJQGOFYMMHKC-QPLCGJKRSA-N 0.000 description 1
- AFIUVDHFLUYPQP-VXPUYCOJSA-N (3z)-5-nitro-3-[(4-nitroanilino)-phenylmethylidene]-1h-indol-2-one Chemical compound C1=CC([N+](=O)[O-])=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC([N+]([O-])=O)=CC=C2NC\1=O AFIUVDHFLUYPQP-VXPUYCOJSA-N 0.000 description 1
- ZHHULJOANYQZRD-QPLCGJKRSA-N (3z)-5-nitro-3-[phenyl-[3-(piperidin-1-ylmethyl)anilino]methylidene]-1h-indol-2-one Chemical compound C12=CC([N+](=O)[O-])=CC=C2NC(=O)\C1=C(C=1C=CC=CC=1)/NC(C=1)=CC=CC=1CN1CCCCC1 ZHHULJOANYQZRD-QPLCGJKRSA-N 0.000 description 1
- JZPLRONLNKVQIK-RQZHXJHFSA-N (3z)-5-nitro-3-[phenyl-[4-(2-piperidin-1-ylethyl)anilino]methylidene]-1h-indol-2-one Chemical compound C12=CC([N+](=O)[O-])=CC=C2NC(=O)\C1=C(C=1C=CC=CC=1)/NC(C=C1)=CC=C1CCN1CCCCC1 JZPLRONLNKVQIK-RQZHXJHFSA-N 0.000 description 1
- CXNVXAIXBZWRBX-NDIQBZANSA-N (3z)-5-nitro-3-[phenyl-[4-(piperazin-1-ylmethyl)anilino]methylidene]-1h-indol-2-one;dihydrochloride Chemical compound Cl.Cl.C12=CC([N+](=O)[O-])=CC=C2NC(=O)\C1=C(C=1C=CC=CC=1)/NC(C=C1)=CC=C1CN1CCNCC1 CXNVXAIXBZWRBX-NDIQBZANSA-N 0.000 description 1
- JBCFFAZDUBFGQW-QPLCGJKRSA-N (3z)-5-nitro-3-[phenyl-[4-(piperidin-1-ylmethyl)anilino]methylidene]-1h-indol-2-one Chemical compound C12=CC([N+](=O)[O-])=CC=C2NC(=O)\C1=C(C=1C=CC=CC=1)/NC(C=C1)=CC=C1CN1CCCCC1 JBCFFAZDUBFGQW-QPLCGJKRSA-N 0.000 description 1
- YYLAZRLHIRKJGH-VHXPQNKSSA-N (3z)-5-nitro-3-[phenyl-[4-(propylaminomethyl)anilino]methylidene]-1h-indol-2-one Chemical compound C1=CC(CNCCC)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC([N+]([O-])=O)=CC=C2NC\1=O YYLAZRLHIRKJGH-VHXPQNKSSA-N 0.000 description 1
- OKTPMFZXJGXIAC-IZHYLOQSSA-N (3z)-5-nitro-3-[phenyl-[4-(thiomorpholin-4-ylmethyl)anilino]methylidene]-1h-indol-2-one Chemical compound C12=CC([N+](=O)[O-])=CC=C2NC(=O)\C1=C(C=1C=CC=CC=1)/NC(C=C1)=CC=C1CN1CCSCC1 OKTPMFZXJGXIAC-IZHYLOQSSA-N 0.000 description 1
- GDGHRCMAMPRLLB-VXPUYCOJSA-N (3z)-5-nitro-3-[phenyl-[4-(trifluoromethyl)anilino]methylidene]-1h-indol-2-one Chemical compound C12=CC([N+](=O)[O-])=CC=C2NC(=O)\C1=C(C=1C=CC=CC=1)/NC1=CC=C(C(F)(F)F)C=C1 GDGHRCMAMPRLLB-VXPUYCOJSA-N 0.000 description 1
- LWKFKWXABANCQR-QPLCGJKRSA-N (3z)-5-nitro-3-[phenyl-[4-[(pyridin-2-ylamino)methyl]anilino]methylidene]-1h-indol-2-one Chemical compound C12=CC([N+](=O)[O-])=CC=C2NC(=O)\C1=C(C=1C=CC=CC=1)/NC(C=C1)=CC=C1CNC1=CC=CC=N1 LWKFKWXABANCQR-QPLCGJKRSA-N 0.000 description 1
- SMIXZZMSWYOQPW-UHFFFAOYSA-N (4-nitrophenyl)methylazanium;chloride Chemical compound [Cl-].[NH3+]CC1=CC=C([N+]([O-])=O)C=C1 SMIXZZMSWYOQPW-UHFFFAOYSA-N 0.000 description 1
- 125000004890 (C1-C6) alkylamino group Chemical group 0.000 description 1
- 125000006593 (C2-C3) alkynyl group Chemical group 0.000 description 1
- 125000006705 (C5-C7) cycloalkyl group Chemical group 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- UKGJZDSUJSPAJL-YPUOHESYSA-N (e)-n-[(1r)-1-[3,5-difluoro-4-(methanesulfonamido)phenyl]ethyl]-3-[2-propyl-6-(trifluoromethyl)pyridin-3-yl]prop-2-enamide Chemical compound CCCC1=NC(C(F)(F)F)=CC=C1\C=C\C(=O)N[C@H](C)C1=CC(F)=C(NS(C)(=O)=O)C(F)=C1 UKGJZDSUJSPAJL-YPUOHESYSA-N 0.000 description 1
- MOWXJLUYGFNTAL-DEOSSOPVSA-N (s)-[2-chloro-4-fluoro-5-(7-morpholin-4-ylquinazolin-4-yl)phenyl]-(6-methoxypyridazin-3-yl)methanol Chemical compound N1=NC(OC)=CC=C1[C@@H](O)C1=CC(C=2C3=CC=C(C=C3N=CN=2)N2CCOCC2)=C(F)C=C1Cl MOWXJLUYGFNTAL-DEOSSOPVSA-N 0.000 description 1
- YYGXWGFETIURIJ-UHFFFAOYSA-N 1,4-dioxane;sodium Chemical compound [Na].C1COCCO1 YYGXWGFETIURIJ-UHFFFAOYSA-N 0.000 description 1
- NDOVLWQBFFJETK-UHFFFAOYSA-N 1,4-thiazinane 1,1-dioxide Chemical compound O=S1(=O)CCNCC1 NDOVLWQBFFJETK-UHFFFAOYSA-N 0.000 description 1
- APWRZPQBPCAXFP-UHFFFAOYSA-N 1-(1-oxo-2H-isoquinolin-5-yl)-5-(trifluoromethyl)-N-[2-(trifluoromethyl)pyridin-4-yl]pyrazole-4-carboxamide Chemical compound O=C1NC=CC2=C(C=CC=C12)N1N=CC(=C1C(F)(F)F)C(=O)NC1=CC(=NC=C1)C(F)(F)F APWRZPQBPCAXFP-UHFFFAOYSA-N 0.000 description 1
- GPRYKVSEZCQIHD-UHFFFAOYSA-N 1-(4-aminophenyl)ethanone Chemical compound CC(=O)C1=CC=C(N)C=C1 GPRYKVSEZCQIHD-UHFFFAOYSA-N 0.000 description 1
- JOGOYJJLWNKJIV-UHFFFAOYSA-N 1-[(4-aminophenyl)methyl]-4-phenylpiperidin-4-ol Chemical compound C1=CC(N)=CC=C1CN1CCC(O)(C=2C=CC=CC=2)CC1 JOGOYJJLWNKJIV-UHFFFAOYSA-N 0.000 description 1
- YHULNZHMWVPUQK-UHFFFAOYSA-N 1-[(4-aminophenyl)methyl]piperidin-4-ol Chemical compound C1=CC(N)=CC=C1CN1CCC(O)CC1 YHULNZHMWVPUQK-UHFFFAOYSA-N 0.000 description 1
- ABDDQTDRAHXHOC-QMMMGPOBSA-N 1-[(7s)-5,7-dihydro-4h-thieno[2,3-c]pyran-7-yl]-n-methylmethanamine Chemical compound CNC[C@@H]1OCCC2=C1SC=C2 ABDDQTDRAHXHOC-QMMMGPOBSA-N 0.000 description 1
- YDIVKRNESAIBHZ-UHFFFAOYSA-N 1-[2-(4-nitrophenyl)ethyl]-3,6-dihydro-2h-pyridine Chemical compound C1=CC([N+](=O)[O-])=CC=C1CCN1CC=CCC1 YDIVKRNESAIBHZ-UHFFFAOYSA-N 0.000 description 1
- MKILRFVAYFTRSX-RQZHXJHFSA-N 1-[2-[4-[[(z)-(5-nitro-2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]phenyl]ethyl]piperidine-4-carboxylic acid Chemical compound C1CC(C(=O)O)CCN1CCC(C=C1)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC([N+]([O-])=O)=CC=C2NC\1=O MKILRFVAYFTRSX-RQZHXJHFSA-N 0.000 description 1
- ZYFDEVFRVUUHQI-QPLCGJKRSA-N 1-[[4-[[(z)-(5-nitro-2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]phenyl]methyl]piperidine-4-carboxamide Chemical compound C1CC(C(=O)N)CCN1CC(C=C1)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC([N+]([O-])=O)=CC=C2NC\1=O ZYFDEVFRVUUHQI-QPLCGJKRSA-N 0.000 description 1
- KQHCFJLOYSICDI-QPLCGJKRSA-N 1-[[4-[[(z)-(5-nitro-2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]phenyl]methyl]piperidine-4-carboxylic acid Chemical compound C1CC(C(=O)O)CCN1CC(C=C1)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC([N+]([O-])=O)=CC=C2NC\1=O KQHCFJLOYSICDI-QPLCGJKRSA-N 0.000 description 1
- ARBHPJGDSHONRR-UHFFFAOYSA-N 1-acetyl-3-[chloro-(3-chlorophenyl)methylidene]-5-nitroindol-2-one Chemical compound C12=CC([N+]([O-])=O)=CC=C2N(C(=O)C)C(=O)C1=C(Cl)C1=CC=CC(Cl)=C1 ARBHPJGDSHONRR-UHFFFAOYSA-N 0.000 description 1
- VBEZANSTFXHVGE-UHFFFAOYSA-N 1-acetyl-3-[chloro-(3-chlorophenyl)methylidene]indol-2-one Chemical compound C12=CC=CC=C2N(C(=O)C)C(=O)C1=C(Cl)C1=CC=CC(Cl)=C1 VBEZANSTFXHVGE-UHFFFAOYSA-N 0.000 description 1
- QDEPRCDYLDGVOF-UHFFFAOYSA-N 1-acetyl-3-[chloro-(3-methoxyphenyl)methylidene]-5-nitroindol-2-one Chemical compound COC1=CC=CC(C(Cl)=C2C3=CC(=CC=C3N(C(C)=O)C2=O)[N+]([O-])=O)=C1 QDEPRCDYLDGVOF-UHFFFAOYSA-N 0.000 description 1
- FHEKDVMXEIAYBY-UHFFFAOYSA-N 1-acetyl-3-[chloro-(3-methoxyphenyl)methylidene]indol-2-one Chemical compound COC1=CC=CC(C(Cl)=C2C3=CC=CC=C3N(C(C)=O)C2=O)=C1 FHEKDVMXEIAYBY-UHFFFAOYSA-N 0.000 description 1
- MEQCKWYCIFAHLK-UHFFFAOYSA-N 1-acetyl-3-[chloro-(3-methylphenyl)methylidene]-5-nitroindol-2-one Chemical compound C12=CC([N+]([O-])=O)=CC=C2N(C(=O)C)C(=O)C1=C(Cl)C1=CC=CC(C)=C1 MEQCKWYCIFAHLK-UHFFFAOYSA-N 0.000 description 1
- GSVNDEDVCYZVPE-UHFFFAOYSA-N 1-acetyl-3-[chloro-(3-methylphenyl)methylidene]indol-2-one Chemical compound C12=CC=CC=C2N(C(=O)C)C(=O)C1=C(Cl)C1=CC=CC(C)=C1 GSVNDEDVCYZVPE-UHFFFAOYSA-N 0.000 description 1
- UNHNTUUWXZEODG-UHFFFAOYSA-N 1-acetyl-3-[chloro-(4-chlorophenyl)methylidene]-5-nitroindol-2-one Chemical compound C12=CC([N+]([O-])=O)=CC=C2N(C(=O)C)C(=O)C1=C(Cl)C1=CC=C(Cl)C=C1 UNHNTUUWXZEODG-UHFFFAOYSA-N 0.000 description 1
- XRSFSIJKBCYGLM-UHFFFAOYSA-N 1-acetyl-3-[chloro-(4-chlorophenyl)methylidene]indol-2-one Chemical compound C12=CC=CC=C2N(C(=O)C)C(=O)C1=C(Cl)C1=CC=C(Cl)C=C1 XRSFSIJKBCYGLM-UHFFFAOYSA-N 0.000 description 1
- AXALTPYVBIEWCL-UHFFFAOYSA-N 1-acetyl-3-[chloro-(4-methoxyphenyl)methylidene]-5-nitroindol-2-one Chemical compound C1=CC(OC)=CC=C1C(Cl)=C1C2=CC([N+]([O-])=O)=CC=C2N(C(C)=O)C1=O AXALTPYVBIEWCL-UHFFFAOYSA-N 0.000 description 1
- KROVZNJBDJHXKW-UHFFFAOYSA-N 1-acetyl-3-[chloro-(4-methoxyphenyl)methylidene]indol-2-one Chemical compound C1=CC(OC)=CC=C1C(Cl)=C1C2=CC=CC=C2N(C(C)=O)C1=O KROVZNJBDJHXKW-UHFFFAOYSA-N 0.000 description 1
- JHBKIAOGFLRBGV-UHFFFAOYSA-N 1-acetyl-3-[chloro-(4-methylphenyl)methylidene]-5-nitroindol-2-one Chemical compound C12=CC([N+]([O-])=O)=CC=C2N(C(=O)C)C(=O)C1=C(Cl)C1=CC=C(C)C=C1 JHBKIAOGFLRBGV-UHFFFAOYSA-N 0.000 description 1
- BSBAJSVPIPJMOE-UHFFFAOYSA-N 1-acetyl-3-[chloro-(4-methylphenyl)methylidene]indol-2-one Chemical compound C12=CC=CC=C2N(C(=O)C)C(=O)C1=C(Cl)C1=CC=C(C)C=C1 BSBAJSVPIPJMOE-UHFFFAOYSA-N 0.000 description 1
- UGSDSLDENFGTAO-UHFFFAOYSA-N 1-acetyl-3-[chloro-(4-nitrophenyl)methylidene]-5-nitroindol-2-one Chemical compound C12=CC([N+]([O-])=O)=CC=C2N(C(=O)C)C(=O)C1=C(Cl)C1=CC=C([N+]([O-])=O)C=C1 UGSDSLDENFGTAO-UHFFFAOYSA-N 0.000 description 1
- DIWAKJHSJQCQSX-UHFFFAOYSA-N 1-acetyl-3-[chloro-(4-nitrophenyl)methylidene]indol-2-one Chemical compound C12=CC=CC=C2N(C(=O)C)C(=O)C1=C(Cl)C1=CC=C([N+]([O-])=O)C=C1 DIWAKJHSJQCQSX-UHFFFAOYSA-N 0.000 description 1
- BMDPDMQPIPVDNL-UHFFFAOYSA-N 1-benzoyl-3-[hydroxy(phenyl)methylidene]-5-nitroindol-2-one Chemical compound C=1C=CC=CC=1C(O)=C(C1=CC(=CC=C11)[N+]([O-])=O)C(=O)N1C(=O)C1=CC=CC=C1 BMDPDMQPIPVDNL-UHFFFAOYSA-N 0.000 description 1
- TXUAIIYHILSAFA-UHFFFAOYSA-N 1-benzoyl-3-[methoxy(phenyl)methylidene]-5-nitroindol-2-one Chemical compound C=1C=CC=CC=1C(OC)=C(C1=CC(=CC=C11)[N+]([O-])=O)C(=O)N1C(=O)C1=CC=CC=C1 TXUAIIYHILSAFA-UHFFFAOYSA-N 0.000 description 1
- ZDFBKZUDCQQKAC-UHFFFAOYSA-N 1-bromo-4-nitrobenzene Chemical compound [O-][N+](=O)C1=CC=C(Br)C=C1 ZDFBKZUDCQQKAC-UHFFFAOYSA-N 0.000 description 1
- CYNYIHKIEHGYOZ-UHFFFAOYSA-N 1-bromopropane Chemical compound CCCBr CYNYIHKIEHGYOZ-UHFFFAOYSA-N 0.000 description 1
- SDVUGYBXYRPXIC-VHXPQNKSSA-N 1-butyl-3-[4-[[(z)-(2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]phenyl]urea Chemical compound C1=CC(NC(=O)NCCCC)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC=CC=C2NC\1=O SDVUGYBXYRPXIC-VHXPQNKSSA-N 0.000 description 1
- BJSZMPUYUZILQV-DQRAZIAOSA-N 1-ethyl-3-[4-[[(z)-(2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]phenyl]urea Chemical compound C1=CC(NC(=O)NCC)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC=CC=C2NC\1=O BJSZMPUYUZILQV-DQRAZIAOSA-N 0.000 description 1
- RSQUAQMIGSMNNE-UHFFFAOYSA-N 1-methyl-3h-indol-2-one Chemical compound C1=CC=C2N(C)C(=O)CC2=C1 RSQUAQMIGSMNNE-UHFFFAOYSA-N 0.000 description 1
- HEWZVZIVELJPQZ-UHFFFAOYSA-N 2,2-dimethoxypropane Chemical compound COC(C)(C)OC HEWZVZIVELJPQZ-UHFFFAOYSA-N 0.000 description 1
- ILUYJGDLNQXJQE-UHFFFAOYSA-N 2,2-dimethylpropane-1,1,1-triol Chemical compound CC(C)(C)C(O)(O)O ILUYJGDLNQXJQE-UHFFFAOYSA-N 0.000 description 1
- LNSCNEJNLACZPA-UHFFFAOYSA-N 2,3-dihydroxy-2,3-bis(2-methylphenyl)butanedioic acid Chemical compound CC1=CC=CC=C1C(O)(C(O)=O)C(O)(C(O)=O)C1=CC=CC=C1C LNSCNEJNLACZPA-UHFFFAOYSA-N 0.000 description 1
- FRBGULMTIORCQU-ZIADKAODSA-N 2-(1,3-dioxoisoindol-2-yl)-n-methyl-n-[4-[[(z)-(5-nitro-2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]phenyl]acetamide Chemical compound O=C1C2=CC=CC=C2C(=O)N1CC(=O)N(C)C(C=C1)=CC=C1N\C(=C/1C2=CC(=CC=C2NC\1=O)[N+]([O-])=O)C1=CC=CC=C1 FRBGULMTIORCQU-ZIADKAODSA-N 0.000 description 1
- PAWQVTBBRAZDMG-UHFFFAOYSA-N 2-(3-bromo-2-fluorophenyl)acetic acid Chemical compound OC(=O)CC1=CC=CC(Br)=C1F PAWQVTBBRAZDMG-UHFFFAOYSA-N 0.000 description 1
- HXKPBZZKBXEHIL-YHZPTAEISA-N 2-(4-benzylpiperazin-1-yl)-n-methyl-n-[4-[[(z)-(2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]phenyl]acetamide Chemical compound C=1C=C(N\C(=C/2C3=CC=CC=C3NC\2=O)C=2C=CC=CC=2)C=CC=1N(C)C(=O)CN(CC1)CCN1CC1=CC=CC=C1 HXKPBZZKBXEHIL-YHZPTAEISA-N 0.000 description 1
- WQTZIUWBQRZLPC-RQZHXJHFSA-N 2-(4-methylpiperazin-1-yl)-n-[4-[[(z)-(5-nitro-2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]phenyl]acetamide Chemical compound C1CN(C)CCN1CC(=O)NC(C=C1)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC([N+]([O-])=O)=CC=C2NC\1=O WQTZIUWBQRZLPC-RQZHXJHFSA-N 0.000 description 1
- CUNGDWMGLRMRAH-OQKDUQJOSA-N 2-(diethylamino)-n-[4-[[(z)-(2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]phenyl]acetamide;hydrochloride Chemical compound Cl.C1=CC(NC(=O)CN(CC)CC)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC=CC=C2NC\1=O CUNGDWMGLRMRAH-OQKDUQJOSA-N 0.000 description 1
- PEBHWYKGKNORBV-OQKDUQJOSA-N 2-(diethylamino)-n-[4-[[(z)-(5-nitro-2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]phenyl]acetamide;hydrochloride Chemical compound Cl.C1=CC(NC(=O)CN(CC)CC)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC([N+]([O-])=O)=CC=C2NC\1=O PEBHWYKGKNORBV-OQKDUQJOSA-N 0.000 description 1
- VUHNCOSDSQCIPX-RQZHXJHFSA-N 2-(diethylamino)-n-methyl-n-[4-[[(z)-(2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]phenyl]acetamide Chemical compound C1=CC(N(C)C(=O)CN(CC)CC)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC=CC=C2NC\1=O VUHNCOSDSQCIPX-RQZHXJHFSA-N 0.000 description 1
- PPPXPUOBHLJWJE-VHXPQNKSSA-N 2-(dimethylamino)-n-[4-[[(z)-(2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]phenyl]acetamide Chemical compound C1=CC(NC(=O)CN(C)C)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC=CC=C2NC\1=O PPPXPUOBHLJWJE-VHXPQNKSSA-N 0.000 description 1
- AYKSCQRLKKCOCV-VHXPQNKSSA-N 2-(dimethylamino)-n-[4-[[(z)-(5-nitro-2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]phenyl]acetamide Chemical compound C1=CC(NC(=O)CN(C)C)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC([N+]([O-])=O)=CC=C2NC\1=O AYKSCQRLKKCOCV-VHXPQNKSSA-N 0.000 description 1
- GGNCALZIESQFEI-IZHYLOQSSA-N 2-(dimethylamino)-n-[[3-[[(z)-(5-nitro-2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]phenyl]methyl]acetamide Chemical compound CN(C)CC(=O)NCC1=CC=CC(N\C(=C/2C3=CC(=CC=C3NC\2=O)[N+]([O-])=O)C=2C=CC=CC=2)=C1 GGNCALZIESQFEI-IZHYLOQSSA-N 0.000 description 1
- SSXJEYHMLMGYEB-IZHYLOQSSA-N 2-(dimethylamino)-n-[[4-[[(z)-(2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]phenyl]methyl]acetamide Chemical compound C1=CC(CNC(=O)CN(C)C)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC=CC=C2NC\1=O SSXJEYHMLMGYEB-IZHYLOQSSA-N 0.000 description 1
- HETNPHOULPYIFA-BJFQDICYSA-N 2-(dimethylamino)-n-methyl-n-[4-[[(z)-(2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]phenyl]acetamide;hydrochloride Chemical compound Cl.C1=CC(N(C)C(=O)CN(C)C)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC=CC=C2NC\1=O HETNPHOULPYIFA-BJFQDICYSA-N 0.000 description 1
- AJXLFJVQXSNVCN-DQRAZIAOSA-N 2-[3-[[(z)-(2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]phenyl]acetic acid Chemical compound OC(=O)CC1=CC=CC(N\C(=C/2C3=CC=CC=C3NC\2=O)C=2C=CC=CC=2)=C1 AJXLFJVQXSNVCN-DQRAZIAOSA-N 0.000 description 1
- RCLGLPQHXUVLLS-VXPUYCOJSA-N 2-[3-[[(z)-(2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]phenyl]guanidine Chemical compound NC(=N)NC1=CC=CC(N\C(=C/2C3=CC=CC=C3NC\2=O)C=2C=CC=CC=2)=C1 RCLGLPQHXUVLLS-VXPUYCOJSA-N 0.000 description 1
- CFCLCLSJDZCORO-DQRAZIAOSA-N 2-[4-[[(z)-(2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]phenyl]acetic acid Chemical compound C1=CC(CC(=O)O)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC=CC=C2NC\1=O CFCLCLSJDZCORO-DQRAZIAOSA-N 0.000 description 1
- WWOKVSSFDQGJDV-VXPUYCOJSA-N 2-[4-[[(z)-(2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]phenyl]guanidine Chemical compound C1=CC(N=C(N)N)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC=CC=C2NC\1=O WWOKVSSFDQGJDV-VXPUYCOJSA-N 0.000 description 1
- IZJZIOBYEDDNBN-VXPUYCOJSA-N 2-[[(z)-(2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]benzoic acid Chemical compound OC(=O)C1=CC=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC=CC=C2NC\1=O IZJZIOBYEDDNBN-VXPUYCOJSA-N 0.000 description 1
- DVLQUTSVOKLSPM-DQRAZIAOSA-N 2-[[3-[[(z)-(2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]benzoyl]amino]acetic acid Chemical compound OC(=O)CNC(=O)C1=CC=CC(N\C(=C/2C3=CC=CC=C3NC\2=O)C=2C=CC=CC=2)=C1 DVLQUTSVOKLSPM-DQRAZIAOSA-N 0.000 description 1
- HHEWBIALIIURGU-UHFFFAOYSA-N 2-[ethyl-[2-[4-(2-phenylhydrazinyl)phenyl]ethyl]amino]ethanol Chemical compound C1=CC(CCN(CCO)CC)=CC=C1NNC1=CC=CC=C1 HHEWBIALIIURGU-UHFFFAOYSA-N 0.000 description 1
- GUTXPJZJAJBPDA-FCQUAONHSA-N 2-[methyl-[3-[[(z)-(2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]benzoyl]amino]acetic acid Chemical compound OC(=O)CN(C)C(=O)C1=CC=CC(N\C(=C/2C3=CC=CC=C3NC\2=O)C=2C=CC=CC=2)=C1 GUTXPJZJAJBPDA-FCQUAONHSA-N 0.000 description 1
- UYMOXOAGSUFIMP-FLWNBWAVSA-N 2-[n-(benzenesulfonyl)-4-[[(z)-(2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]anilino]-n,n-dimethylacetamide Chemical compound C=1C=CC=CC=1S(=O)(=O)N(CC(=O)N(C)C)C(C=C1)=CC=C1N\C(=C/1C2=CC=CC=C2NC\1=O)C1=CC=CC=C1 UYMOXOAGSUFIMP-FLWNBWAVSA-N 0.000 description 1
- BMAMMVXSWGUEMT-FLWNBWAVSA-N 2-[n-(benzenesulfonyl)-4-[[(z)-(5-nitro-2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]anilino]-n,n-dimethylacetamide Chemical compound C=1C=CC=CC=1S(=O)(=O)N(CC(=O)N(C)C)C(C=C1)=CC=C1N\C(=C/1C2=CC(=CC=C2NC\1=O)[N+]([O-])=O)C1=CC=CC=C1 BMAMMVXSWGUEMT-FLWNBWAVSA-N 0.000 description 1
- LOQMWEBMCMBYGR-KTMFPKCZSA-N 2-[n-benzylsulfonyl-4-[[(z)-(2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]anilino]-n,n-dimethylacetamide Chemical compound C=1C=CC=CC=1CS(=O)(=O)N(CC(=O)N(C)C)C(C=C1)=CC=C1N\C(=C/1C2=CC=CC=C2NC\1=O)C1=CC=CC=C1 LOQMWEBMCMBYGR-KTMFPKCZSA-N 0.000 description 1
- GFQWYSBUVAVPFR-QPLCGJKRSA-N 2-[n-ethylsulfonyl-4-[[(z)-(5-nitro-2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]anilino]-n,n-dimethylacetamide Chemical compound C1=CC(N(CC(=O)N(C)C)S(=O)(=O)CC)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC([N+]([O-])=O)=CC=C2NC\1=O GFQWYSBUVAVPFR-QPLCGJKRSA-N 0.000 description 1
- SSSBTUOQBLUITL-FCQUAONHSA-N 2-[n-methylsulfonyl-4-[[(z)-(2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]anilino]acetamide Chemical compound C1=CC(N(CC(N)=O)S(=O)(=O)C)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC=CC=C2NC\1=O SSSBTUOQBLUITL-FCQUAONHSA-N 0.000 description 1
- JQIAEBNIHIZLTE-IZHYLOQSSA-N 2-acetamido-n-methyl-n-[4-[[(z)-(5-nitro-2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]phenyl]acetamide Chemical compound C1=CC(N(C(=O)CNC(C)=O)C)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC([N+]([O-])=O)=CC=C2NC\1=O JQIAEBNIHIZLTE-IZHYLOQSSA-N 0.000 description 1
- MYXZPKTXJCMJPB-SVXKRPBISA-N 2-amino-3-[4-[[(z)-(5-nitro-2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]phenyl]propanoic acid;hydrochloride Chemical compound Cl.C1=CC(CC(N)C(O)=O)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC([N+]([O-])=O)=CC=C2NC\1=O MYXZPKTXJCMJPB-SVXKRPBISA-N 0.000 description 1
- LZKCWEYQIJQNOS-YJACDMIVSA-N 2-amino-n-[[4-[[(z)-(2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]phenyl]methyl]acetamide;hydrochloride Chemical compound Cl.C1=CC(CNC(=O)CN)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC=CC=C2NC\1=O LZKCWEYQIJQNOS-YJACDMIVSA-N 0.000 description 1
- KMGUEILFFWDGFV-UHFFFAOYSA-N 2-benzoyl-2-benzoyloxy-3-hydroxybutanedioic acid Chemical compound C=1C=CC=CC=1C(=O)C(C(C(O)=O)O)(C(O)=O)OC(=O)C1=CC=CC=C1 KMGUEILFFWDGFV-UHFFFAOYSA-N 0.000 description 1
- XSKCUIFGKBMFOW-UHFFFAOYSA-N 2-bromo-n-(4-nitrophenyl)acetamide Chemical compound [O-][N+](=O)C1=CC=C(NC(=O)CBr)C=C1 XSKCUIFGKBMFOW-UHFFFAOYSA-N 0.000 description 1
- REXUYBKPWIPONM-UHFFFAOYSA-N 2-bromoacetonitrile Chemical compound BrCC#N REXUYBKPWIPONM-UHFFFAOYSA-N 0.000 description 1
- ULQQGOGMQRGFFR-UHFFFAOYSA-N 2-chlorobenzenecarboperoxoic acid Chemical compound OOC(=O)C1=CC=CC=C1Cl ULQQGOGMQRGFFR-UHFFFAOYSA-N 0.000 description 1
- UNCQVRBWJWWJBF-UHFFFAOYSA-N 2-chloropyrimidine Chemical compound ClC1=NC=CC=N1 UNCQVRBWJWWJBF-UHFFFAOYSA-N 0.000 description 1
- PAULIRRXECKSOF-VHXPQNKSSA-N 2-methoxy-n-[[4-[[(z)-(2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]phenyl]methyl]acetamide Chemical compound C1=CC(CNC(=O)COC)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC=CC=C2NC\1=O PAULIRRXECKSOF-VHXPQNKSSA-N 0.000 description 1
- YOETUEMZNOLGDB-UHFFFAOYSA-N 2-methylpropyl carbonochloridate Chemical compound CC(C)COC(Cl)=O YOETUEMZNOLGDB-UHFFFAOYSA-N 0.000 description 1
- NCFZYIGWHNJYTG-QPLCGJKRSA-N 2-morpholin-4-yl-n-[4-[[(z)-(5-nitro-2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]phenyl]acetamide Chemical compound C12=CC([N+](=O)[O-])=CC=C2NC(=O)\C1=C(C=1C=CC=CC=1)/NC(C=C1)=CC=C1NC(=O)CN1CCOCC1 NCFZYIGWHNJYTG-QPLCGJKRSA-N 0.000 description 1
- KHBWFBLWJSAEPN-RQZHXJHFSA-N 2-morpholin-4-yl-n-[[4-[[(z)-(5-nitro-2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]phenyl]methyl]acetamide Chemical compound C12=CC([N+](=O)[O-])=CC=C2NC(=O)\C1=C(C=1C=CC=CC=1)/NC(C=C1)=CC=C1CNC(=O)CN1CCOCC1 KHBWFBLWJSAEPN-RQZHXJHFSA-N 0.000 description 1
- HCDMJFOHIXMBOV-UHFFFAOYSA-N 3-(2,6-difluoro-3,5-dimethoxyphenyl)-1-ethyl-8-(morpholin-4-ylmethyl)-4,7-dihydropyrrolo[4,5]pyrido[1,2-d]pyrimidin-2-one Chemical compound C=1C2=C3N(CC)C(=O)N(C=4C(=C(OC)C=C(OC)C=4F)F)CC3=CN=C2NC=1CN1CCOCC1 HCDMJFOHIXMBOV-UHFFFAOYSA-N 0.000 description 1
- GVQXUIJHNUHNCG-UHFFFAOYSA-N 3-(methoxymethyl)aniline;hydrochloride Chemical compound Cl.COCC1=CC=CC(N)=C1 GVQXUIJHNUHNCG-UHFFFAOYSA-N 0.000 description 1
- IHHKTIKNEDOMIK-UHFFFAOYSA-N 3-(morpholin-4-ylmethyl)aniline Chemical compound NC1=CC=CC(CN2CCOCC2)=C1 IHHKTIKNEDOMIK-UHFFFAOYSA-N 0.000 description 1
- SEJNYLBEEMVJNN-UHFFFAOYSA-N 3-(piperidin-1-ylmethyl)aniline Chemical compound NC1=CC=CC(CN2CCCCC2)=C1 SEJNYLBEEMVJNN-UHFFFAOYSA-N 0.000 description 1
- ZGPHZHCPWKOKDX-UHFFFAOYSA-N 3-[(4-methylpiperazin-1-yl)methyl]aniline Chemical compound C1CN(C)CCN1CC1=CC=CC(N)=C1 ZGPHZHCPWKOKDX-UHFFFAOYSA-N 0.000 description 1
- YGYGASJNJTYNOL-CQSZACIVSA-N 3-[(4r)-2,2-dimethyl-1,1-dioxothian-4-yl]-5-(4-fluorophenyl)-1h-indole-7-carboxamide Chemical compound C1CS(=O)(=O)C(C)(C)C[C@@H]1C1=CNC2=C(C(N)=O)C=C(C=3C=CC(F)=CC=3)C=C12 YGYGASJNJTYNOL-CQSZACIVSA-N 0.000 description 1
- WOJBIBHVUSZAGS-UHFFFAOYSA-N 3-[(dimethylamino)methyl]aniline Chemical compound CN(C)CC1=CC=CC(N)=C1 WOJBIBHVUSZAGS-UHFFFAOYSA-N 0.000 description 1
- LLJJDLHGZUOMQP-UHFFFAOYSA-N 3-[1-[3-(dimethylamino)propyl]-5-methoxy-3-indolyl]-4-(1H-indol-3-yl)pyrrole-2,5-dione Chemical compound C1=CC=C2C(C3=C(C(NC3=O)=O)C3=CN(CCCN(C)C)C4=CC=C(C=C43)OC)=CNC2=C1 LLJJDLHGZUOMQP-UHFFFAOYSA-N 0.000 description 1
- WNEODWDFDXWOLU-QHCPKHFHSA-N 3-[3-(hydroxymethyl)-4-[1-methyl-5-[[5-[(2s)-2-methyl-4-(oxetan-3-yl)piperazin-1-yl]pyridin-2-yl]amino]-6-oxopyridin-3-yl]pyridin-2-yl]-7,7-dimethyl-1,2,6,8-tetrahydrocyclopenta[3,4]pyrrolo[3,5-b]pyrazin-4-one Chemical compound C([C@@H](N(CC1)C=2C=NC(NC=3C(N(C)C=C(C=3)C=3C(=C(N4C(C5=CC=6CC(C)(C)CC=6N5CC4)=O)N=CC=3)CO)=O)=CC=2)C)N1C1COC1 WNEODWDFDXWOLU-QHCPKHFHSA-N 0.000 description 1
- SRVXSISGYBMIHR-UHFFFAOYSA-N 3-[3-[3-(2-amino-2-oxoethyl)phenyl]-5-chlorophenyl]-3-(5-methyl-1,3-thiazol-2-yl)propanoic acid Chemical compound S1C(C)=CN=C1C(CC(O)=O)C1=CC(Cl)=CC(C=2C=C(CC(N)=O)C=CC=2)=C1 SRVXSISGYBMIHR-UHFFFAOYSA-N 0.000 description 1
- FARRLVNUTDPCKZ-VXPUYCOJSA-N 3-[[(z)-(2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]benzamide Chemical compound NC(=O)C1=CC=CC(N\C(=C/2C3=CC=CC=C3NC\2=O)C=2C=CC=CC=2)=C1 FARRLVNUTDPCKZ-VXPUYCOJSA-N 0.000 description 1
- JECZANQOTCBTPI-VXPUYCOJSA-N 3-[[(z)-(2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]benzenecarboximidamide Chemical compound NC(=N)C1=CC=CC(N\C(=C/2C3=CC=CC=C3NC\2=O)C=2C=CC=CC=2)=C1 JECZANQOTCBTPI-VXPUYCOJSA-N 0.000 description 1
- KXCPLFRBMOJFAE-BLTQDSCZSA-N 3-[[(z)-(5-nitro-2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]benzenecarboximidamide;hydrochloride Chemical compound Cl.NC(=N)C1=CC=CC(N\C(=C/2C3=CC(=CC=C3NC\2=O)[N+]([O-])=O)C=2C=CC=CC=2)=C1 KXCPLFRBMOJFAE-BLTQDSCZSA-N 0.000 description 1
- QJRNFTHLSCULPS-MRCUWXFGSA-N 3-[[(z)-(5-nitro-2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]benzonitrile Chemical compound C12=CC([N+](=O)[O-])=CC=C2NC(=O)\C1=C(C=1C=CC=CC=1)/NC1=CC=CC(C#N)=C1 QJRNFTHLSCULPS-MRCUWXFGSA-N 0.000 description 1
- MPGFDLPTKSCBFM-VHXPQNKSSA-N 3-[[3-[[(z)-(5-nitro-2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]phenyl]methylamino]propanoic acid Chemical compound OC(=O)CCNCC1=CC=CC(N\C(=C/2C3=CC(=CC=C3NC\2=O)[N+]([O-])=O)C=2C=CC=CC=2)=C1 MPGFDLPTKSCBFM-VHXPQNKSSA-N 0.000 description 1
- QUEUIUFAYYSJPK-VHXPQNKSSA-N 3-[[4-[[(z)-(5-nitro-2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]phenyl]methylamino]propanoic acid Chemical compound C1=CC(CNCCC(=O)O)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC([N+]([O-])=O)=CC=C2NC\1=O QUEUIUFAYYSJPK-VHXPQNKSSA-N 0.000 description 1
- GSCPDZHWVNUUFI-UHFFFAOYSA-N 3-aminobenzamide Chemical compound NC(=O)C1=CC=CC(N)=C1 GSCPDZHWVNUUFI-UHFFFAOYSA-N 0.000 description 1
- VWDSNVUXQDDXBN-UHFFFAOYSA-N 3-aminobenzenecarboximidamide Chemical compound NC(=N)C1=CC=CC(N)=C1 VWDSNVUXQDDXBN-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- OXFDNUZWKFKMSB-UHFFFAOYSA-N 4-(2,2,2-trifluoroethoxy)aniline Chemical compound NC1=CC=C(OCC(F)(F)F)C=C1 OXFDNUZWKFKMSB-UHFFFAOYSA-N 0.000 description 1
- LLPIMIMXCXEFER-UHFFFAOYSA-N 4-(2-morpholin-4-ylethyl)aniline Chemical compound C1=CC(N)=CC=C1CCN1CCOCC1 LLPIMIMXCXEFER-UHFFFAOYSA-N 0.000 description 1
- BUEFNCLNVXCFFS-UHFFFAOYSA-N 4-(2-piperidin-1-ylethyl)aniline Chemical compound C1=CC(N)=CC=C1CCN1CCCCC1 BUEFNCLNVXCFFS-UHFFFAOYSA-N 0.000 description 1
- MHCRLDZZHOVFEE-UHFFFAOYSA-N 4-(4-aminophenyl)morpholin-3-one Chemical compound C1=CC(N)=CC=C1N1C(=O)COCC1 MHCRLDZZHOVFEE-UHFFFAOYSA-N 0.000 description 1
- SGMPFYOXEVRSHS-UHFFFAOYSA-N 4-(azepan-1-ylmethyl)aniline Chemical compound C1=CC(N)=CC=C1CN1CCCCCC1 SGMPFYOXEVRSHS-UHFFFAOYSA-N 0.000 description 1
- JEDXDYXIRZOEKG-UHFFFAOYSA-N 4-(methylamino)benzonitrile Chemical compound CNC1=CC=C(C#N)C=C1 JEDXDYXIRZOEKG-UHFFFAOYSA-N 0.000 description 1
- DRYFDUUAYSVNSN-UHFFFAOYSA-N 4-(piperidin-1-ylmethyl)aniline Chemical compound C1=CC(N)=CC=C1CN1CCCCC1 DRYFDUUAYSVNSN-UHFFFAOYSA-N 0.000 description 1
- TZMCILRCGMFRJC-UHFFFAOYSA-N 4-[(1,1-dioxo-1,4-thiazinan-4-yl)methyl]aniline Chemical compound C1=CC(N)=CC=C1CN1CCS(=O)(=O)CC1 TZMCILRCGMFRJC-UHFFFAOYSA-N 0.000 description 1
- ZWKIQKGSORSPTH-UHFFFAOYSA-N 4-[(2-methoxyethylamino)methyl]aniline Chemical compound COCCNCC1=CC=C(N)C=C1 ZWKIQKGSORSPTH-UHFFFAOYSA-N 0.000 description 1
- VJPPLCNBDLZIFG-ZDUSSCGKSA-N 4-[(3S)-3-(but-2-ynoylamino)piperidin-1-yl]-5-fluoro-2,3-dimethyl-1H-indole-7-carboxamide Chemical compound C(C#CC)(=O)N[C@@H]1CN(CCC1)C1=C2C(=C(NC2=C(C=C1F)C(=O)N)C)C VJPPLCNBDLZIFG-ZDUSSCGKSA-N 0.000 description 1
- BIWGVNAYKPHYHU-UHFFFAOYSA-N 4-[(4-benzylpiperidin-1-yl)methyl]aniline Chemical compound C1=CC(N)=CC=C1CN1CCC(CC=2C=CC=CC=2)CC1 BIWGVNAYKPHYHU-UHFFFAOYSA-N 0.000 description 1
- MYUXYVDWWHXMMH-UHFFFAOYSA-N 4-[(4-ethylpiperidin-1-yl)methyl]aniline Chemical compound C1CC(CC)CCN1CC1=CC=C(N)C=C1 MYUXYVDWWHXMMH-UHFFFAOYSA-N 0.000 description 1
- GQWQLBVBTIRPCU-UHFFFAOYSA-N 4-[(4-methoxypiperidin-1-yl)methyl]aniline Chemical compound C1CC(OC)CCN1CC1=CC=C(N)C=C1 GQWQLBVBTIRPCU-UHFFFAOYSA-N 0.000 description 1
- UJZKENORBCZXBM-UHFFFAOYSA-N 4-[(4-methylpiperidin-1-yl)methyl]aniline Chemical compound C1CC(C)CCN1CC1=CC=C(N)C=C1 UJZKENORBCZXBM-UHFFFAOYSA-N 0.000 description 1
- PFSAJWAUWMBHTP-UHFFFAOYSA-N 4-[(4-nitrophenyl)methyl]-1,4-thiazinane 1,1-dioxide Chemical compound C1=CC([N+](=O)[O-])=CC=C1CN1CCS(=O)(=O)CC1 PFSAJWAUWMBHTP-UHFFFAOYSA-N 0.000 description 1
- NZEPOTOSLXJCLQ-UHFFFAOYSA-N 4-[(4-nitrophenyl)methyl]thiomorpholine Chemical compound C1=CC([N+](=O)[O-])=CC=C1CN1CCSCC1 NZEPOTOSLXJCLQ-UHFFFAOYSA-N 0.000 description 1
- IMMDNRXGZICMBC-UHFFFAOYSA-N 4-[2-(diethylamino)ethyl]aniline Chemical compound CCN(CC)CCC1=CC=C(N)C=C1 IMMDNRXGZICMBC-UHFFFAOYSA-N 0.000 description 1
- XPKKPVBDOPPWJU-UHFFFAOYSA-N 4-[2-(dimethylamino)ethyl]aniline Chemical compound CN(C)CCC1=CC=C(N)C=C1 XPKKPVBDOPPWJU-UHFFFAOYSA-N 0.000 description 1
- YFCIFWOJYYFDQP-PTWZRHHISA-N 4-[3-amino-6-[(1S,3S,4S)-3-fluoro-4-hydroxycyclohexyl]pyrazin-2-yl]-N-[(1S)-1-(3-bromo-5-fluorophenyl)-2-(methylamino)ethyl]-2-fluorobenzamide Chemical compound CNC[C@@H](NC(=O)c1ccc(cc1F)-c1nc(cnc1N)[C@H]1CC[C@H](O)[C@@H](F)C1)c1cc(F)cc(Br)c1 YFCIFWOJYYFDQP-PTWZRHHISA-N 0.000 description 1
- XYWIPYBIIRTJMM-IBGZPJMESA-N 4-[[(2S)-2-[4-[5-chloro-2-[4-(trifluoromethyl)triazol-1-yl]phenyl]-5-methoxy-2-oxopyridin-1-yl]butanoyl]amino]-2-fluorobenzamide Chemical compound CC[C@H](N1C=C(OC)C(=CC1=O)C1=C(C=CC(Cl)=C1)N1C=C(N=N1)C(F)(F)F)C(=O)NC1=CC(F)=C(C=C1)C(N)=O XYWIPYBIIRTJMM-IBGZPJMESA-N 0.000 description 1
- GYNXIPISMJHYPG-RQZHXJHFSA-N 4-[[(z)-(1-benzoyl-2-oxoindol-3-ylidene)-phenylmethyl]amino]benzonitrile Chemical compound C=1C=CC=CC=1C(=O)N(C1=CC=CC=C11)C(=O)\C1=C(C=1C=CC=CC=1)/NC1=CC=C(C#N)C=C1 GYNXIPISMJHYPG-RQZHXJHFSA-N 0.000 description 1
- YGIKIIZOJZKPFV-VXPUYCOJSA-N 4-[[(z)-(2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]benzamide Chemical compound C1=CC(C(=O)N)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC=CC=C2NC\1=O YGIKIIZOJZKPFV-VXPUYCOJSA-N 0.000 description 1
- FTVDIXZMZVYOPD-MRCUWXFGSA-N 4-[[(z)-(2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]benzonitrile Chemical compound O=C1NC2=CC=CC=C2\C1=C(C=1C=CC=CC=1)\NC1=CC=C(C#N)C=C1 FTVDIXZMZVYOPD-MRCUWXFGSA-N 0.000 description 1
- XOTHPVVNBJSFOE-BLTQDSCZSA-N 4-[[(z)-(5-nitro-2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]benzenecarboximidamide;hydrochloride Chemical compound Cl.C1=CC(C(=N)N)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC([N+]([O-])=O)=CC=C2NC\1=O XOTHPVVNBJSFOE-BLTQDSCZSA-N 0.000 description 1
- OKKBLILNOVAFDN-VXPUYCOJSA-N 4-[[(z)-(5-nitro-2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]benzoic acid Chemical compound C1=CC(C(=O)O)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC([N+]([O-])=O)=CC=C2NC\1=O OKKBLILNOVAFDN-VXPUYCOJSA-N 0.000 description 1
- JRJBTEMRIFGSMS-MRCUWXFGSA-N 4-[[(z)-(5-nitro-2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]benzonitrile Chemical compound C12=CC([N+](=O)[O-])=CC=C2NC(=O)\C1=C(C=1C=CC=CC=1)/NC1=CC=C(C#N)C=C1 JRJBTEMRIFGSMS-MRCUWXFGSA-N 0.000 description 1
- KVCQTKNUUQOELD-UHFFFAOYSA-N 4-amino-n-[1-(3-chloro-2-fluoroanilino)-6-methylisoquinolin-5-yl]thieno[3,2-d]pyrimidine-7-carboxamide Chemical compound N=1C=CC2=C(NC(=O)C=3C4=NC=NC(N)=C4SC=3)C(C)=CC=C2C=1NC1=CC=CC(Cl)=C1F KVCQTKNUUQOELD-UHFFFAOYSA-N 0.000 description 1
- WPANETAWYGDRLL-UHFFFAOYSA-N 4-aminobenzenecarboximidamide Chemical compound NC(=N)C1=CC=C(N)C=C1 WPANETAWYGDRLL-UHFFFAOYSA-N 0.000 description 1
- WDFQBORIUYODSI-UHFFFAOYSA-N 4-bromoaniline Chemical compound NC1=CC=C(Br)C=C1 WDFQBORIUYODSI-UHFFFAOYSA-N 0.000 description 1
- QSNSCYSYFYORTR-UHFFFAOYSA-N 4-chloroaniline Chemical compound NC1=CC=C(Cl)C=C1 QSNSCYSYFYORTR-UHFFFAOYSA-N 0.000 description 1
- PHNDZBFLOPIMSM-UHFFFAOYSA-N 4-morpholin-4-ylaniline Chemical compound C1=CC(N)=CC=C1N1CCOCC1 PHNDZBFLOPIMSM-UHFFFAOYSA-N 0.000 description 1
- TYMLOMAKGOJONV-UHFFFAOYSA-N 4-nitroaniline Chemical compound NC1=CC=C([N+]([O-])=O)C=C1 TYMLOMAKGOJONV-UHFFFAOYSA-N 0.000 description 1
- BXRFQSNOROATLV-UHFFFAOYSA-N 4-nitrobenzaldehyde Chemical compound [O-][N+](=O)C1=CC=C(C=O)C=C1 BXRFQSNOROATLV-UHFFFAOYSA-N 0.000 description 1
- VOLRSQPSJGXRNJ-UHFFFAOYSA-N 4-nitrobenzyl bromide Chemical compound [O-][N+](=O)C1=CC=C(CBr)C=C1 VOLRSQPSJGXRNJ-UHFFFAOYSA-N 0.000 description 1
- VIIMCVYWOVXCTL-IZHYLOQSSA-N 4-oxo-4-[[4-[[(z)-(2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]phenyl]methylamino]butanoic acid Chemical compound C1=CC(CNC(=O)CCC(=O)O)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC=CC=C2NC\1=O VIIMCVYWOVXCTL-IZHYLOQSSA-N 0.000 description 1
- YYROPELSRYBVMQ-UHFFFAOYSA-N 4-toluenesulfonyl chloride Chemical compound CC1=CC=C(S(Cl)(=O)=O)C=C1 YYROPELSRYBVMQ-UHFFFAOYSA-N 0.000 description 1
- IRPVABHDSJVBNZ-RTHVDDQRSA-N 5-[1-(cyclopropylmethyl)-5-[(1R,5S)-3-(oxetan-3-yl)-3-azabicyclo[3.1.0]hexan-6-yl]pyrazol-3-yl]-3-(trifluoromethyl)pyridin-2-amine Chemical compound C1=C(C(F)(F)F)C(N)=NC=C1C1=NN(CC2CC2)C(C2[C@@H]3CN(C[C@@H]32)C2COC2)=C1 IRPVABHDSJVBNZ-RTHVDDQRSA-N 0.000 description 1
- JQCGHRDKVZPCRO-UHFFFAOYSA-N 5-nitro-1,3-dihydroindol-2-one Chemical compound [O-][N+](=O)C1=CC=C2NC(=O)CC2=C1 JQCGHRDKVZPCRO-UHFFFAOYSA-N 0.000 description 1
- KCBWAFJCKVKYHO-UHFFFAOYSA-N 6-(4-cyclopropyl-6-methoxypyrimidin-5-yl)-1-[[4-[1-propan-2-yl-4-(trifluoromethyl)imidazol-2-yl]phenyl]methyl]pyrazolo[3,4-d]pyrimidine Chemical compound C1(CC1)C1=NC=NC(=C1C1=NC=C2C(=N1)N(N=C2)CC1=CC=C(C=C1)C=1N(C=C(N=1)C(F)(F)F)C(C)C)OC KCBWAFJCKVKYHO-UHFFFAOYSA-N 0.000 description 1
- CYJRNFFLTBEQSQ-UHFFFAOYSA-N 8-(3-methyl-1-benzothiophen-5-yl)-N-(4-methylsulfonylpyridin-3-yl)quinoxalin-6-amine Chemical compound CS(=O)(=O)C1=C(C=NC=C1)NC=1C=C2N=CC=NC2=C(C=1)C=1C=CC2=C(C(=CS2)C)C=1 CYJRNFFLTBEQSQ-UHFFFAOYSA-N 0.000 description 1
- ZRPZPNYZFSJUPA-UHFFFAOYSA-N ARS-1620 Chemical compound Oc1cccc(F)c1-c1c(Cl)cc2c(ncnc2c1F)N1CCN(CC1)C(=O)C=C ZRPZPNYZFSJUPA-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 101100067974 Arabidopsis thaliana POP2 gene Proteins 0.000 description 1
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 208000020084 Bone disease Diseases 0.000 description 1
- IKEZHXBDGBTWDX-QPLCGJKRSA-N C(C)(C)(C)OC(=O)N(C)C(C1=CC=C(C=C1)N\C(\C1=CC=CC=C1)=C\1/C(NC2=CC=C(C=C12)[N+](=O)[O-])=O)NC(=O)C Chemical compound C(C)(C)(C)OC(=O)N(C)C(C1=CC=C(C=C1)N\C(\C1=CC=CC=C1)=C\1/C(NC2=CC=C(C=C12)[N+](=O)[O-])=O)NC(=O)C IKEZHXBDGBTWDX-QPLCGJKRSA-N 0.000 description 1
- MVCNTGQGYDYPGQ-RQZHXJHFSA-N C(C)(C)(C)OC(=O)N(C)C1=CC=C(C=C1)N(\C(\C1=CC=CC=C1)=C\1/C(NC2=CC=C(C=C12)[N+](=O)[O-])=O)CNC(=O)C Chemical compound C(C)(C)(C)OC(=O)N(C)C1=CC=C(C=C1)N(\C(\C1=CC=CC=C1)=C\1/C(NC2=CC=C(C=C12)[N+](=O)[O-])=O)CNC(=O)C MVCNTGQGYDYPGQ-RQZHXJHFSA-N 0.000 description 1
- GVUWGJMXHWANKL-QPLCGJKRSA-N C1=CC(CC(C(=O)OC)NC(=O)OC(C)(C)C)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC([N+]([O-])=O)=CC=C2NC\1=O Chemical compound C1=CC(CC(C(=O)OC)NC(=O)OC(C)(C)C)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC([N+]([O-])=O)=CC=C2NC\1=O GVUWGJMXHWANKL-QPLCGJKRSA-N 0.000 description 1
- CXEWMJXTWNOUHU-IZHYLOQSSA-N C1=CC(CC(NC(=O)OC(C)(C)C)C(O)=O)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC([N+]([O-])=O)=CC=C2NC\1=O Chemical compound C1=CC(CC(NC(=O)OC(C)(C)C)C(O)=O)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC([N+]([O-])=O)=CC=C2NC\1=O CXEWMJXTWNOUHU-IZHYLOQSSA-N 0.000 description 1
- UBTKSFKIOXUXTN-FCQUAONHSA-N C1=CC(CCN)=CC=C1N\C(C=1C=CC(CN)=CC=1)=C/1C2=CC([N+]([O-])=O)=CC=C2NC\1=O Chemical compound C1=CC(CCN)=CC=C1N\C(C=1C=CC(CN)=CC=1)=C/1C2=CC([N+]([O-])=O)=CC=C2NC\1=O UBTKSFKIOXUXTN-FCQUAONHSA-N 0.000 description 1
- YUFKFIIVYMUSJI-QPLCGJKRSA-N C1=CC(CNC(=O)C)=CC=C1N\C(C=1C=CC(CNC(C)=O)=CC=1)=C/1C2=CC([N+]([O-])=O)=CC=C2NC\1=O Chemical compound C1=CC(CNC(=O)C)=CC=C1N\C(C=1C=CC(CNC(C)=O)=CC=1)=C/1C2=CC([N+]([O-])=O)=CC=C2NC\1=O YUFKFIIVYMUSJI-QPLCGJKRSA-N 0.000 description 1
- UTSVQDCKCCXXNS-KTMFPKCZSA-N C1=CC(CNC(=O)OC(C)(C)C)=CC=C1N\C(C=1C=CC(CNC(=O)C=2C(=CC=CC=2)C(O)=O)=CC=1)=C/1C2=CC([N+]([O-])=O)=CC=C2NC\1=O Chemical compound C1=CC(CNC(=O)OC(C)(C)C)=CC=C1N\C(C=1C=CC(CNC(=O)C=2C(=CC=CC=2)C(O)=O)=CC=1)=C/1C2=CC([N+]([O-])=O)=CC=C2NC\1=O UTSVQDCKCCXXNS-KTMFPKCZSA-N 0.000 description 1
- HVKVJSGPXQQDQT-DQRAZIAOSA-N C1=CC(NC(=O)C)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC=CC=C2NC\1=O Chemical compound C1=CC(NC(=O)C)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC=CC=C2NC\1=O HVKVJSGPXQQDQT-DQRAZIAOSA-N 0.000 description 1
- HJHZDKVSVGHDKT-DQSJHHFOSA-N C1CN(C(=O)OC(C)(C)C)CCN1CC(C=C1)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC([N+]([O-])=O)=CC=C2NC\1=O Chemical compound C1CN(C(=O)OC(C)(C)C)CCN1CC(C=C1)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC([N+]([O-])=O)=CC=C2NC\1=O HJHZDKVSVGHDKT-DQSJHHFOSA-N 0.000 description 1
- DBSMMBVZOSPPFZ-KTMFPKCZSA-N C=1C=C(N\C(=C/2C3=CC(=CC=C3NC\2=O)[N+]([O-])=O)C=2C=CC=CC=2)C=CC=1CN(C(=O)OC(C)(C)C)CC1=CC=CC=C1 Chemical compound C=1C=C(N\C(=C/2C3=CC(=CC=C3NC\2=O)[N+]([O-])=O)C=2C=CC=CC=2)C=CC=1CN(C(=O)OC(C)(C)C)CC1=CC=CC=C1 DBSMMBVZOSPPFZ-KTMFPKCZSA-N 0.000 description 1
- 101150012716 CDK1 gene Proteins 0.000 description 1
- HPWVNGQYQSEYNT-UHFFFAOYSA-N CN(C)CCNC(=O)C=1C=C(C=CC1)NC(C1=CC=CC=C1)=C1/C(NC2=CC=CC=C12)=O Chemical compound CN(C)CCNC(=O)C=1C=C(C=CC1)NC(C1=CC=CC=C1)=C1/C(NC2=CC=CC=C12)=O HPWVNGQYQSEYNT-UHFFFAOYSA-N 0.000 description 1
- LSPHULWDVZXLIL-UHFFFAOYSA-N Camphoric acid Natural products CC1(C)C(C(O)=O)CCC1(C)C(O)=O LSPHULWDVZXLIL-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- HZUKWULYINVGHJ-YJACDMIVSA-N Cl.C1=CC(CNC(=O)CN)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC([N+]([O-])=O)=CC=C2NC\1=O Chemical compound Cl.C1=CC(CNC(=O)CN)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC([N+]([O-])=O)=CC=C2NC\1=O HZUKWULYINVGHJ-YJACDMIVSA-N 0.000 description 1
- KDUBXLAHXBRPAV-DCXSSQDFSA-N Cl.C1=CC(CNC(=O)CNC)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC([N+]([O-])=O)=CC=C2NC\1=O Chemical compound Cl.C1=CC(CNC(=O)CNC)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC([N+]([O-])=O)=CC=C2NC\1=O KDUBXLAHXBRPAV-DCXSSQDFSA-N 0.000 description 1
- AAWZDTNXLSGCEK-UHFFFAOYSA-N Cordycepinsaeure Natural products OC1CC(O)(C(O)=O)CC(O)C1O AAWZDTNXLSGCEK-UHFFFAOYSA-N 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 102000002554 Cyclin A Human genes 0.000 description 1
- 108010068192 Cyclin A Proteins 0.000 description 1
- 102000002427 Cyclin B Human genes 0.000 description 1
- 108010068150 Cyclin B Proteins 0.000 description 1
- 102000003909 Cyclin E Human genes 0.000 description 1
- 108090000257 Cyclin E Proteins 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- 102000001301 EGF receptor Human genes 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- 108091008794 FGF receptors Proteins 0.000 description 1
- GISRWBROCYNDME-PELMWDNLSA-N F[C@H]1[C@H]([C@H](NC1=O)COC1=NC=CC2=CC(=C(C=C12)OC)C(=O)N)C Chemical compound F[C@H]1[C@H]([C@H](NC1=O)COC1=NC=CC2=CC(=C(C=C12)OC)C(=O)N)C GISRWBROCYNDME-PELMWDNLSA-N 0.000 description 1
- 240000006927 Foeniculum vulgare Species 0.000 description 1
- 235000004204 Foeniculum vulgare Nutrition 0.000 description 1
- 206010017533 Fungal infection Diseases 0.000 description 1
- 206010018364 Glomerulonephritis Diseases 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 108010033040 Histones Proteins 0.000 description 1
- 102000006947 Histones Human genes 0.000 description 1
- 101100118549 Homo sapiens EGFR gene Proteins 0.000 description 1
- 101001012157 Homo sapiens Receptor tyrosine-protein kinase erbB-2 Proteins 0.000 description 1
- 101000805434 Human herpesvirus 8 type P (isolate GK18) viral cyclin homolog Proteins 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- 208000007766 Kaposi sarcoma Diseases 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- 206010025323 Lymphomas Diseases 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 208000031888 Mycoses Diseases 0.000 description 1
- FFDGPVCHZBVARC-UHFFFAOYSA-N N,N-dimethylglycine Chemical compound CN(C)CC(O)=O FFDGPVCHZBVARC-UHFFFAOYSA-N 0.000 description 1
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 description 1
- AYCPARAPKDAOEN-LJQANCHMSA-N N-[(1S)-2-(dimethylamino)-1-phenylethyl]-6,6-dimethyl-3-[(2-methyl-4-thieno[3,2-d]pyrimidinyl)amino]-1,4-dihydropyrrolo[3,4-c]pyrazole-5-carboxamide Chemical compound C1([C@H](NC(=O)N2C(C=3NN=C(NC=4C=5SC=CC=5N=C(C)N=4)C=3C2)(C)C)CN(C)C)=CC=CC=C1 AYCPARAPKDAOEN-LJQANCHMSA-N 0.000 description 1
- FEYNFHSRETUBEM-UHFFFAOYSA-N N-[3-(1,1-difluoroethyl)phenyl]-1-(4-methoxyphenyl)-3-methyl-5-oxo-4H-pyrazole-4-carboxamide Chemical compound COc1ccc(cc1)N1N=C(C)C(C(=O)Nc2cccc(c2)C(C)(F)F)C1=O FEYNFHSRETUBEM-UHFFFAOYSA-N 0.000 description 1
- RFMMMVDNIPUKGG-YFKPBYRVSA-N N-acetyl-L-glutamic acid Chemical compound CC(=O)N[C@H](C(O)=O)CCC(O)=O RFMMMVDNIPUKGG-YFKPBYRVSA-N 0.000 description 1
- ZQNDFCKVFFXBEV-KTMFPKCZSA-N OC1(CCN(CC1)CC1=CC=C(C=C1)N\C(\C1=CC=CC=C1)=C\1/C(NC2=CC=C(C=C12)[N+](=O)[O-])=O)C1=CC=CC=C1 Chemical compound OC1(CCN(CC1)CC1=CC=C(C=C1)N\C(\C1=CC=CC=C1)=C\1/C(NC2=CC=C(C=C12)[N+](=O)[O-])=O)C1=CC=CC=C1 ZQNDFCKVFFXBEV-KTMFPKCZSA-N 0.000 description 1
- IDRGFNPZDVBSSE-UHFFFAOYSA-N OCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)c(F)c1F Chemical compound OCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)c(F)c1F IDRGFNPZDVBSSE-UHFFFAOYSA-N 0.000 description 1
- 239000002033 PVDF binder Substances 0.000 description 1
- 208000030852 Parasitic disease Diseases 0.000 description 1
- YGYAWVDWMABLBF-UHFFFAOYSA-N Phosgene Chemical compound ClC(Cl)=O YGYAWVDWMABLBF-UHFFFAOYSA-N 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 101710182846 Polyhedrin Proteins 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- AAWZDTNXLSGCEK-ZHQZDSKASA-N Quinic acid Natural products O[C@H]1CC(O)(C(O)=O)C[C@H](O)C1O AAWZDTNXLSGCEK-ZHQZDSKASA-N 0.000 description 1
- IWYDHOAUDWTVEP-UHFFFAOYSA-N R-2-phenyl-2-hydroxyacetic acid Natural products OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 description 1
- 102100030086 Receptor tyrosine-protein kinase erbB-2 Human genes 0.000 description 1
- 230000018199 S phase Effects 0.000 description 1
- 101100123851 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) HER1 gene Proteins 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 description 1
- 229910021626 Tin(II) chloride Inorganic materials 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 102220502023 Ubiquitin-like modifier-activating enzyme 1_H25N_mutation Human genes 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- LXRZVMYMQHNYJB-UNXOBOICSA-N [(1R,2S,4R)-4-[[5-[4-[(1R)-7-chloro-1,2,3,4-tetrahydroisoquinolin-1-yl]-5-methylthiophene-2-carbonyl]pyrimidin-4-yl]amino]-2-hydroxycyclopentyl]methyl sulfamate Chemical compound CC1=C(C=C(S1)C(=O)C1=C(N[C@H]2C[C@H](O)[C@@H](COS(N)(=O)=O)C2)N=CN=C1)[C@@H]1NCCC2=C1C=C(Cl)C=C2 LXRZVMYMQHNYJB-UNXOBOICSA-N 0.000 description 1
- KUWVJIVPSQBQOX-UHFFFAOYSA-J [benzotriazol-1-yloxy(dimethylamino)methylidene]-dimethylazanium tetrafluoride Chemical compound [F-].[F-].[F-].[F-].N1(N=NC2=C1C=CC=C2)OC(=[N+](C)C)N(C)C.N2(N=NC1=C2C=CC=C1)OC(=[N+](C)C)N(C)C.N1(N=NC2=C1C=CC=C2)OC(=[N+](C)C)N(C)C.N2(N=NC1=C2C=CC=C1)OC(=[N+](C)C)N(C)C KUWVJIVPSQBQOX-UHFFFAOYSA-J 0.000 description 1
- PQLVXDKIJBQVDF-UHFFFAOYSA-N acetic acid;hydrate Chemical compound O.CC(O)=O PQLVXDKIJBQVDF-UHFFFAOYSA-N 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 125000004471 alkyl aminosulfonyl group Chemical group 0.000 description 1
- 150000001350 alkyl halides Chemical class 0.000 description 1
- 125000005037 alkyl phenyl group Chemical group 0.000 description 1
- 239000002168 alkylating agent Substances 0.000 description 1
- 229940100198 alkylating agent Drugs 0.000 description 1
- 238000005905 alkynylation reaction Methods 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 230000002547 anomalous effect Effects 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 150000004982 aromatic amines Chemical class 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- HKVFISRIUUGTIB-UHFFFAOYSA-O azanium;cerium;nitrate Chemical compound [NH4+].[Ce].[O-][N+]([O-])=O HKVFISRIUUGTIB-UHFFFAOYSA-O 0.000 description 1
- HGQULGDOROIPJN-UHFFFAOYSA-N azetidin-1-ium;chloride Chemical compound Cl.C1CNC1 HGQULGDOROIPJN-UHFFFAOYSA-N 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- APYXQTXFRIDSGE-UHFFFAOYSA-N bisindolylmaleimide III Chemical compound C12=CC=CC=C2N(CCCN)C=C1C1=C(C=2C3=CC=CC=C3NC=2)C(=O)NC1=O APYXQTXFRIDSGE-UHFFFAOYSA-N 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000012888 bovine serum Substances 0.000 description 1
- 239000012267 brine Substances 0.000 description 1
- 125000001246 bromo group Chemical group Br* 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- LSPHULWDVZXLIL-QUBYGPBYSA-N camphoric acid Chemical compound CC1(C)[C@H](C(O)=O)CC[C@]1(C)C(O)=O LSPHULWDVZXLIL-QUBYGPBYSA-N 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 125000003739 carbamimidoyl group Chemical group C(N)(=N)* 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- DGLFSNZWRYADFC-UHFFFAOYSA-N chembl2334586 Chemical compound C1CCC2=CN=C(N)N=C2C2=C1NC1=CC=C(C#CC(C)(O)C)C=C12 DGLFSNZWRYADFC-UHFFFAOYSA-N 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000011097 chromatography purification Methods 0.000 description 1
- RRWXSVSMTCNULZ-FBMPGHKGSA-N cid_16405948 Chemical compound C1=CC(C(C)C)=CC=C1C1C(NC=2C3=CC=CC=2)=C3C[C@@H]2N1C(=O)N(C=1C(=CC=CC=1)C(=O)N1[C@H](CCC1)C(O)=O)C2=O RRWXSVSMTCNULZ-FBMPGHKGSA-N 0.000 description 1
- 206010009887 colitis Diseases 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 229940099112 cornstarch Drugs 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- VAYGXNSJCAHWJZ-UHFFFAOYSA-N dimethyl sulfate Chemical compound COS(=O)(=O)OC VAYGXNSJCAHWJZ-UHFFFAOYSA-N 0.000 description 1
- 108700003601 dimethylglycine Proteins 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 239000006196 drop Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 1
- UVUDNJXFMOTJFN-UHFFFAOYSA-N ethyl 1-[(4-aminophenyl)methyl]piperidine-4-carboxylate Chemical compound C1CC(C(=O)OCC)CCN1CC1=CC=C(N)C=C1 UVUDNJXFMOTJFN-UHFFFAOYSA-N 0.000 description 1
- PRRODZCDZUABMQ-ZIADKAODSA-N ethyl 1-[2-[4-[[(z)-(5-nitro-2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]phenyl]ethyl]piperidine-4-carboxylate Chemical compound C1CC(C(=O)OCC)CCN1CCC(C=C1)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC([N+]([O-])=O)=CC=C2NC\1=O PRRODZCDZUABMQ-ZIADKAODSA-N 0.000 description 1
- BTKSUULMJNNXHG-UHFFFAOYSA-N ethyl 2-(methylamino)acetate Chemical compound CCOC(=O)CNC BTKSUULMJNNXHG-UHFFFAOYSA-N 0.000 description 1
- DEEPMBABKIECFU-UHFFFAOYSA-N ethyl 2-[(3-aminophenyl)methylamino]acetate Chemical compound CCOC(=O)CNCC1=CC=CC(N)=C1 DEEPMBABKIECFU-UHFFFAOYSA-N 0.000 description 1
- HEPSROBHVGPRSX-UHFFFAOYSA-N ethyl 2-[2-(4-aminophenyl)ethylamino]acetate Chemical compound CCOC(=O)CNCCC1=CC=C(N)C=C1 HEPSROBHVGPRSX-UHFFFAOYSA-N 0.000 description 1
- NUNYDJMEKFCTJU-QPLCGJKRSA-N ethyl 2-[2-[4-[[(z)-(5-nitro-2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]phenyl]ethylamino]acetate Chemical compound C1=CC(CCNCC(=O)OCC)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC([N+]([O-])=O)=CC=C2NC\1=O NUNYDJMEKFCTJU-QPLCGJKRSA-N 0.000 description 1
- GGEQXLHPGBUBSG-IZHYLOQSSA-N ethyl 2-[[3-[[(z)-(5-nitro-2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]phenyl]methylamino]acetate Chemical compound CCOC(=O)CNCC1=CC=CC(N\C(=C/2C3=CC(=CC=C3NC\2=O)[N+]([O-])=O)C=2C=CC=CC=2)=C1 GGEQXLHPGBUBSG-IZHYLOQSSA-N 0.000 description 1
- GZQRZCDESWAJBX-IZHYLOQSSA-N ethyl 2-[n-methylsulfonyl-4-[[(z)-(5-nitro-2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]anilino]acetate Chemical compound C1=CC(N(CC(=O)OCC)S(C)(=O)=O)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC([N+]([O-])=O)=CC=C2NC\1=O GZQRZCDESWAJBX-IZHYLOQSSA-N 0.000 description 1
- NTNZTEQNFHNYBC-UHFFFAOYSA-N ethyl 2-aminoacetate Chemical compound CCOC(=O)CN NTNZTEQNFHNYBC-UHFFFAOYSA-N 0.000 description 1
- BGRWJZDCVZNJAO-UHFFFAOYSA-N ethyl 3-[(3-aminophenyl)methylamino]propanoate Chemical compound CCOC(=O)CCNCC1=CC=CC(N)=C1 BGRWJZDCVZNJAO-UHFFFAOYSA-N 0.000 description 1
- AFVQIPHZLHYRKH-DQRAZIAOSA-N ethyl 3-[[(z)-(2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]benzoate Chemical compound CCOC(=O)C1=CC=CC(N\C(=C/2C3=CC=CC=C3NC\2=O)C=2C=CC=CC=2)=C1 AFVQIPHZLHYRKH-DQRAZIAOSA-N 0.000 description 1
- QHWCIHRPRVCPTK-QPLCGJKRSA-N ethyl 3-[[3-[[(z)-(5-nitro-2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]phenyl]methylamino]propanoate Chemical compound CCOC(=O)CCNCC1=CC=CC(N\C(=C/2C3=CC(=CC=C3NC\2=O)[N+]([O-])=O)C=2C=CC=CC=2)=C1 QHWCIHRPRVCPTK-QPLCGJKRSA-N 0.000 description 1
- YXOAZAYAKGREOF-QPLCGJKRSA-N ethyl 3-[[4-[[(z)-(5-nitro-2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]phenyl]methylamino]propanoate Chemical compound C1=CC(CNCCC(=O)OCC)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC([N+]([O-])=O)=CC=C2NC\1=O YXOAZAYAKGREOF-QPLCGJKRSA-N 0.000 description 1
- UXPCEMWKTJKEKR-RQZHXJHFSA-N ethyl 4-[n-methylsulfonyl-4-[[(z)-(2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]anilino]butanoate Chemical compound C1=CC(N(CCCC(=O)OCC)S(C)(=O)=O)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC=CC=C2NC\1=O UXPCEMWKTJKEKR-RQZHXJHFSA-N 0.000 description 1
- IIEWJVIFRVWJOD-UHFFFAOYSA-N ethyl cyclohexane Natural products CCC1CCCCC1 IIEWJVIFRVWJOD-UHFFFAOYSA-N 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- WUDNUHPRLBTKOJ-UHFFFAOYSA-N ethyl isocyanate Chemical compound CCN=C=O WUDNUHPRLBTKOJ-UHFFFAOYSA-N 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 102000052178 fibroblast growth factor receptor activity proteins Human genes 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000001640 fractional crystallisation Methods 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-M hexanoate Chemical compound CCCCCC([O-])=O FUZZWVXGSFPDMH-UHFFFAOYSA-M 0.000 description 1
- 150000004678 hydrides Chemical class 0.000 description 1
- 238000007327 hydrogenolysis reaction Methods 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- JBFYUZGYRGXSFL-UHFFFAOYSA-N imidazolide Chemical compound C1=C[N-]C=N1 JBFYUZGYRGXSFL-UHFFFAOYSA-N 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 238000000021 kinase assay Methods 0.000 description 1
- 229940043355 kinase inhibitor Drugs 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229960001375 lactose Drugs 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 229960004873 levomenthol Drugs 0.000 description 1
- 239000012280 lithium aluminium hydride Substances 0.000 description 1
- 238000011866 long-term treatment Methods 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 208000037841 lung tumor Diseases 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 229940057948 magnesium stearate Drugs 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 229960002510 mandelic acid Drugs 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 229910052987 metal hydride Inorganic materials 0.000 description 1
- 150000004681 metal hydrides Chemical class 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Substances CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 description 1
- SYOIZJPNEIWICV-YJACDMIVSA-N methyl 2-amino-3-[4-[[(z)-(5-nitro-2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]phenyl]propanoate;hydrochloride Chemical compound Cl.C1=CC(CC(N)C(=O)OC)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC([N+]([O-])=O)=CC=C2NC\1=O SYOIZJPNEIWICV-YJACDMIVSA-N 0.000 description 1
- LZXXNPOYQCLXRS-UHFFFAOYSA-N methyl 4-aminobenzoate Chemical compound COC(=O)C1=CC=C(N)C=C1 LZXXNPOYQCLXRS-UHFFFAOYSA-N 0.000 description 1
- 125000000250 methylamino group Chemical group [H]N(*)C([H])([H])[H] 0.000 description 1
- 125000004458 methylaminocarbonyl group Chemical group [H]N(C(*)=O)C([H])([H])[H] 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- DILRJUIACXKSQE-UHFFFAOYSA-N n',n'-dimethylethane-1,2-diamine Chemical compound CN(C)CCN DILRJUIACXKSQE-UHFFFAOYSA-N 0.000 description 1
- KBSXRTYVXFLZJB-MRCUWXFGSA-N n'-methyl-3-[[(z)-(2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]benzenecarboximidamide Chemical compound CNC(=N)C1=CC=CC(N\C(=C/2C3=CC=CC=C3NC\2=O)C=2C=CC=CC=2)=C1 KBSXRTYVXFLZJB-MRCUWXFGSA-N 0.000 description 1
- IVBGXEWFXJJHCN-ZIADKAODSA-N n,n-dimethyl-1-[2-[4-[[(z)-(5-nitro-2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]phenyl]ethyl]piperidine-4-carboxamide Chemical compound C1CC(C(=O)N(C)C)CCN1CCC(C=C1)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC([N+]([O-])=O)=CC=C2NC\1=O IVBGXEWFXJJHCN-ZIADKAODSA-N 0.000 description 1
- CRERXNYMPIAGLY-DQSJHHFOSA-N n,n-dimethyl-1-[[4-[[(z)-(5-nitro-2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]phenyl]methyl]piperidine-4-carboxamide Chemical compound C1CC(C(=O)N(C)C)CCN1CC(C=C1)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC([N+]([O-])=O)=CC=C2NC\1=O CRERXNYMPIAGLY-DQSJHHFOSA-N 0.000 description 1
- OIKBEBYIMTZWET-IZHYLOQSSA-N n,n-dimethyl-2-[n-methylsulfonyl-4-[[(z)-(2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]anilino]acetamide Chemical compound C1=CC(N(CC(=O)N(C)C)S(C)(=O)=O)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC=CC=C2NC\1=O OIKBEBYIMTZWET-IZHYLOQSSA-N 0.000 description 1
- LNWZBSHPXGFHMZ-IZHYLOQSSA-N n,n-dimethyl-2-[n-methylsulfonyl-4-[[(z)-(5-nitro-2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]anilino]acetamide Chemical compound C1=CC(N(CC(=O)N(C)C)S(C)(=O)=O)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC([N+]([O-])=O)=CC=C2NC\1=O LNWZBSHPXGFHMZ-IZHYLOQSSA-N 0.000 description 1
- DEORIQOLSHARKP-DQRAZIAOSA-N n,n-dimethyl-3-[[(z)-(2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]benzamide Chemical compound CN(C)C(=O)C1=CC=CC(N\C(=C/2C3=CC=CC=C3NC\2=O)C=2C=CC=CC=2)=C1 DEORIQOLSHARKP-DQRAZIAOSA-N 0.000 description 1
- YTIMJBHOGUEICT-QPLCGJKRSA-N n,n-dimethyl-3-[[3-[[(z)-(5-nitro-2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]phenyl]methylamino]propanamide Chemical compound CN(C)C(=O)CCNCC1=CC=CC(N\C(=C/2C3=CC(=CC=C3NC\2=O)[N+]([O-])=O)C=2C=CC=CC=2)=C1 YTIMJBHOGUEICT-QPLCGJKRSA-N 0.000 description 1
- MJVOQYWGWFFPMS-QPLCGJKRSA-N n,n-dimethyl-3-[[4-[[(z)-(5-nitro-2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]phenyl]methylamino]propanamide Chemical compound C1=CC(CNCCC(=O)N(C)C)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC([N+]([O-])=O)=CC=C2NC\1=O MJVOQYWGWFFPMS-QPLCGJKRSA-N 0.000 description 1
- JBPOOBQADSGBJN-DQRAZIAOSA-N n,n-dimethyl-4-[[(z)-(2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]benzamide Chemical compound C1=CC(C(=O)N(C)C)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC=CC=C2NC\1=O JBPOOBQADSGBJN-DQRAZIAOSA-N 0.000 description 1
- PSHKMPUSSFXUIA-UHFFFAOYSA-N n,n-dimethylpyridin-2-amine Chemical compound CN(C)C1=CC=CC=N1 PSHKMPUSSFXUIA-UHFFFAOYSA-N 0.000 description 1
- RSBGUKWVTUXWRV-RQZHXJHFSA-N n-(2-morpholin-4-ylethyl)-n-[4-[[(z)-(2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]phenyl]methanesulfonamide Chemical compound C=1C=C(N\C(=C/2C3=CC=CC=C3NC\2=O)C=2C=CC=CC=2)C=CC=1N(S(=O)(=O)C)CCN1CCOCC1 RSBGUKWVTUXWRV-RQZHXJHFSA-N 0.000 description 1
- KAPCUHGASXBVKC-RQZHXJHFSA-N n-(2-morpholin-4-ylethyl)-n-[4-[[(z)-(5-nitro-2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]phenyl]methanesulfonamide Chemical compound C=1C=C(N\C(=C/2C3=CC(=CC=C3NC\2=O)[N+]([O-])=O)C=2C=CC=CC=2)C=CC=1N(S(=O)(=O)C)CCN1CCOCC1 KAPCUHGASXBVKC-RQZHXJHFSA-N 0.000 description 1
- PEMGGJDINLGTON-UHFFFAOYSA-N n-(3-aminophenyl)acetamide Chemical compound CC(=O)NC1=CC=CC(N)=C1 PEMGGJDINLGTON-UHFFFAOYSA-N 0.000 description 1
- UQRRCQRFQGOHAI-UHFFFAOYSA-N n-(3-aminophenyl)methanesulfonamide Chemical compound CS(=O)(=O)NC1=CC=CC(N)=C1 UQRRCQRFQGOHAI-UHFFFAOYSA-N 0.000 description 1
- UGWBTNVQAQQSAJ-UHFFFAOYSA-N n-(4-aminophenyl)-2-(1,3-dioxoisoindol-2-yl)-n-methylacetamide Chemical compound O=C1C2=CC=CC=C2C(=O)N1CC(=O)N(C)C1=CC=C(N)C=C1 UGWBTNVQAQQSAJ-UHFFFAOYSA-N 0.000 description 1
- XWNSOTJCQVAZAM-UHFFFAOYSA-N n-(4-aminophenyl)-2-(4-methylpiperazin-1-yl)acetamide Chemical compound C1CN(C)CCN1CC(=O)NC1=CC=C(N)C=C1 XWNSOTJCQVAZAM-UHFFFAOYSA-N 0.000 description 1
- RLHBCXKHVSXMKY-UHFFFAOYSA-N n-(4-aminophenyl)-2-methoxyacetamide Chemical compound COCC(=O)NC1=CC=C(N)C=C1 RLHBCXKHVSXMKY-UHFFFAOYSA-N 0.000 description 1
- JKZOYHKRETUJPU-UHFFFAOYSA-N n-(4-aminophenyl)-n-(2-morpholin-4-ylethyl)methanesulfonamide Chemical compound C=1C=C(N)C=CC=1N(S(=O)(=O)C)CCN1CCOCC1 JKZOYHKRETUJPU-UHFFFAOYSA-N 0.000 description 1
- QFELUFGHFLYZEZ-UHFFFAOYSA-N n-(4-aminophenyl)-n-methylacetamide Chemical compound CC(=O)N(C)C1=CC=C(N)C=C1 QFELUFGHFLYZEZ-UHFFFAOYSA-N 0.000 description 1
- MGZAFDOASDXMRY-UHFFFAOYSA-N n-(4-aminophenyl)-n-methylmethanesulfonamide Chemical compound CS(=O)(=O)N(C)C1=CC=C(N)C=C1 MGZAFDOASDXMRY-UHFFFAOYSA-N 0.000 description 1
- FMASTMURQSHELY-UHFFFAOYSA-N n-(4-fluoro-2-methylphenyl)-3-methyl-n-[(2-methyl-1h-indol-4-yl)methyl]pyridine-4-carboxamide Chemical compound C1=CC=C2NC(C)=CC2=C1CN(C=1C(=CC(F)=CC=1)C)C(=O)C1=CC=NC=C1C FMASTMURQSHELY-UHFFFAOYSA-N 0.000 description 1
- AXEHDVUAWILBRN-UHFFFAOYSA-N n-(4-nitrophenyl)methanesulfonamide Chemical compound CS(=O)(=O)NC1=CC=C([N+]([O-])=O)C=C1 AXEHDVUAWILBRN-UHFFFAOYSA-N 0.000 description 1
- JRVCNDYACVZBNR-UHFFFAOYSA-N n-[(3-aminophenyl)methyl]-2-(dimethylamino)acetamide Chemical compound CN(C)CC(=O)NCC1=CC=CC(N)=C1 JRVCNDYACVZBNR-UHFFFAOYSA-N 0.000 description 1
- YYFXYUXNYSNJHC-RQZHXJHFSA-N n-[2-(dimethylamino)ethyl]-2-[n-methylsulfonyl-4-[[(z)-(2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]anilino]acetamide Chemical compound C1=CC(N(CC(=O)NCCN(C)C)S(C)(=O)=O)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC=CC=C2NC\1=O YYFXYUXNYSNJHC-RQZHXJHFSA-N 0.000 description 1
- VHPHXIXGHLAWNX-IZHYLOQSSA-N n-[2-(dimethylamino)ethyl]-n-[4-[[(z)-(5-nitro-2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]phenyl]methanesulfonamide Chemical compound C1=CC(N(CCN(C)C)S(C)(=O)=O)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC([N+]([O-])=O)=CC=C2NC\1=O VHPHXIXGHLAWNX-IZHYLOQSSA-N 0.000 description 1
- FPYZKYRGSLUBCG-VHXPQNKSSA-N n-[2-[4-[[(z)-(5-nitro-2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]phenyl]ethyl]acetamide Chemical compound C1=CC(CCNC(=O)C)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC([N+]([O-])=O)=CC=C2NC\1=O FPYZKYRGSLUBCG-VHXPQNKSSA-N 0.000 description 1
- VGLWJLLNHQSQDB-DQRAZIAOSA-N n-[3-[[(z)-(2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]phenyl]acetamide Chemical compound CC(=O)NC1=CC=CC(N\C(=C/2C3=CC=CC=C3NC\2=O)C=2C=CC=CC=2)=C1 VGLWJLLNHQSQDB-DQRAZIAOSA-N 0.000 description 1
- PAKSJHXWKGAHSP-MRCUWXFGSA-N n-[3-[[(z)-(2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]phenyl]formamide Chemical compound O=CNC1=CC=CC(N\C(=C/2C3=CC=CC=C3NC\2=O)C=2C=CC=CC=2)=C1 PAKSJHXWKGAHSP-MRCUWXFGSA-N 0.000 description 1
- LBWMUZWSUBXZGC-MRCUWXFGSA-N n-[3-[[(z)-(2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]phenyl]methanesulfonamide Chemical compound CS(=O)(=O)NC1=CC=CC(N\C(=C/2C3=CC=CC=C3NC\2=O)C=2C=CC=CC=2)=C1 LBWMUZWSUBXZGC-MRCUWXFGSA-N 0.000 description 1
- JWTQEZFTRYVQQY-ZIADKAODSA-N n-[4-[[(z)-(1-acetyl-2-oxoindol-3-ylidene)-phenylmethyl]amino]phenyl]-1-phenylmethanesulfonamide Chemical compound C12=CC=CC=C2N(C(=O)C)C(=O)\C1=C(C=1C=CC=CC=1)/NC(C=C1)=CC=C1NS(=O)(=O)CC1=CC=CC=C1 JWTQEZFTRYVQQY-ZIADKAODSA-N 0.000 description 1
- CWPZZPFIVUZCLX-ZIADKAODSA-N n-[4-[[(z)-(1-acetyl-2-oxoindol-3-ylidene)-phenylmethyl]amino]phenyl]-4-methylbenzenesulfonamide Chemical compound C12=CC=CC=C2N(C(=O)C)C(=O)\C1=C(C=1C=CC=CC=1)/NC(C=C1)=CC=C1NS(=O)(=O)C1=CC=C(C)C=C1 CWPZZPFIVUZCLX-ZIADKAODSA-N 0.000 description 1
- KZHPEEKPBDBZRC-DQSJHHFOSA-N n-[4-[[(z)-(1-acetyl-2-oxoindol-3-ylidene)-phenylmethyl]amino]phenyl]benzenesulfonamide Chemical compound C12=CC=CC=C2N(C(=O)C)C(=O)\C1=C(C=1C=CC=CC=1)/NC(C=C1)=CC=C1NS(=O)(=O)C1=CC=CC=C1 KZHPEEKPBDBZRC-DQSJHHFOSA-N 0.000 description 1
- AQDXIMGGALJYGX-VHXPQNKSSA-N n-[4-[[(z)-(1-acetyl-2-oxoindol-3-ylidene)-phenylmethyl]amino]phenyl]ethanesulfonamide Chemical compound C1=CC(NS(=O)(=O)CC)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC=CC=C2N(C(C)=O)C\1=O AQDXIMGGALJYGX-VHXPQNKSSA-N 0.000 description 1
- DXGQWCLCLFRVBQ-ZIADKAODSA-N n-[4-[[(z)-(1-acetyl-5-nitro-2-oxoindol-3-ylidene)-phenylmethyl]amino]phenyl]-4-methylbenzenesulfonamide Chemical compound C12=CC([N+]([O-])=O)=CC=C2N(C(=O)C)C(=O)\C1=C(C=1C=CC=CC=1)/NC(C=C1)=CC=C1NS(=O)(=O)C1=CC=C(C)C=C1 DXGQWCLCLFRVBQ-ZIADKAODSA-N 0.000 description 1
- VRKYKDLGJAVWIP-DQSJHHFOSA-N n-[4-[[(z)-(1-acetyl-5-nitro-2-oxoindol-3-ylidene)-phenylmethyl]amino]phenyl]benzenesulfonamide Chemical compound C12=CC([N+]([O-])=O)=CC=C2N(C(=O)C)C(=O)\C1=C(C=1C=CC=CC=1)/NC(C=C1)=CC=C1NS(=O)(=O)C1=CC=CC=C1 VRKYKDLGJAVWIP-DQSJHHFOSA-N 0.000 description 1
- OYRXFEANKHXUSK-VHXPQNKSSA-N n-[4-[[(z)-(1-acetyl-5-nitro-2-oxoindol-3-ylidene)-phenylmethyl]amino]phenyl]ethanesulfonamide Chemical compound C1=CC(NS(=O)(=O)CC)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC([N+]([O-])=O)=CC=C2N(C(C)=O)C\1=O OYRXFEANKHXUSK-VHXPQNKSSA-N 0.000 description 1
- AODLLWSNZLYWBA-MRCUWXFGSA-N n-[4-[[(z)-(2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]phenyl]methanesulfonamide Chemical compound C1=CC(NS(=O)(=O)C)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC=CC=C2NC\1=O AODLLWSNZLYWBA-MRCUWXFGSA-N 0.000 description 1
- VIJVYQINPQKATL-DQRAZIAOSA-N n-[4-[[(z)-(5-nitro-2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]phenyl]acetamide Chemical compound C1=CC(NC(=O)C)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC([N+]([O-])=O)=CC=C2NC\1=O VIJVYQINPQKATL-DQRAZIAOSA-N 0.000 description 1
- ZYGDWENUCLNKHL-MRCUWXFGSA-N n-[4-[[(z)-(5-nitro-2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]phenyl]formamide Chemical compound C12=CC([N+](=O)[O-])=CC=C2NC(=O)\C1=C(C=1C=CC=CC=1)/NC1=CC=C(NC=O)C=C1 ZYGDWENUCLNKHL-MRCUWXFGSA-N 0.000 description 1
- HSPPBXXOLJVEJD-MRCUWXFGSA-N n-[4-[[(z)-(5-nitro-2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]phenyl]methanesulfonamide Chemical compound C1=CC(NS(=O)(=O)C)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC([N+]([O-])=O)=CC=C2NC\1=O HSPPBXXOLJVEJD-MRCUWXFGSA-N 0.000 description 1
- GQCPCRHHPGJBOY-FCQUAONHSA-N n-[[3-[[(z)-(5-nitro-2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]phenyl]methyl]acetamide Chemical compound CC(=O)NCC1=CC=CC(N\C(=C/2C3=CC(=CC=C3NC\2=O)[N+]([O-])=O)C=2C=CC=CC=2)=C1 GQCPCRHHPGJBOY-FCQUAONHSA-N 0.000 description 1
- RIAYCMBRORCHKB-FCQUAONHSA-N n-[[4-[[(z)-(2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]phenyl]methyl]acetamide Chemical compound C1=CC(CNC(=O)C)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC=CC=C2NC\1=O RIAYCMBRORCHKB-FCQUAONHSA-N 0.000 description 1
- ICXGWKIEHZFYFW-RQZHXJHFSA-N n-[[4-[[(z)-(2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]phenyl]methyl]benzenesulfonamide Chemical compound O=C1NC2=CC=CC=C2\C1=C(C=1C=CC=CC=1)\NC(C=C1)=CC=C1CNS(=O)(=O)C1=CC=CC=C1 ICXGWKIEHZFYFW-RQZHXJHFSA-N 0.000 description 1
- LDZCMEYKZDHLJV-DQRAZIAOSA-N n-[[4-[[(z)-(2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]phenyl]methyl]methanesulfonamide Chemical compound C1=CC(CNS(=O)(=O)C)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC=CC=C2NC\1=O LDZCMEYKZDHLJV-DQRAZIAOSA-N 0.000 description 1
- VZXQJCOAKKIKCO-DQRAZIAOSA-N n-[[4-[[(z)-(5-nitro-2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]phenyl]methyl]methanesulfonamide Chemical compound C1=CC(CNS(=O)(=O)C)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC([N+]([O-])=O)=CC=C2NC\1=O VZXQJCOAKKIKCO-DQRAZIAOSA-N 0.000 description 1
- HNHVTXYLRVGMHD-UHFFFAOYSA-N n-butyl isocyanate Chemical compound CCCCN=C=O HNHVTXYLRVGMHD-UHFFFAOYSA-N 0.000 description 1
- NNKPHNTWNILINE-UHFFFAOYSA-N n-cyclopropyl-3-fluoro-4-methyl-5-[3-[[1-[2-[2-(methylamino)ethoxy]phenyl]cyclopropyl]amino]-2-oxopyrazin-1-yl]benzamide Chemical compound CNCCOC1=CC=CC=C1C1(NC=2C(N(C=3C(=C(F)C=C(C=3)C(=O)NC3CC3)C)C=CN=2)=O)CC1 NNKPHNTWNILINE-UHFFFAOYSA-N 0.000 description 1
- FCLPVPNWFDOVKL-DQSJHHFOSA-N n-methyl-2-(4-methylpiperazin-1-yl)-n-[4-[[(z)-(2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]phenyl]acetamide Chemical compound C=1C=C(N\C(=C/2C3=CC=CC=C3NC\2=O)C=2C=CC=CC=2)C=CC=1N(C)C(=O)CN1CCN(C)CC1 FCLPVPNWFDOVKL-DQSJHHFOSA-N 0.000 description 1
- ALVPUIQLWZIAME-VHXPQNKSSA-N n-methyl-2-[n-methylsulfonyl-4-[[(z)-(2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]anilino]acetamide Chemical compound C1=CC(N(CC(=O)NC)S(C)(=O)=O)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC=CC=C2NC\1=O ALVPUIQLWZIAME-VHXPQNKSSA-N 0.000 description 1
- OSKCDGAYZYVSCI-VHXPQNKSSA-N n-methyl-2-[n-methylsulfonyl-4-[[(z)-(5-nitro-2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]anilino]acetamide Chemical compound C1=CC(N(CC(=O)NC)S(C)(=O)=O)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC([N+]([O-])=O)=CC=C2NC\1=O OSKCDGAYZYVSCI-VHXPQNKSSA-N 0.000 description 1
- AOTUIYAORPGXEM-RQZHXJHFSA-N n-methyl-2-morpholin-4-yl-n-[4-[[(z)-(2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]phenyl]acetamide Chemical compound C=1C=C(N\C(=C/2C3=CC=CC=C3NC\2=O)C=2C=CC=CC=2)C=CC=1N(C)C(=O)CN1CCOCC1 AOTUIYAORPGXEM-RQZHXJHFSA-N 0.000 description 1
- YKQNAAXCOYOAMJ-RQZHXJHFSA-N n-methyl-2-morpholin-4-yl-n-[4-[[(z)-(5-nitro-2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]phenyl]acetamide Chemical compound C=1C=C(N\C(=C/2C3=CC(=CC=C3NC\2=O)[N+]([O-])=O)C=2C=CC=CC=2)C=CC=1N(C)C(=O)CN1CCOCC1 YKQNAAXCOYOAMJ-RQZHXJHFSA-N 0.000 description 1
- FTQQLJCSOQZLAJ-MRCUWXFGSA-N n-methyl-3-[[(z)-(2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]benzamide Chemical compound CNC(=O)C1=CC=CC(N\C(=C/2C3=CC=CC=C3NC\2=O)C=2C=CC=CC=2)=C1 FTQQLJCSOQZLAJ-MRCUWXFGSA-N 0.000 description 1
- BAEDFVZBJOCTJJ-MRCUWXFGSA-N n-methyl-4-[[(z)-(2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]benzamide Chemical compound C1=CC(C(=O)NC)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC=CC=C2NC\1=O BAEDFVZBJOCTJJ-MRCUWXFGSA-N 0.000 description 1
- VKERRSGOTBGKPN-FCQUAONHSA-N n-methyl-n-[3-[[(z)-(2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]phenyl]acetamide Chemical compound CC(=O)N(C)C1=CC=CC(N\C(=C/2C3=CC=CC=C3NC\2=O)C=2C=CC=CC=2)=C1 VKERRSGOTBGKPN-FCQUAONHSA-N 0.000 description 1
- LVUSQCLSBKGBDN-DQRAZIAOSA-N n-methyl-n-[3-[[(z)-(2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]phenyl]methanesulfonamide Chemical compound CS(=O)(=O)N(C)C1=CC=CC(N\C(=C/2C3=CC=CC=C3NC\2=O)C=2C=CC=CC=2)=C1 LVUSQCLSBKGBDN-DQRAZIAOSA-N 0.000 description 1
- STGRQSVKKOESIN-ZNKLZGLFSA-N n-methyl-n-[4-[[(z)-(2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]phenyl]-2-piperazin-1-ylacetamide;dihydrochloride Chemical compound Cl.Cl.C=1C=C(N\C(=C/2C3=CC=CC=C3NC\2=O)C=2C=CC=CC=2)C=CC=1N(C)C(=O)CN1CCNCC1 STGRQSVKKOESIN-ZNKLZGLFSA-N 0.000 description 1
- BBMVKFPQALLUIM-DQSJHHFOSA-N n-methyl-n-[4-[[(z)-(2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]phenyl]-2-piperidin-1-ylacetamide Chemical compound C=1C=C(N\C(=C/2C3=CC=CC=C3NC\2=O)C=2C=CC=CC=2)C=CC=1N(C)C(=O)CN1CCCCC1 BBMVKFPQALLUIM-DQSJHHFOSA-N 0.000 description 1
- AUZJMHKYJUQFEK-FCQUAONHSA-N n-methyl-n-[4-[[(z)-(2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]phenyl]acetamide Chemical compound C1=CC(N(C(C)=O)C)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC=CC=C2NC\1=O AUZJMHKYJUQFEK-FCQUAONHSA-N 0.000 description 1
- QTRRABBRNMUFSC-DQRAZIAOSA-N n-methyl-n-[4-[[(z)-(2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]phenyl]methanesulfonamide Chemical compound C1=CC(N(C)S(C)(=O)=O)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC=CC=C2NC\1=O QTRRABBRNMUFSC-DQRAZIAOSA-N 0.000 description 1
- MAERZWMRWWOMLO-FCQUAONHSA-N n-methyl-n-[4-[[(z)-(5-nitro-2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]phenyl]acetamide Chemical compound C1=CC(N(C(C)=O)C)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC([N+]([O-])=O)=CC=C2NC\1=O MAERZWMRWWOMLO-FCQUAONHSA-N 0.000 description 1
- UEKLOURANZIVFP-DQRAZIAOSA-N n-methyl-n-[4-[[(z)-(5-nitro-2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]phenyl]methanesulfonamide Chemical compound C1=CC(N(C)S(C)(=O)=O)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC([N+]([O-])=O)=CC=C2NC\1=O UEKLOURANZIVFP-DQRAZIAOSA-N 0.000 description 1
- JQSKZPYNWCMPBG-VHXPQNKSSA-N n-methyl-n-[[4-[[(z)-(5-nitro-2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]phenyl]methyl]acetamide Chemical compound C1=CC(CN(C)C(C)=O)=CC=C1N\C(C=1C=CC=CC=1)=C/1C2=CC([N+]([O-])=O)=CC=C2NC\1=O JQSKZPYNWCMPBG-VHXPQNKSSA-N 0.000 description 1
- VBEGHXKAFSLLGE-UHFFFAOYSA-N n-phenylnitramide Chemical compound [O-][N+](=O)NC1=CC=CC=C1 VBEGHXKAFSLLGE-UHFFFAOYSA-N 0.000 description 1
- 238000013421 nuclear magnetic resonance imaging Methods 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 238000006053 organic reaction Methods 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 1
- 239000003757 phosphotransferase inhibitor Substances 0.000 description 1
- 125000004193 piperazinyl group Chemical group 0.000 description 1
- 239000000902 placebo Substances 0.000 description 1
- 229940068196 placebo Drugs 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- LZMJNVRJMFMYQS-UHFFFAOYSA-N poseltinib Chemical compound C1CN(C)CCN1C(C=C1)=CC=C1NC1=NC(OC=2C=C(NC(=O)C=C)C=CC=2)=C(OC=C2)C2=N1 LZMJNVRJMFMYQS-UHFFFAOYSA-N 0.000 description 1
- FYRHIOVKTDQVFC-UHFFFAOYSA-M potassium phthalimide Chemical compound [K+].C1=CC=C2C(=O)[N-]C(=O)C2=C1 FYRHIOVKTDQVFC-UHFFFAOYSA-M 0.000 description 1
- IZLFUDHPNDYYHS-UHFFFAOYSA-M potassium;2-bromoacetate Chemical compound [K+].[O-]C(=O)CBr IZLFUDHPNDYYHS-UHFFFAOYSA-M 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 150000003141 primary amines Chemical class 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- TVDSBUOJIPERQY-UHFFFAOYSA-N prop-2-yn-1-ol Chemical compound OCC#C TVDSBUOJIPERQY-UHFFFAOYSA-N 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- WYVAMUWZEOHJOQ-UHFFFAOYSA-N propionic anhydride Chemical compound CCC(=O)OC(=O)CC WYVAMUWZEOHJOQ-UHFFFAOYSA-N 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 208000037803 restenosis Diseases 0.000 description 1
- 102220006493 rs80338873 Human genes 0.000 description 1
- XIIOFHFUYBLOLW-UHFFFAOYSA-N selpercatinib Chemical compound OC(COC=1C=C(C=2N(C=1)N=CC=2C#N)C=1C=NC(=CC=1)N1CC2N(C(C1)C2)CC=1C=NC(=CC=1)OC)(C)C XIIOFHFUYBLOLW-UHFFFAOYSA-N 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- XGVXKJKTISMIOW-ZDUSSCGKSA-N simurosertib Chemical compound N1N=CC(C=2SC=3C(=O)NC(=NC=3C=2)[C@H]2N3CCC(CC3)C2)=C1C XGVXKJKTISMIOW-ZDUSSCGKSA-N 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 235000009518 sodium iodide Nutrition 0.000 description 1
- 229940054269 sodium pyruvate Drugs 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 239000001119 stannous chloride Substances 0.000 description 1
- 235000011150 stannous chloride Nutrition 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 229960004793 sucrose Drugs 0.000 description 1
- 229910021653 sulphate ion Inorganic materials 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- OOPUFXZJWLZPLC-UHFFFAOYSA-N tert-butyl 2-(4-aminophenyl)acetate Chemical compound CC(C)(C)OC(=O)CC1=CC=C(N)C=C1 OOPUFXZJWLZPLC-UHFFFAOYSA-N 0.000 description 1
- GSIBTIUXYYFCPU-UHFFFAOYSA-N tert-butyl 4-(bromomethyl)benzoate Chemical compound CC(C)(C)OC(=O)C1=CC=C(CBr)C=C1 GSIBTIUXYYFCPU-UHFFFAOYSA-N 0.000 description 1
- COSXQRGJLFEFGJ-SECBINFHSA-N tert-butyl n-[(1r)-1-(4-aminophenyl)ethyl]carbamate Chemical compound CC(C)(C)OC(=O)N[C@H](C)C1=CC=C(N)C=C1 COSXQRGJLFEFGJ-SECBINFHSA-N 0.000 description 1
- COSXQRGJLFEFGJ-VIFPVBQESA-N tert-butyl n-[(1s)-1-(4-aminophenyl)ethyl]carbamate Chemical compound CC(C)(C)OC(=O)N[C@@H](C)C1=CC=C(N)C=C1 COSXQRGJLFEFGJ-VIFPVBQESA-N 0.000 description 1
- LSOZALWRNWQPLK-UHFFFAOYSA-N tert-butyl n-[(3-aminophenyl)methyl]carbamate Chemical compound CC(C)(C)OC(=O)NCC1=CC=CC(N)=C1 LSOZALWRNWQPLK-UHFFFAOYSA-N 0.000 description 1
- UXWQXBSQQHAGMG-UHFFFAOYSA-N tert-butyl n-[(4-aminophenyl)methyl]carbamate Chemical compound CC(C)(C)OC(=O)NCC1=CC=C(N)C=C1 UXWQXBSQQHAGMG-UHFFFAOYSA-N 0.000 description 1
- COSXQRGJLFEFGJ-UHFFFAOYSA-N tert-butyl n-[1-(4-aminophenyl)ethyl]carbamate Chemical compound CC(C)(C)OC(=O)NC(C)C1=CC=C(N)C=C1 COSXQRGJLFEFGJ-UHFFFAOYSA-N 0.000 description 1
- PFRVYIWPKDNRTE-UHFFFAOYSA-N tert-butyl n-[2-[(3-aminophenyl)methylamino]-2-oxoethyl]carbamate Chemical compound CC(C)(C)OC(=O)NCC(=O)NCC1=CC=CC(N)=C1 PFRVYIWPKDNRTE-UHFFFAOYSA-N 0.000 description 1
- FTRZBMDCTHWEPN-QPLCGJKRSA-N tert-butyl n-[2-[4-[[(z)-[4-(aminomethyl)phenyl]-(5-nitro-2-oxo-1h-indol-3-ylidene)methyl]amino]phenyl]ethyl]carbamate Chemical compound C1=CC(CCNC(=O)OC(C)(C)C)=CC=C1N\C(C=1C=CC(CN)=CC=1)=C/1C2=CC([N+]([O-])=O)=CC=C2NC\1=O FTRZBMDCTHWEPN-QPLCGJKRSA-N 0.000 description 1
- WPGHSTNTDBVERP-QPLCGJKRSA-N tert-butyl n-[2-[[3-[[(z)-(5-nitro-2-oxo-1h-indol-3-ylidene)-phenylmethyl]amino]phenyl]methylamino]-2-oxoethyl]carbamate Chemical compound CC(C)(C)OC(=O)NCC(=O)NCC1=CC=CC(N\C(=C/2C3=CC(=CC=C3NC\2=O)[N+]([O-])=O)C=2C=CC=CC=2)=C1 WPGHSTNTDBVERP-QPLCGJKRSA-N 0.000 description 1
- IXPWEHVNHAGEFG-KARKAFJISA-N tert-butyl n-[[4-[[(z)-(1-acetyl-5-nitro-2-oxoindol-3-ylidene)-[4-[(1,3-dioxoisoindol-2-yl)methyl]phenyl]methyl]amino]phenyl]methyl]carbamate Chemical compound C12=CC([N+]([O-])=O)=CC=C2N(C(=O)C)C(=O)\C1=C(C=1C=CC(CN2C(C3=CC=CC=C3C2=O)=O)=CC=1)/NC1=CC=C(CNC(=O)OC(C)(C)C)C=C1 IXPWEHVNHAGEFG-KARKAFJISA-N 0.000 description 1
- BVAXBEKMSGDUBK-UHFFFAOYSA-N tert-butyl n-methyl-n-[4-(methylamino)phenyl]carbamate Chemical compound CNC1=CC=C(N(C)C(=O)OC(C)(C)C)C=C1 BVAXBEKMSGDUBK-UHFFFAOYSA-N 0.000 description 1
- 125000001412 tetrahydropyranyl group Chemical group 0.000 description 1
- LFQCEHFDDXELDD-UHFFFAOYSA-N tetramethyl orthosilicate Chemical compound CO[Si](OC)(OC)OC LFQCEHFDDXELDD-UHFFFAOYSA-N 0.000 description 1
- 125000000383 tetramethylene group Chemical group [H]C([H])([*:1])C([H])([H])C([H])([H])C([H])([H])[*:2] 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 125000002088 tosyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])[H])S(*)(=O)=O 0.000 description 1
- 238000005809 transesterification reaction Methods 0.000 description 1
- BQFPCTXLBRVFJL-UHFFFAOYSA-N triethoxymethylbenzene Chemical compound CCOC(OCC)(OCC)C1=CC=CC=C1 BQFPCTXLBRVFJL-UHFFFAOYSA-N 0.000 description 1
- IECKAVQTURBPON-UHFFFAOYSA-N trimethoxymethylbenzene Chemical compound COC(OC)(OC)C1=CC=CC=C1 IECKAVQTURBPON-UHFFFAOYSA-N 0.000 description 1
- 239000005051 trimethylchlorosilane Substances 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- DJXRIQMCROIRCZ-XOEOCAAJSA-N vibegron Chemical compound C1([C@H]([C@@H]2N[C@H](CC=3C=CC(NC(=O)[C@H]4N5C(=O)C=CN=C5CC4)=CC=3)CC2)O)=CC=CC=C1 DJXRIQMCROIRCZ-XOEOCAAJSA-N 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/34—Oxygen atoms in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19844003A DE19844003A1 (de) | 1998-09-25 | 1998-09-25 | Neue substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel |
DE19937496A DE19937496A1 (de) | 1999-08-07 | 1999-08-07 | Neue substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel |
PCT/EP1999/007040 WO2000018734A1 (fr) | 1998-09-25 | 1999-09-22 | Nouvelles indolinones substituees a effet inhibiteur sur differentes kinases et differents complexes cycline/cdk |
Publications (1)
Publication Number | Publication Date |
---|---|
SK4032001A3 true SK4032001A3 (en) | 2001-11-06 |
Family
ID=26049076
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SK403-2001A SK4032001A3 (en) | 1998-09-25 | 1999-09-22 | Novel substituted indolinones with an inhibitory effect on various kinases and cyclin/cdk complexes |
Country Status (28)
Country | Link |
---|---|
US (1) | US6855710B2 (fr) |
EP (1) | EP1115704B1 (fr) |
JP (1) | JP2002525356A (fr) |
KR (1) | KR20010085841A (fr) |
CN (1) | CN1319090A (fr) |
AT (1) | ATE243195T1 (fr) |
AU (1) | AU763361B2 (fr) |
BG (1) | BG105327A (fr) |
BR (1) | BR9914065A (fr) |
CA (1) | CA2342622A1 (fr) |
DE (1) | DE59906030D1 (fr) |
DK (1) | DK1115704T3 (fr) |
EA (1) | EA200100320A1 (fr) |
EE (1) | EE200100184A (fr) |
ES (1) | ES2196860T3 (fr) |
HR (1) | HRP20010216A2 (fr) |
HU (1) | HUP0104973A3 (fr) |
ID (1) | ID27757A (fr) |
IL (1) | IL141622A0 (fr) |
NO (1) | NO20011477D0 (fr) |
NZ (1) | NZ510845A (fr) |
PL (1) | PL346898A1 (fr) |
PT (1) | PT1115704E (fr) |
SI (1) | SI1115704T1 (fr) |
SK (1) | SK4032001A3 (fr) |
TR (1) | TR200100854T2 (fr) |
WO (1) | WO2000018734A1 (fr) |
YU (1) | YU21301A (fr) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9904933D0 (en) * | 1999-03-04 | 1999-04-28 | Glaxo Group Ltd | Compounds |
WO2003027102A1 (fr) * | 2001-09-27 | 2003-04-03 | Allergan, Inc. | L'utilisation de 3-(arylamino)methylene-1, 3-dihydro-2h-indol-2-ones en tant qu'inhibiteurs de kinases |
US20030187026A1 (en) | 2001-12-13 | 2003-10-02 | Qun Li | Kinase inhibitors |
US6797825B2 (en) | 2001-12-13 | 2004-09-28 | Abbott Laboratories | Protein kinase inhibitors |
EA008830B1 (ru) | 2002-03-26 | 2007-08-31 | Бёрингер Ингельхайм Фармасьютиклз, Инк. | Миметики глюкокортикоидов, способы их получения, фармацевтические композиции и их применение |
US7169936B2 (en) | 2002-07-23 | 2007-01-30 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Indolinone derivatives substituted in the 6-position, their preparation and their use as medicaments |
US7514468B2 (en) | 2002-07-23 | 2009-04-07 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Indolinone derivatives substituted in the 6 position, the preparation thereof and their use as pharmaceutical compositions |
DE10233366A1 (de) * | 2002-07-23 | 2004-02-12 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | In 6-Stellung substituierte Indolinonderivate, ihre Herstellung und ihre Verwendung als Arzneimittel |
PE20040701A1 (es) * | 2002-07-23 | 2004-11-30 | Boehringer Ingelheim Pharma | Derivados de indolinona sustituidos en posicion 6 y su preparacion como medicamentos |
DE10237423A1 (de) * | 2002-08-16 | 2004-02-19 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Verwendung von LCK-Inhibitoren für die Behandlung von immunologischen Erkrankungen |
US20040204458A1 (en) | 2002-08-16 | 2004-10-14 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Use of Lck inhibitors for treatment of immunologic diseases |
BR0313923A (pt) * | 2002-08-29 | 2005-07-12 | Boehringer Ingelheim Pharma | Derivados de 3-(sulfonamidoetil)-indol para uso como miméticos de glicocorticóide no tratamento de doenças inflamatórias, alérgicas e proliferativas |
US7148249B2 (en) * | 2002-09-12 | 2006-12-12 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Indolinones substituted by heterocycles, the preparation thereof and their use as medicaments |
JP4879492B2 (ja) * | 2002-11-27 | 2012-02-22 | アラーガン、インコーポレイテッド | 疾患の治療のためのキナーゼ阻害剤 |
US20050043233A1 (en) | 2003-04-29 | 2005-02-24 | Boehringer Ingelheim International Gmbh | Combinations for the treatment of diseases involving cell proliferation, migration or apoptosis of myeloma cells or angiogenesis |
UY28526A1 (es) | 2003-09-24 | 2005-04-29 | Boehringer Ingelheim Pharma | Miméticos de glucocorticoides, métodos de preparación composiciones farmacéuticas y usos de los mismos |
ATE414701T1 (de) * | 2003-10-03 | 2008-12-15 | Boehringer Ingelheim Pharma | Fluoreszenzsonden zur verwendung bei einem bindungsassay auf proteinkinaseinhibitoren |
JP4861976B2 (ja) | 2004-03-11 | 2012-01-25 | アクテリオン ファーマシューティカルズ リミテッド | インドール−1−イル酢酸誘導体 |
US7795272B2 (en) | 2004-03-13 | 2010-09-14 | Boehringer Ingelheim Pharmaceutical, Inc. | Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof |
PE20061155A1 (es) * | 2004-12-24 | 2006-12-16 | Boehringer Ingelheim Int | Derivados de indolinona como agentes para el tratamiento o la prevencion de enfermedades fibroticas |
PE20060777A1 (es) | 2004-12-24 | 2006-10-06 | Boehringer Ingelheim Int | Derivados de indolinona para el tratamiento o la prevencion de enfermedades fibroticas |
PE20060776A1 (es) | 2004-12-27 | 2006-09-26 | Boehringer Ingelheim Pharma | Mimeticos de glucocorticoides, metodos para prepararlos y composiciones farmaceuticas |
WO2006114371A1 (fr) | 2005-04-28 | 2006-11-02 | Boehringer Ingelheim International Gmbh | Nouveaux composes destines au traitement de maladies inflammatoires |
CN101547909A (zh) | 2006-12-06 | 2009-09-30 | 贝林格尔.英格海姆国际有限公司 | 糖皮质激素模拟物、其制备方法、药物组合物及其用途 |
US20100086544A1 (en) * | 2006-12-11 | 2010-04-08 | Mass Robert D | Compositions and methods for treating a neoplasm |
CN101273991B (zh) * | 2007-03-28 | 2010-05-26 | 广东同德药业有限公司 | 四氢吲哚酮/四氢吲唑酮/四氢咔唑衍生物及其盐在制备抗病毒药物中的应用 |
PE20091445A1 (es) | 2007-12-03 | 2009-10-19 | Boehringer Ingelheim Int | Derivados de indolinona y procedimiento para su fabricacion |
EP2229359B1 (fr) * | 2007-12-03 | 2017-11-29 | Boehringer Ingelheim International GmbH | Procédé de fabrication d'un dérivé d'indolinone |
ES2394239T3 (es) * | 2008-01-25 | 2013-01-23 | Boehringer Ingelheim International Gmbh | Formas salinas de un derivado de 6-fluoro-1,2-dihidro-2-oxo-3H-indol-3-ilideno, procedimiento para su preparación y composiciones farmacéuticas que las contienen |
JP2011524867A (ja) | 2008-06-06 | 2011-09-08 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 糖質コルチコイド模倣物質、その製造方法、医薬組成物、及びその使用 |
CA2731919A1 (fr) | 2008-07-29 | 2010-02-04 | Boehringer Ingelheim International Gmbh | Nouveaux composes |
JPWO2013137371A1 (ja) * | 2012-03-15 | 2015-08-03 | 興和株式会社 | 新規ピリミジン化合物及びそれらを含有する医薬 |
CN103664737A (zh) * | 2012-09-25 | 2014-03-26 | 杨子娇 | 一类治疗房角狭窄的化合物及其用途 |
EP3749697A4 (fr) | 2018-02-05 | 2021-11-03 | Bio-Rad Laboratories, Inc. | Résine de chromatographie ayant un ligand mode mixte échange anionique/hydrophobe |
CN114957084B (zh) * | 2022-01-21 | 2023-05-09 | 九江学院 | 一种吲哚酮类化合物及其制备方法和应用 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9501567D0 (en) * | 1995-01-26 | 1995-03-15 | Pharmacia Spa | Hydrosoluble 3-arylidene-2-oxindole derivatives as tyrosine kinase inhibitors |
US5880141A (en) * | 1995-06-07 | 1999-03-09 | Sugen, Inc. | Benzylidene-Z-indoline compounds for the treatment of disease |
-
1999
- 1999-09-22 AU AU60863/99A patent/AU763361B2/en not_active Ceased
- 1999-09-22 PL PL99346898A patent/PL346898A1/xx not_active Application Discontinuation
- 1999-09-22 EP EP99947404A patent/EP1115704B1/fr not_active Expired - Lifetime
- 1999-09-22 HU HU0104973A patent/HUP0104973A3/hu unknown
- 1999-09-22 CA CA002342622A patent/CA2342622A1/fr not_active Abandoned
- 1999-09-22 PT PT99947404T patent/PT1115704E/pt unknown
- 1999-09-22 WO PCT/EP1999/007040 patent/WO2000018734A1/fr not_active Application Discontinuation
- 1999-09-22 BR BR9914065-9A patent/BR9914065A/pt unknown
- 1999-09-22 NZ NZ510845A patent/NZ510845A/en unknown
- 1999-09-22 CN CN99811297A patent/CN1319090A/zh active Pending
- 1999-09-22 EA EA200100320A patent/EA200100320A1/ru unknown
- 1999-09-22 DK DK99947404T patent/DK1115704T3/da active
- 1999-09-22 SK SK403-2001A patent/SK4032001A3/sk unknown
- 1999-09-22 IL IL14162299A patent/IL141622A0/xx unknown
- 1999-09-22 TR TR2001/00854T patent/TR200100854T2/xx unknown
- 1999-09-22 DE DE59906030T patent/DE59906030D1/de not_active Expired - Fee Related
- 1999-09-22 ES ES99947404T patent/ES2196860T3/es not_active Expired - Lifetime
- 1999-09-22 KR KR1020017003773A patent/KR20010085841A/ko not_active Application Discontinuation
- 1999-09-22 JP JP2000572194A patent/JP2002525356A/ja active Pending
- 1999-09-22 AT AT99947404T patent/ATE243195T1/de not_active IP Right Cessation
- 1999-09-22 ID IDW20010688A patent/ID27757A/id unknown
- 1999-09-22 YU YU21301A patent/YU21301A/sh unknown
- 1999-09-22 SI SI9930391T patent/SI1115704T1/xx unknown
- 1999-09-22 EE EEP200100184A patent/EE200100184A/xx unknown
-
2001
- 2001-03-09 BG BG105327A patent/BG105327A/xx active Pending
- 2001-03-21 HR HR20010216A patent/HRP20010216A2/hr not_active Application Discontinuation
- 2001-03-22 NO NO20011477A patent/NO20011477D0/no not_active Application Discontinuation
-
2003
- 2003-09-19 US US10/666,643 patent/US6855710B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
NZ510845A (en) | 2003-10-31 |
EA200100320A1 (ru) | 2001-10-22 |
CA2342622A1 (fr) | 2000-04-06 |
PT1115704E (pt) | 2003-11-28 |
NO20011477L (no) | 2001-03-22 |
ID27757A (id) | 2001-04-26 |
DK1115704T3 (da) | 2003-09-29 |
HUP0104973A3 (en) | 2002-06-28 |
HUP0104973A2 (hu) | 2002-04-29 |
EE200100184A (et) | 2002-08-15 |
JP2002525356A (ja) | 2002-08-13 |
BR9914065A (pt) | 2001-06-19 |
YU21301A (sh) | 2003-04-30 |
KR20010085841A (ko) | 2001-09-07 |
AU6086399A (en) | 2000-04-17 |
WO2000018734A1 (fr) | 2000-04-06 |
PL346898A1 (en) | 2002-03-11 |
ATE243195T1 (de) | 2003-07-15 |
US6855710B2 (en) | 2005-02-15 |
SI1115704T1 (en) | 2003-12-31 |
AU763361B2 (en) | 2003-07-17 |
EP1115704A1 (fr) | 2001-07-18 |
TR200100854T2 (tr) | 2001-12-21 |
DE59906030D1 (de) | 2003-07-24 |
IL141622A0 (en) | 2002-03-10 |
EP1115704B1 (fr) | 2003-06-18 |
NO20011477D0 (no) | 2001-03-22 |
US20040058978A1 (en) | 2004-03-25 |
HRP20010216A2 (en) | 2002-04-30 |
ES2196860T3 (es) | 2003-12-16 |
BG105327A (en) | 2001-12-29 |
CN1319090A (zh) | 2001-10-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SK4032001A3 (en) | Novel substituted indolinones with an inhibitory effect on various kinases and cyclin/cdk complexes | |
EP1212318B1 (fr) | Indolinones substituees utilisees comme inhibiteurs de la tyrosine kinase | |
JP4015365B2 (ja) | 新規な置換インドリノン、それらの調製及び医薬組成物としてのそれらの使用 | |
US7173028B2 (en) | Pyrimidine derivatives | |
CA2387013C (fr) | Indolinones substituees en position 6, leur preparation et leur utilisation en tant que compositions pharmaceutiques | |
US6762180B1 (en) | Substituted indolines which inhibit receptor tyrosine kinases | |
AU764782B2 (en) | Substituted indolinones, the production thereof and their use as medicaments | |
US6638965B2 (en) | Substituted indolinones, preparation thereof and their use as pharmaceutical compositions | |
US6169106B1 (en) | Indolinones having kinase inhibitory activity | |
DE19844003A1 (de) | Neue substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel | |
US6319918B1 (en) | Substituted indolinones with kinase inhibitory activity | |
DE19937496A1 (de) | Neue substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel | |
CZ20011080A3 (cs) | Nové substituované indolinony s inhibičním účinkem na různé kinázy a komplexy cyklin/CKD | |
DE10042696A1 (de) | In 6-Stellung substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel | |
DE10029285A1 (de) | Neue substituierte Indolinone,ihre Herstellung und ihre Verwendung als Arzneimittel | |
MXPA01002855A (en) | Novel substituted indolinones with an inhibitory effect on various kinases and cyclin/cdk complexes | |
DE19949208A1 (de) | In 6-Stellung substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel |